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Abstract 
Burkholderia pseudomallei is a soil-dwelling bacterium and the cause of melioidosis. 
Currently knowledge of the distribution of environmental B. pseudomallei and of the factors 
determining it is limited. In Thailand B. thailandensis, a closely related species to B. 
pseudomallei, is common, though the implications for B. pseudomallei distribution is 
unknown. Due to the difficulties in diagnosis of melioidosis and lack of resources, the 
distribution and burden of human melioidosis is likely under-reported. Melioidosis is a 
notifiable disease in Thailand. It has been estimated that more than 2,000 deaths are caused 
by melioidosis in Thailand, but only around 10 melioidosis deaths were officially reported to 
the notifiable diseases surveillance system (Report 506) each year.  
This thesis describes two large epidemiological studies: an environmental survey; and a 
cross-sectional retrospective, multicenter surveillance study using data from hospital 
databases nationwide. The environmental survey examined the distribution of environmental 
B. pseudomallei and B. thailandensis, ecological factors, and the seropositivity of farmers 
working in the fields. The retrospective surveillance study determined the incidence and 
mortality of human melioidosis diagnosed in large public hospitals throughout Thailand. 
I found that B. pseudomallei is widely distributed in East and Northeast Thailand, and 
unevenly distributed in Central Thailand. B. pseudomallei thrives in rice fields that are 
nutrient depleted. Presence of B. pseudomallei and B. thailandensis in the same field is not 
uncommon. In addition, B. thailandensis expressing B. pseudomallei-like capsular 
polysaccharide (BTCV) was isolated from soil for the first time in Thailand. Background 
seropositivity against B. pseudomallei of healthy rice farmers in Thailand is associated with 
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presence of B. pseudomallei in rice fields rather than B. thailandensis or BTCV. Finally, 
melioidosis is endemic and is an important cause of death in Thailand, but is rarely officially 
reported to the Thai Ministry of Public Health. Data from the national notifiable disease-
surveillance system in resource-limited settings should be verified by integrating information 
from readily available databases. 
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 Chapter 1—1 
Chapter 1: Introduction and scope of the thesis 
1.1 A brief history of melioidosis 
Over a hundred years ago, in 1912, the pathologist Alfred Whitmore and his assistant C. 
S. Krishnaswami described “a strange infective diseases somewhat resembling glanders”, 
which took 38 lives in Rangoon, Burma (now Myanmar) (Whitemore and Krishnaswami, 
1912). A new pathogenic organism was identified during their post-mortem investigations. 
The morphology of organism was very similar to Bacillus mallei (now Burkholderia mallei), 
which is the causative organism of glanders. However, the organism was different by its 
relatively rapid growth, its motility and the lack of Strauss reaction when injected into guinea 
pigs. The organism was named “Bacillus pseudomallei” (Whitemore and Krishnaswami, 
1912). In 1913, Fletcher observed a similar infectious disease among his laboratory animals 
in Kuala Lumpur, Malaysia (Rush and Thomas, 2012c). In 1921, Stanton and Fletcher 
published a paper and called this strange infectious disease; “Melioidosis, a new disease of 
the tropics” (Stanton and Fletcher, 1921). Nonetheless, in the twenties, the epidemiology of 
melioidosis was relatively unknown.  
In 1955, Chambon suggested that soil contaminated with Bacillus pseudomallei could 
be the source of infection. In 1966, Bacillus pseudomallei was classified to the genus 
Pseudomonas due to its ability to oxidize carbohydrates. The organism was then called 
“Pseudomonas pseudomallei” (Stanier et al., 1966). In the late sixties, P. pseudomallei was 
frequently isolated from environmental soil and water (Ellison et al., 1969, Strauss et al., 
1969). This suggested that the natural habitat of P. pseudomallei is soil and surface water. 
During the Vietnam War, inhalation of P. pseudomallei contaminated dust was suspected to 
be a route of infection among American helicopter crewmen (Howe et al., 1971). This 
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expanded our understanding that humans may acquire melioidosis following bacterial 
inoculation, ingestion or inhalation.  
In 1992, using DNA and RNA information, P. pseudomallei was reclassified to the 
genus Burkholderia by Yabuuchi et al (Yabuuchi et al., 1992). Since then, the causative 
bacterium of melioidosis has been called Burkholderia pseudomallei.  
1.2 Microbiology of B. pseudomallei and others related species  
B. pseudomallei is a Gram-negative, motile, non-sporing forming, and facultative 
anaerobic bacillus (Rush and Thomas, 2012b). It is an environmental saprophyte, which is 
free-living in the soil and water in tropical regions. The organism can cause an infectious 
disease called melioidosis in both humans and animals. The bacterium is also known for its 
remarkable ability to survive under harsh environment, including in an environment without 
nutrients (Wuthiekanun et al., 1995b, Moore et al., 2008).  
1.2.1 Colony morphology 
B. pseudomallei can grow on common culture media (e.g. sheep blood agar and 
MacConkey agar), and in mixed culture it may grow slower but can be distinguished from 
other organisms by use of selective agars (e.g. Ashdown agar and commercial Burkholderia 
cepacia medium). Its colonies may have different morphologies on different types of agar, 
and these may change over the period of incubation. After 48 hours of incubation, colony 
appearances could be creamy-white to grey, colorless of non-lactose fermenter, and pink 
color on sheep blood agar, MacConkey agar, and Ashdown agar, respectively (Figure 1-1). 
After 4 days of incubation, colonies glisten with a metallic sheen (on sheep blood agar), 
become pale pink and may have a sheen (on MacConkey agar), and change from pink to 
purple with a metallic sheen (on Ashdown agar). The most characteristic feature of B. 
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pseudomallei is its metallic sheen, and the usual progression to dry and wrinkled colonies. 
(Figure 1-1).  
Ashdown agar is the most commonly used selective medium, and on it clinical isolates 
of B. pseudomallei can have one of seven types of colony morphology (categorized as Type 
I to Type VII). Type I is the classical colony morphology, pale purple with a wrinkled outer 
edge (Chantratita et al., 2007a) (Figure 1-2). Environmental isolates of B. pseudomallei are 
reported to have common colony morphologies similar to those of the clinical isolates 
(Smith et al., 1997). However, B. pseudomallei colonies are indistinguishable from a 
closely-related nonpathogenic species, Burkholderia thailandensis (Smith et al., 1997). 
Therefore, definite identification of B. pseudomallei requires additional tests including 
biochemical tests, the latex agglutination test and antimicrobial susceptibility testing 
(described in following diagnostics section 1.3.4). 
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Figure 1-1 Colony morphologies of B. pseudomallei after incubation for 2 days and 4 
days on (a) sheep blood agar, (b) MacConkey agar, and (c) Ashdown agar described 
previously by Wiersinga et al (Wiersinga et al., 2018). 
a. Sheep blood agar 
 
b. MacConkey agar 
 
c. Ashdown agar 
 
 
Figure 1-2 Seven types of colony morphology of B. pseudomallei on Ashdown agar 
described previously by Chantratita et al 2007 (Chantratita et al., 2007a)
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1.2.2 Other related species in the Burkholderia genus 
B. pseudomallei belongs to the Burkholderia genus, which contains over 40 species. 
Other notable species include the pathogenic species B. mallei and B. cepacia, and the non-
pathogenic species B. ubonensis and B. thailandensis. 
1.2.2.1 B. mallei 
B. mallei is the causative organism of glanders. Glanders is an infectious disease that 
occurs primarily in horses, mules and donkeys. Glanders is a communicable disease, which 
can be transmitted from an infected animal to other animals and to human. The transmission 
routes include an exposure to the discharges of infected animals, inhalation of contaminated 
aerosols (respiratory inoculation), and consumption of infected animal meat. Clinical 
manifestations of glanders in infected animals include necrotic ulcers and nodules in nasal 
passages, enlarged mediastinal lymph nodes, and pneumonia with nodular abscesses. 
Human infection presents in a similar way to equine infection, with manifestations including 
pneumonia, pleural nodules, regional lymphadenopathy and abscesses in the liver and 
spleen. However, both animal and human glanders is now rare due to better prevention and 
control, and implementation of multi-national glanders eradication programmes. Sporadic 
animal glanders are still reported in the Middle East (Scholz et al., 2014), Asia (Saqib et al., 
2012), and South America (Mota et al., 2010). 
A genetic study concluded that B. mallei  evolved from B. pseudomallei by gene 
reduction (Godoy et al., 2003, Nierman et al., 2004). Unlike B. pseudomallei, B. mallei is 
an obligate pathogen which does not exist in the environment. 
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1.2.2.2 B. cepacia 
B. cepacia is another pathogenic species which causes opportunistic infections, most 
notably in patients with cystic fibrosis. B. cepacia is also an emerging cause of hospital 
acquired infection. The bacterium can be found in the natural environment such as soil and 
water (LiPuma et al., 2002, Dalmastri et al., 1999, Ibrahim et al., 2012, Butler et al., 1995). 
In the 1990s, B. cepacia was developed to be a bio-pesticide protecting crops against fungal 
diseases (Holmes et al., 1998). Later, the organism became widely acknowledged as an 
opportunistic pathogen causing infections in cystic fibrosis patients (Holmes et al., 1998, 
Tanser et al., 2000, Cipolla et al., 2017). The route of infection include exposure to the 
organism via person-to-person contact, and contact with contaminated surfaces and 
environment (Humphreys et al., 1994).  
1.2.2.3 B. ubonensis 
B. ubonensis is a non-pathogenic saprophyte which can be isolated from soil and water 
(Yabuuchi et al., 2000, Price et al., 2017). A recent report demonstrated that B. ubonensis 
is avirulent in a mouse model (Price et al., 2017).  
1.2.2.4 B. thailandensis 
B. thailandensis is found in soil and water, and was first recognized by Wuthiekanun et 
al. in 1996 (Wuthiekanun et al., 1996). The organism is genetically closely related to B. 
pseudomallei; however, it is non-pathogenic (Wuthiekanun et al., 1996, Trakulsomboon et 
al., 1997, Sermswan et al., 2015). The colony morphologies of B. thailandensis and B. 
pseudomallei are very similar. B. thailandensis can be differentiated from B. pseudomallei 
by its ability to assimilate L-arabinose (Smith et al., 1997, Brett et al., 1998). The genomic 
study shows that an arabinose assimilation operon (BTH_II1626–1633) on Chromosome 2 
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is present in B. thailandensis but absent in B. pseudomallei (Yu et al., 2006). In addition, B. 
thailandensis has polysaccharide-related genes that are distinct from B. pseudomallei 
(74.8% and 72.8% nucleotide and protein similarity, respectively) and usually lacks the 
virulence-associated capsular polysaccharide (also referred to as CPS or CPS-I) of B. 
pseudomallei (Reckseidler et al., 2001, Smith et al., 1993, Wuthiekanun et al., 2002, Sim et 
al., 2010). B. thailandensis also lacks a gene cluster BPSL2790-2810, which is considered 
a major determinant of virulence in B. pseudomallei. The gene cluster BSP2790-2810 is 
involved in the synthesis and export of the capsular polysaccharide (Reckseidler et al., 
2001).  
A variant of B. thailandensis that contains genes encoding a B. pseudomallei-like 
capsular polysaccharide cluster (BTCV) was isolated from soil in Cambodia (strain E555; 
ST696) (Sim et al., 2010). This organism exhibits several B. pseudomallei-like phenotypes 
including colony wrinkling, resistance to human complement binding, and intracellular 
macrophage survival. In a mouse model, E555 is avirulent (Sim et al., 2010), induces higher 
levels of IgG and gives better protection against melioidosis than non-capsulated B. 
thailandensis (Scott et al., 2013). The capsular polysaccharide (CPS) biosynthesis gene 
cluster of E555 and that of B. pseudomallei are highly similar (94.4% and 96% nucleotide 
and protein similarity, respectively) (Sim et al., 2010), and nuclear magnetic resonance 
spectroscopy has shown that the structures of CPS produced by E555 and that of B. 
pseudomallei are identical (Bayliss et al., 2017). In addition, this variant of B. thailandensis 
(BTCV) has been isolated from human blood in the USA (strain CDC3015869; ST101, USA 
(Glass et al., 2006)) and from environmental samples in Gabon (strain D50; ST1126 
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(Wiersinga et al., 2015)) and Laos (strain ST_10; ST696 (Knappik et al., 2015)). BTCV has 
not been reported in Thailand, and its full distribution is unknown.  
The geographical distribution of B. thailandensis is uncertain but the organism has rarely 
been isolated from fields that are culture positive for B. pseudomallei (Vuddhakul et al., 
1999, Trakulsomboon et al., 1999). It was recently shown that B. pseudomallei can inhibit 
the growth and motility of B. thailandensis in the laboratory (Ngamdee et al., 2015). 
However, previous environmental studies did not systematically evaluate the presence of 
both organisms, so the presence of B. thailandensis and co-localization of both organisms 
may have been underestimated (Vuddhakul et al., 1999, Trakulsomboon et al., 1999). In an 
experimental mouse model, lipopolysaccharide extracted from B. thailandensis induced 
measurable IgG and IgM, and provided partial protection against melioidosis (Ngugi et al., 
2010). The association between exposure to environmental B. thailandensis and 
seropositivity to B. pseudomallei as measured by the indirect hemagglutination assay (IHA) 
in humans is still largely unknown. 
1.2.3 Virulence determinants in B. pseudomallei 
Multiple factors are associated with the virulence of B. pseudomallei. Humans may 
acquire B. pseudomallei via percutaneous inoculation, inhalation, aspiration or ingestion. B. 
pseudomallei infection may start from attaching to and passing into human epithelial cells 
(i.e. mucosal surface or broken skin), and then replicating inside those cells (Lazar Adler et 
al., 2009). Bacterial surface components including flagella, capsular polysaccharide and 
type IV pili (hair-like structures on the bacterial surface) facilitate the close contact and 
attachment to epithelial cells (Ahmed et al., 1999). B. pseudomallei can also replicate and 
survive within many eukaryotic cell lines, including professional phagocytes such as 
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neutrophils and macrophages. Important bacterial virulence factors of B. pseudomallei 
include the type III secretion system, capsular polysaccharide, lipopolysaccharide and 
quorum sensing. 
1.2.3.1 Type III secretion system (TTSS)  
B. pseudomallei contains three Type III secretion system gene clusters, TTSS-1, TTSS-
2 and TTSS-3 (Holden et al., 2004), that play an important role in virulence. A gene cluster 
in B. pseudomallei called bsa (Burkholderia secretion apparatus)-encoded TTSS is essential 
for invading cells, escaping from endocytic vacuoles, replicating inside host cells (Stevens 
et al., 2002, Stevens et al., 2003, Stevens et al., 2004), forming multinucleated giant cells, 
and inducing apoptosis of infected host cell (Suparak et al., 2005). Specifically, TTSS-3 is 
required for full virulence in a hamster infection model (Warawa and Woods, 2005). TTSS-
3 encodes a secretion apparatus that injects bacterial effector proteins into the host-cell 
cytoplasm and enhance cell invasion (Cornelis and Van Gijsegem, 2000).  
A genetic study comparing between B. pseudomallei, B. mallei and B. thailandensis 
shows that the TTSS1 cluster in B. pseudomallei is not present in either B. mallei or B. 
thailandensis (Kim et al., 2005) (Figure 1-3 panel C). Thus, TTSS1 is used as a target for 
the molecular identification of B. pseudomallei (Novak et al., 2006).  
1.2.3.2 Capsular polysaccharide (CPS) 
CPS has been shown to be a virulence factor in other organisms through a number of 
mechanisms such as adherence for colonization, resistance to complement mediated 
phagocytosis and killing, and resistance to specific host immunity. B. pseudomallei possess 
CPS with structure -3)-2-O-acetyl-6-de-oxy-b-D-manno-heptopyranose-, which has been 
previously characterized as type I O-polysacharide (OPS) (Perry et al., 1995, Reckseidler et 
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al., 2001). A study using a Syrian hamster model shows that this CPS is required for B. 
pseudomallei infection (Reckseidler et al., 2001). A subsequent experiment using the serum 
bactericidal assay shows that the CPS contributes to resistance to complement mediated 
phagocytosis (Reckseidler-Zenteno et al., 2005). CPS may be involved in epithelial 
adherence because it mediates attachment of bacteria to pharyngeal epithelial cells (Ahmed 
et al., 1999).  
CPS gene clusters are present in B. pseudomallei and B. mallei but not in B. thailandensis 
(Sim et al., 2010, Kim et al., 2005). A genomic study showed that this CPS gene cluster is 
also present in environmental B. thailandensis strain E555; B. thailandensis expressing B. 
pseudomallei-like CPS variant (BTCV). However, BTCV is not virulent in a mouse model 
(Sim et al., 2010). 
1.2.3.3 Lipopolysaccharide (LPS)  
LPS extends from the outer membrane of Gram-negative bacterium, and plays important 
roles in providing a strong barrier against toxic compounds such as antibiotics, and 
enhancing survival in harsh environments. The Lipid A component may assist B. 
pseudomallei to avoid recognition by the host immune system (such as through Toll-like 
receptors) and enhances its survival in host cells (DeShazer et al., 1998, Burtnick and 
Woods, 1999, Arjcharoen et al., 2007, Wiersinga et al., 2007). 
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Figure 1-3 Comparison of the Type III secretion Systems (TTSSs) and the 
surrounding regions in B. pseudomallei (B. ps), B. mallei (B. ma), and B. thailandensis 
(B. th) by Kim et al 2005 (Kim et al., 2005) 
The orthologous genes in the three species are denoted with connecting lines.(A) Comparison of TTSS-3 
locus among the three species. The % amino acid identity was determined using TBLASTN from B. ps 
proteins, and is color coded accordingly. (B) Comparison of TTSS-2 and its vicinity. Large deletions in the 
genes coding for non ribosomal peptide syn-thases (NRPSs) in B. ma and B. th are shown. Two frame shift 
mutations in the two genes in the TTSS-2 of B. ma also are shown. (C) Comparison of the regions around 
TTSS-1. The fragment containing TTSS-1 and the surrounding genes that are only present in B. ps, and the 
replacement fragments of this in B. th and B. ma are shown. 
 
1.2.3.4 Quorum sensing (QS)  
QS is an intercellular (cell-to-cell) communication system in Gram-negative bacteria. 
QS produces and detects diffusible signalling molecules – acylated homoserine lactones 
(AHLs) – which leads to changes in gene expression (Lazdunski et al., 2004, Ulrich et al., 
2004). In a Syrian hamster model, B. pseudomallei with luxl mutations (especially bpmI1, 
bpmI3) showed increased time to death and reduced lung colonization in an aerosolized 
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BALB/c mice model, indicating that QS networks is essential for B. pseudomallei 
pathogenicity (Ulrich et al., 2004).  
1.3 Epidemiology of human melioidosis 
Melioidosis is a serious community-acquired infectious disease caused by B. 
pseudomallei. The distribution of human melioidosis, risk factors for infection, clinical 
manifestations, diagnosis and identification of B. pseudomallei, and treatment are 
described in this section. 
1.3.1 Worldwide distribution of human melioidosis 
Northeast Thailand and the most northern regions of Australia are known as highly 
endemic areas for melioidosis, with annual incidence rates of up to 50 cases per 100,000 
people (Limmathurotsakul et al., 2010b, Currie et al., 2010). A number of countries in East 
and South Asia are also endemic areas for the disease, including China (including Southern 
China, Taiwan and Hong Kong), Cambodia, Indonesia, Brunei, Malaysia, Lao PDR, 
Myanmar, Vietnam, Philippines, and Singapore. In recent years, there has been an increase 
in the reporting of melioidosis cases from South Asian countries (Bangladesh, India, Nepal, 
Pakistan, Bhutan, Maldives and Sri Lanka), and African countries (Burkina Faso, Gabon, 
Gambia, Kenya, Madagascar, Mauritius, Malawi, Nigeria,  and Uganda) (Figure 1-4). 
Sporadic cases of melioidosis have been reported from Western Asia, the Middle East, 
and the Americas. The reporting countries in Western Asia and the Middle East are Turkey 
and Iran. Countries or islands in the Americas reporting melioidosis cases include Costa 
Rica, Peru, Brazil, Colombia, Dominican Republic, Ecuador, Guatemala, Honduras, 
Mexico, Panama, Puerto Rico, Aruba, Martinique, British Virgin Islands, and Venezuela 
(Figure 1-4). The majority of human cases in Central and South Americas are speculated to 
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be indigenous melioidosis, because environmental B. pseudomallei is also found in the 
region (Benoit et al., 2015a).  
Melioidosis is not indigenous in European countries, Canada and the United States of 
America (USA). Melioidosis cases reported in those countries were returned-travelers who 
acquired the infection from endemic regions, and their clinical symptoms appeared after 
their return home (Dan, 2015, Benoit et al., 2015a). There have been several cases reported 
from Canada and the USA of laboratory acquired melioidosis (Green and Tuffnell, 1968, 
Schlech et al., 1981, Benoit et al., 2015b). 
Figure 1-4 Published distribution of human melioidosis (www.melioidosis.info) 
 
Despite the recent increase in publications of melioidosis cases, the global distribution 
of melioidosis is still largely unclear. A recent modelling study predicted 165,000 (95% 
credible interval 68,000 – 412,000) human melioidosis cases per year worldwide, with a 
predicted 89,000 (36,000-227,000) deaths (Limmathurotsakul et al., 2016). Modelling 
environmental factors, the same study also predicted that the highest incidence of 
melioidosis would occur in South Asia, followed by East Asia and the Pacific, Sub-Saharan 
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Africa, Latin America and Caribean, and Middle East and North Africa (Limmathurotsakul 
et al., 2016). The study predicted that melioidosis is not present in Europe, Central Asia, and 
North America because their environment is not suitable for B. pseudomallei 
(Limmathurotsakul et al., 2016). 
1.3.2 Risk factors  
The most important risk factor for melioidosis is diabetes mellitus, which is present in 
half of culture-confirmed melioidosis patients (White, 2003, Limmathurotsakul and 
Peacock, 2011). Having diabetes mellitus increases the odds of having B. pseudomallei 
infection about 10 times more than control groups of non-infected controls and patients with 
bacteraemia caused by other organisms (Suputtamongkol et al., 1999). Other clinical risk 
factors for melioidosis include chronic kidney disease, chronic lung disease, rheumatic heart 
disease/congestive heart failure, malignancy, immunosuppressive therapy (including steroid 
use) and other immunosuppression – but not HIV (Limmathurotsakul et al., 2006a, Currie 
et al., 2010). These risk factors may represent an impairment of the ability of neutrophils 
and other phagocytic cells to attenuate or kill the pathogenic organism once inside host cells 
(Easton et al., 2007). In addition to host risk factors, climatic factors (Kaestli et al., 2016), 
daily living activities including rice farming and exposure to soil and environmental water 
(Limmathurotsakul et al., 2013b), and occupational activities, such as accidental laboratory 
exposure, are also associated with an increased risk of acquiring the infection. A rise in the 
dew point, cloud cover, rainfall, maximum temperature and groundwater could contribute 
to the risk of infection (Kaestli et al., 2016).  
Despite melioidosis being prominent in people age from 40 to 60 years, this infectious 
disease occurs at all ages. About 20% of all melioidosis cases in adults have no known 
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clinical risk factors (Currie et al., 2010, Currie et al., 2004, Limmathurotsakul et al., 2010b). 
Unlike melioidosis in adults, clinical risk factors are not commonly observed in pediatric 
cases (Turner et al., 2016, Edmond et al., 1998, Lumbiganon and Viengnondha, 1995). 
1.3.3 Clinical presentations 
Severity and outcome of melioidosis relate to acquired bacterial load, host risk factors 
and the putative variation in virulence of B. pseudomallei strains. An exposure which leads 
to acquisition of the pathogen could be via occupational or daily living activities 
(Limmathurotsakul et al., 2013b), though not all exposures to the pathogen lead to infection 
(Limmathurotsakul and Peacock, 2011). Little is known about the magnitude (e.g. frequency 
and durations) of exposure to environmental B. pseudomallei that could lead to infection in 
humans. An incubation period from exposure to clinical presentation is 1-21 days (Currie et 
al., 2000c), and depends on routes of infection. Routes of infection include cutaneous 
inoculation, inhalation, aspiration, or ingestion (White, 2003, Cheng and Currie, 2005, 
Limmathurotsakul and Peacock, 2011). An infection through inhalation is hypothesized to 
occur during extreme weather events (Currie et al., 2010).  
Patients with melioidosis can present with a wide range of clinical presentations, 
including an acute, chronic, latent and recurrent melioidosis. Acute and chronic infection 
are defined as duration of symptoms less than 2 weeks and more than 2 months prior to full 
clinical presentation, respectively (Currie et al., 2000a). About 80% of melioidosis patients 
presenting in endemic areas have an acute infection (Currie et al., 2000a, Currie et al., 2010). 
The proportion of patients with asymptomatic B. pseudomallei infection or latent 
melioidosis, in which the organism remains dormant in the host body for months or years, 
is unknown. Nonetheless, the proportion of patients presenting with an activation of latent 
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infection is not high. Recurrent melioidosis is defined as the development of signs and 
symptoms of melioidosis after a satisfactory initial treatment of the first infection (Sarovich 
et al., 2014). Recurrent melioidosis could be due to relapse of the original strain from the 
first infection or due to a re-infection of a new strain of B. pseudomallei. 
Clinical manifestations of melioidosis include bacteraemia (55%), pneumonia (51%), 
chronic lung diseases (26-36%), genitourinary (14%), skin infection (13%), no evident focus 
(12%), neurological (3%), and osteomyelitis/septic arthritis (4%) (Currie et al., 2010, 
Limmathurotsakul et al., 2006a, Meumann et al., 2012, Currie et al., 2004). Localized 
infections, such as skin and soft tissue infection (38%) and parotitis (30%), are common 
presentations among children with melioidosis in Southeast Asia (Lumbiganon et al., 2011). 
Systemic infections with bacteraemia and pneumonia together account for up to 39% of all 
pediatric cases (Lumbiganon and Viengnondha, 1995, Turner et al., 2016).  
There are a few differences in the clinical manifestations of melioidosis between 
Southeast Asia and Australia. First is that suppurative parotitis, which accounts for up to 
40% of paediatric meloiodosis in Thailand and Cambodia (Lumbiganon and Viengnondha, 
1995), is rare in Australia. Second, prostatic melioidosis and neurological melioidosis 
(especially brain stem encephalitis) present in 18% of male melioidosis patients, and 4% of 
all melioidosis patients in Australia (Currie et al., 2000b) but are less frequently observed in 
Thai patients. Figure 1-5 shows a summary of clinical manifestations of melioidosis by 
organ system.  
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Figure 1-5 Summary of clinical manifestation of melioidosis by Wiersinga et al 
(Wiersinga et al., 2018) 
 
The case fatality rate (CFR) of melioidosis is about 14% in Australia and about 40% in 
Thailand (Currie et al., 2010, Limmathurotsakul et al., 2006a, Chierakul et al., 2005a). The 
CFR of patients with known co-morbidities in Australia ranges from 15% to 26% (Currie 
et al., 2004). Overall, co-morbidities were not associated with mortality except for chronic 
renal disease which increases the risk of mortality with a relative risk of 2.05 (95% 
confident interval 1.15-3.65) (Currie et al., 2004). 
Patients who survive a primary episode of melioidosis may experience recurrent 
melioidosis in about 10%-17% of cases in Thailand (Chaowagul et al., 1993, 
Limmathurotsakul et al., 2008), 6% in Australia (Currie et al., 2010), 10% in India (Halim 
et al., 2017), and 2% in Lao PDR (Rachlin et al., 2016). B. pseudomallei is difficult to 
eradicated from the human body and this could lead to a relapse. The recurrent episode could 
be due to a relapse of the original infection or a new infection of a new strain of B. 
pseudomallei. Recurrence is classified as relapse when the isolates of the first and 
subsequent episodes of melioidosis are indistinguisable, as determined by genotyping 
(Limmathurotsakul et al., 2006b). Of all recurrent melioidosis, 65%-75% are dure to relapse 
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with the remaining proportion (25%-35%) associated with re-infection (new infections/ 
infected with different strains) (Limmathurotsakul et al., 2008, Sarovich et al., 2014). 
Clinical manifestations of recurrent melioidosis were similar to the primary episodes, 
including bacteraemia, pneumonia, liver and splenic abscesses, skin or soft tissue infection, 
and septic arthritis and osteomyelitis (Limmathurotsakul et al., 2006b). Bacteraemia and 
disseminated melioidosis occurrence during the primary infection is associated with an 
increased risk of relapse (Limmathurotsakul et al., 2006b, Currie et al., 2010).  
The duration from the primary episode to relapse episode ranges from 2 to 28 months, 
while duration to re-infection ranges from 9 to 169 months (Sarovich et al., 2014, Currie et 
al., 2010, Limmathurotsakul et al., 2008). The duration from the primary episode to relapse 
observed in Thailand is shorter than Australia (median 9.4 months versus 24 months, 
respectively) (Limmathurotsakul et al., 2008, Sarovich et al., 2014). Relapse of melioidosis 
is associated with insufficient duration of initial intensive therapy, the duration of 
eradication treatment, and low patient-compliance to the eradication therapy (Currie et al., 
2000a, Limmathurotsakul et al., 2006b, Sarovich et al., 2014, Chaowagul et al., 1993). In 
Thai patients, poor adherence to the eradication therapy is associated with increasing risk of 
re-presenting with clinical deterioration prior to completion of the 2 phases of therapy, and 
the relapse of melioidosis (Limmathurotsakul et al., 2006a, Wiersinga et al., 2018). In 
Darwin, Australia, lengthening intravenous parenteral therapy (ceftazidime and/or 
meropenem) to an average of 4-week was found to be effective, and the relapse rate declined 
from 6.4% to 1.2% from 1989 to 2012 (Sarovich et al., 2014). The CFR of patients with 
recurrent melioidosis is lower than that of the primary infection; 24% vs. 49% in Thailand, 
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respectively (Limmathurotsakul et al., 2006b) and 7% vs. 17.9% in Australia, respectively 
(Currie et al., 2010). 
1.3.4 Diagnosis and identification of B. pseudomallei in clinical specimens 
A laboratory diagnosis is necessary for the definite diagnosis of melioidosis, because 
clinical manifestations of melioidosis vary and can resemble a number of other infectious 
diseases. During the diagnostic process, melioidosis should be considered in febrile patients 
who are living in or have travelled from melioidosis endemic regions (Currie, 2015, White, 
1994).  
1.3.4.1 Bacterial culture 
The gold standard diagnostic test for melioidosis is bacterial culture. Melioidosis is 
diagnosed if B. pseudomallei can be isolated from any clinical specimens. It has 100% 
specificity, but its sensitivity is as low as 60%. Sensitivity of culture largely depends on the 
number of clinical specimens collected for culture, volumes of blood specimen collected for 
culture, culture media used, and the experience of laboratory personnel in identifying B. 
pseudomallei (Limmathurotsakul et al., 2010a). 
Blood culture should be taken on all suspected melioidosis patients because bacteraemia 
is a common clinical manifestation of melioidosis. Conventional culture methods and 
automated culture systems (e.g. BACTEC and BacT/ALERT) are widely used for blood 
culture (Hoffmaster et al., 2015, Teerawattanasook et al., 2014). Conventional culture is 
performed by incubating either home-made or commercial blood culture bottles, visually 
observing bottles regularly, and identifying bottles with cloudy broth. Then the cloudy broth 
is sub-cultured for bacterial identification. Automated culture system will automatically 
identify bottles with bacteria growth. For example, the BacT/Alert system (Organon 
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Teknika Corp., Durham, N.C.) uses colorimetric detection of CO2 produced by growing 
microorganisms in the blood culture bottle. 
Then, the isolated organism can be identified with either conventional methods or an 
automated bacterial identification method (e.g. Vitek2 and MALDI-TOF MS). The 
conventional method is largely based on Gram stain, colony morphology, oxidase test, 
biochemical tests, and antimicrobial susceptibility testing. Automated bacterial 
identification methods are based on either automated biochemical testing (e.g. Vitek2, 
Biomeriuex, USA) or matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry (i.e. MALDI-TOF MS). The accuracy of the identification made by automated 
systems is based on the strains database embedded in the system. Nonetheless, both 
conventional and automated identification methods share a major pitfall in that B. 
pseudomallei may be discarded as an environmental contaminant and no identification 
performed. In addition, misidentification of B. pseudomallei as Pseudomomas species or 
other Burkholderia species is also common with both conventional and automated 
identification methods, particularly if laboratory personnel are not aware of B. pseudomallei 
and a comprehensive database is not used, respectively (Podin et al., 2013).  
Several strategies can be employed to increase accuracy of B. pseudomallei detection 
and identification. First, clinicians should collect all available clinical specimens, including 
blood, urine, sputum, pus, skin lesion swabs, throat swab and rectal swab for bacterial 
culture. Second, for non-sterile specimens, laboratory personnel should use a selective 
medium such as Ashdown broth, Ashdown agar or commercial B. cepacia media. These 
selective medium contain a mixture of crystal violet, colistin or polymyxin B and gentamicin 
that facilitate growth of B. pseudomallei over other organisms (Hoffmaster et al., 2015, 
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Peacock et al., 2005, Wuthiekanun et al., 1990). Third, laboratory personnel should identify 
and perform antimicrobial susceptibility testing for all Gram-negative oxidase-positive 
bacilli grown from all clinical specimens, particularly blood culture. B. pseudomallei is 
generally resistant to aminoglycodises (e.g. gentamicin), colistin, and polymyxin but 
susceptible to amoxicillin/ clavulanic acid (Podin et al., 2014). Finally, it is recommended 
not to discard any non-Pseudomonas aeruginosa, Gram-negative and oxidase-positive 
bacillus isolated from clinical specimens until definite identification of non-B. pseudomallei 
is made (Hoffmaster et al., 2015, Currie, 2015).  
In addition, a few methods may be used in adjunct with conventional and automated 
bacterial identifications. These methods include a commercial API 20 NE kit (Dance et al., 
1989b), B. pseudomallei-specific latext agglutination (Anuntagool et al., 2000a), and real-
time polymerase chain reaction (PCR) targeting the B. pseudomallei type III secretion 
system (TSS1) gene cluster (Novak et al., 2006). 
1.3.4.2 Serological diagnostic tests 
Serological tests have limited utility in diagnosing melioidosis in endemic areas. The 
methods used to evaluate antibodies against B. pseudomallei antigens for diagnosis of 
melioidosis are the indirect hemagglutination assay (IHA) and enzyme-linked 
immunoabsorbent assays (ELISA).   
The IHA detects the level of antibodies (IgG and IgM) against crude B. pseudomallei 
antigens, and is widely used worldwide. However, the method lacks antigen standardization, 
and its accuracy is low. IHA has specificity of around 60% (Chantratita et al., 2007b, 
Suttisunhakul et al., 2015, Suttisunhakul et al., 2016) and sensitivity ranged from 41% to 
56% (Cheng et al., 2006). In areas endemic for melioidosis, the IHA should not be used for 
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diagnosing melioidosis. This is because populations in endemic regions have high 
background seropositivity due to the repeated exposure to B. pseudomallei in the 
environment (Harris et al., 2009, Cheng et al., 2006). Nevertheless, a laboratory study 
showed low levels of antibodies to B. pseudomallei in the serum of US donors (IHA titers 
ranged from <1:10 to 1:40), suggesting that IHA is useful for evaluation of exposure to B. 
pseudomallei (Suttisunhakul et al., 2016, Hoffmaster et al., 2015).  
An ELISA method measures antibodies to specific antigens or targeted proteins of B. 
pseudomallei, e.g. O-polysaccharide (OPS) and hemolysin co-regulated protein 1 (Hcp1), 
respecitevely, which show  potential diagnostic utility for melioidosis (Suttisunhakul et al., 
2016, Pumpuang et al., 2017). An O-antigen based ELISA detecting IgG provided a better 
diagnostic accuracy with a sensitivity of 72% and specificity of 98% when compared to a 
capsular polysaccharide based ELISA and the IHA (Suttisunhakul et al., 2016). A recent 
study showed that an ELISA using a combination of B. pseudomallei specific OPS and Hcp1 
(combined Hcp1/OPS-ELISA) performed better at detecting antibodies in the serum of 
melioidosis patients on admission day (Pumpuang et al., 2017). This could potentially be 
useful for diagnosing melioidosis; however, this test is still under the development and 
requires further evaluation. 
1.3.4.3 Rapid diagnostic tests 
Rapid diagnostic tests for melioidosis are crucial for improving the outcome of 
meliodosis. However, currently none of these rapid diagnostic and point-of-care tests for 
melioidosis are commercially available.  
A lateral flow immunoassay (LFI) has been developed to detect capsular polysaccharide 
(CPS) specific to B. pseudomallei. A laboratory study showed that 98.7% of 77 strains of B. 
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pseudomallei react with  the LFI assay, whereas 97.2% of near neighbor species were not 
reactive to the assay   (Houghton et al., 2014). Therefore, the LFI could be used as a 
supplementary test for bacterial identification (Houghton et al., 2014).  
An Active Melioidosis Detect™ lateral flow immunoassay (ADM LFI; InBios 
International, USA) has been evaluated with clinical specimens in Thailand, Lao PDR, India 
and Australia (Houghton et al., 2014). The test shows high specificity when compared with 
bacterial culture as the gold standard. Sensitivity of the test varies with type of specimen, 
ranging from 33% when tested with serum specimens (Wongsuvan et al., 2018), 33% when 
tested with sputum, 47% when tested with pus, 87% when tested with urine, and 99% when 
tested with turbid blood culture bottles (Woods et al., 2018). 
The immunofluorescence assay (IFA) is a rapid diagnostic test that can be used to 
identify B. pseudomallei in clinical specimens directly and can be used to identify colonies 
of B. pseudomallei from bacterial culture. This IFA is used in a specialized laboratory in 
Thailand. The IFA identifies B. pseudomallei by using a monoclonal antibody against CPS 
and fluorescent dyes. The organism can then be observed using a fluorescence microscope 
(Tandhavanant et al., 2013, Chantratita et al., 2013). IFA has high specificity and can give 
a rapid result within 15 minutes. Nonetheless, the diagnostic sensitivity of the IFA is lower 
than bacterial culture (Wuthiekanun et al., 2005). A recent study shows high utility in 
detection of B. pseudomallei in turbid blood culture bottles and sterile fluid with sensitivity 
(99% and 100%, respectively) and specificity (100% in both specimens) (Woods et al., 
2018). The IFA has lower utility in detection of the organism when tested with pus 
(sensitivity 66.7% and specificity 90.7%), and sputum (sensitivity 100% and specificity 
85%) (Woods et al., 2018). 
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A rapid immunochromatography test using hemolysin-coregulated protein as a target 
antigen (Hcp1-ICT) has been developed recently as a point-of-care test for the serological 
diagnosis of melioidosis (Phokrai et al., 2018). The Hcp1-ICT detects IgG antibody specific 
to Hcp1. The Hcp1-ICT was evaluated on human serum samples obtained from four groups 
of participants, including (1) culture confirmed melioidosis patients, (2) healthy blood 
donors from Northeast Thailand, (3) healthy blood donors from the US, and (4) patients 
infected with other organisms from Northeast Thailand. The sensitivity of Hcp1-ICT was 
88.3% in comparison with bacterial culture. The specitivities  in Thai donors and US donors 
were 86% and 100%, respectively (Phokrai et al., 2018). This test is another potential point-
of-care test of melioidosis.  
In Thailand, the commonly used diagnostic tests for melioidosis are serological tests 
(IHA) and bacterial culture (conventional culture and automated bacterial culture system 
[BACTEC or BacT/ALERT]). The IHA is still commonly misused to diagnose melioidosis 
in Thailand, where the disease is highly endemic. Availability of microbiology laboratories 
is limited to secondary or tertiary hospitals, and they are absent in community hospitals. At 
community level, clinicians usually use the IHA for the diagnosis of melioidosis. A titer of 
antibody against B. pseudomallei of at least 1:160 is widely used as a cut-off for the 
diagnosis of melioidisis in Thailand, although it is proven to have low specificity. The latex 
agglutination assay and IFA are available in specialized laboratories belonging to research 
institutes in Thailand.  
1.3.5 Treatment of melioidosis 
Administration of antimicrobials effective against B. pseudomallei is crucial for 
improving the outcome of melioidosis (White, 1994, Wuthiekanun and Peacock, 2006, 
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Currie, 2015). In areas where melioidosis is endemic, immediate administration of specific 
antimicrobial against B. pseudomallei is  recommended to all patients with suspected 
melioidosis (White, 1994).  
In vitro studies show that B. pseudomallei is intrinsically resistant to penicillins, 
ampicillin, first- and second-generation cephalosporins, most of third-generation 
cephalosporins, gentamicin, aminoglycodises, and polymixin (Puthucheary and Parasakthi, 
1987, Ashdown, 1988, Dance et al., 1989a, Yamamoto et al., 1990). There is a limited 
number of antimicrobials possessing bactericidal activities against B. pseudomallei. These 
include ceftazidime, imipenem, meropenem, piperacillin, and amoxicillin-clavulanate 
(Dance et al., 1989a, Yamamoto et al., 1990).  
The treatment of melioidosis comprises of two phases; an initial intensive therapy with 
a parenteral antimicrobial for at least 10-14 days, followed by oral eradication therapy for 
12-20 weeks (Lipsitz et al., 2012, Dance, 2014).  
In 1986 the result of a large randomized control trial from Thailand led to a change in 
the first-line parenteral antimicrobial for melioidosis from ‘conventional therapy’ (a 
combination of chloramphenicol, doxycycline, trimethoprim, and sulphamethoxazole) to 
ceftazidime (White et al., 1989). The current drugs of choice for the initial treatment are 
ceftazidime or meropenem (White et al., 1989, White, 2003, Chierakul et al., 2005a, Currie, 
2015). There are no clinical trials showing that treatment with meropenem has a lower 
mortality outcome than treatment with ceftazidime. Nonetheless, meropenem is 
recommended for severe melioidosis in Australia, due to its superior outcome observed in a 
non-trial study (Currie, 2014, Cheng et al., 2004). 
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The oral eradication treatment phase aims to prevent the recrudescence and relapse of 
melioidosis (White et al., 1989, White, 2003, Chierakul et al., 2005a). The recommended 
oral antimicrobial regimen is trimethoprim-sulfamethoxazole alone for 12-20 weeks 
(Chetchotisakd et al., 2013).   
1.3.6 Prevention of melioidosis 
Melioidosis is a preventable disease. In endemic areas, the recommended preventive 
measures include avoiding direct contact with soil and water, wearing protective gear (i.e. 
gloves and boots) when in direct contact with soil or water if direct contact with soil or 
environmental water is necessary, washing skin thoroughly after any exposure, and drinking 
only boiled or bottled water (Queensland Government., 2010, Suntornsut et al., 2016). 
However, only a small proportion of people follow such recommendations (Suntornsut et 
al., 2016). Public health interventions such as a behaviour change programme could be 
implemented by the MoPH. A feasibility study shows that a multifaceted prevention 
programme could lead to the adoption of recommended preventive behaviours. However, 
commitment and action by the government are essential for these preventive programmes to 
occur and be successful (Suntornsut et al., 2018).  
Laboratory accidents involving exposure to B. pseudomallei can lead to infection, and 
good laboratory practices are required to prevent that (Peacock et al., 2008). The organism 
should be handled by trained personnel within a Biosafety Level 3 (BSL-3) facility (or 
national equivalent); laboratory practices specified by the respective national legislative and 
institutional biosafety committees should be used. However, diagnostic laboratories in 
resource-poor settings across tropical countries rarely have access to BSL-3 facilities; such 
laboratories can adapt many of the practices and work safely in a BSL-2 laboratory for little 
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or no extra cost. Safe laboratory practices will serve to minimize the risk of exposure to 
laboratory workers.  
In general, laboratory workers should obtain organism- and site-specific training that 
includes orientation training for new workers and annual refresher training for all workers. 
Work should be conducted in a biologic safety cabinet and gloves should always be worn 
when manipulating clinical specimens suspected colonies of B. pseudomallei and B. 
pseudomallei. Respiratory protection must be used during centrifugation. Sealed cups 
should be used in all centrifuges, and these should be opened only in a biologic safety 
cabinet. In addition, research laboratories require clearly defined readiness guidelines and 
preparation in the event that one or more persons require postexposure prophylaxis (PEP) 
(Peacock et al., 2008). 
1.4 Animal melioidosis 
The epidemiology and global distribution of animal melioidosis is poorly understood. 
From 1917 to 2018, cases of animal melioidosis have been published from 23 countries 
worldwide (Figure 1-6). Most of the publications of animal melioidosis are from Australia, 
Malaysia, Indonesia, Thailand and Singapore (Choy et al., 2000, Limmathurotsakul et al., 
2012a, Sim et al., 2018), all of which are countries endemic for human melioidosis 
(Golledge et al., 1992). Sporadic imported animal melioidosis cases have been reported in 
countries outside endemic areas; including the United States (Ryan et al., 2018, Butler et al., 
1971), United Kingdom (Dance et al., 1992), and France (Mollaret, 1988). It is likely that 
melioiosis is also endemic in animals in countries where melioidosis is endemic in humans 
but animal melioidosis has never been reported.  
 Chapter 1—28 
A wide range of animal species is susceptible to B. pseudomallei infection, including 
pigs (Millan et al., 2007), poultry, sheep, lambs, goats, caprine (Thomas et al., 1988), cattle 
(also calves), buffalo calf, horse, alpaca (Lama pacos), boar, wallabies, koala, camels, orang-
utan (Pongo pygmaeus), a macaque monkey (Macaca nemestrina), cats, birds, marine 
mammals (such as dolphin, whale, seals), and zoo animals (www.melioidosis.info). Animals 
are largely exposed via the environment, and routes of infection are possibly through 
ingestion, mucous membranes contamination and abraded skin inoculation (Rush and 
Thomas, 2012a).  
Clinical manifestations in animal melioidosis range from acute infection with fever, 
septicaemia, pneumonia, gastroenteritis, diarrhea, infection in skin or parotid gland or 
mastitis to a chronic infection with abscesses in multiple organs (lung, liver, spleen) and 
arthritis (Tonpitak et al., 2014, Rush and Thomas, 2012a). B. pseudomallei can be isolated 
from multiple types of organs and specimens; including blood, pus, lung, liver, kidney, 
spleen, gonad, and skin (Sim et al., 2018, Limmathurotsakul et al., 2012a, Tonpitak et al., 
2014). Diagnostic methods for animal melioidosis include isolation of B. pseudomallei, 
serological assays (IHA, ELISA, complement fixation testing [CFT], and IFA) and 
molecular methods (e.g. PCR). Isolation of the organism provides a definitive diagnosis of 
meloidosis. Serological assays such as IHA and CFT are used to evaluate infection status 
and exposure to the pathogen for surveillance purpose. However, serological assays cannot 
be used to provide a definite diagnosis of a current infection (Rush and Thomas, 2012a).  
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Figure 1-6 Distribution of animal meliodosis (www.melioidosis.info) 
Image of rabbit represent location of published animal meliodosis. 
 
In Thailand, animal melioidosis has been reported in a number of species. These 
include pigs, cattle, sheep, goat, crocodile, deer, horse, and zoo animals (for example 
chimpanzee, orangutan, kangaroo, zebra, camel, meerkat and cheetah) (Limmathurotsakul 
et al., 2012a, Tonpitak et al., 2014, Sommanustweechai et al., 2013, Kasantikul et al., 
2015).  
Animal melioidosis is one of the 20 diseases listed in the animal disease surveillance 
system conducted by the Bureau of Disease Control and Veterinary Services (BODCVS), 
Department of Livestock Development, Ministry of Agriculture and Cooperatives (MoAC), 
Thailand. However, the numbers of reported cases of animal melioidosis are low. Five years 
of animal surveillance data (2013 to March 2018) shows 14 cases of animal melioidosis; 13 
in goats, and 1 in sheep (BODCVS, MoAC., 2015).  
It is possible that a number of wild animals also acquire melioidosis but it is rarely 
reported. Routes of infection in animals in Thailand are unclear. It is hypothesized that 
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animals acquire B. pseudomallei through skin inoculation (Kasantikul et al., 2015). IHA is 
an official test for the diagnosis of animal melioidosis in the Thai animal surveillance 
system; seropositivity is defined as a titer ≥1:160 (BODCVS). Nonetheless, for a definite 
diagnostic of melioidosis in zoo animals, the methods should be bacterial culture or PCR 
assays (Kasantikul et al., 2015). A study in Thailand showed that culture-confirmed 
melioidosis in animals occurs in all six geographical regions in Thailand; including North, 
Northeast, Central, East, West and South, Thailand (Limmathurotsakul et al., 2012a).  
1.5 Environmental B. pseudomallei 
1.5.1 Distribution of environmental B. pseudomallei 
The presence of environmental B. pseudomallei indicates a risk of acquiring melioidosis 
in both humans and animals living in those areas. However, the global distribution of this 
pathogen is still unclear. To date, environmental B. pseudomallei has been isolated from soil 
and/or water in East Asia (China, Hong Kong, Taiwan), the Middle East (Iran), Southeast 
Asia (Thailand, Cambodia, Laos, Viet Nam, Malaysia, Singapore), South Asia (India, Sri 
Lanka, Bangladesh), Australia (Australia, Papua New Guinea), Latin America and 
Caribbean (Brazil, Peru, Haiti), and Africa (Madagascar, Burkina Faso, Niger, Ivory Coast, 
Gabon) (www.melioidosis.info) (Figure 1-7).  
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Figure 1-7 Worldwide distribution of environmental B. pseudomallei 
(www.melioidosis.info) 
 
The discovery of the organism in soil or water is often part of a follow-up investigation 
of a cases or cases of human or animal melioidosis (Wiersinga et al., 2015). Conversely, 
defining the distribution of the pathogen in the environment before melioidosis cases are 
reported can help raise awareness of the disease, increasing the chance of melioidosis 
identification, and leading to disease management and control (Limmathurotsakul et al., 
2013a). A good example is from Lao PDR, where B. pseudomallei in soil was discovered in 
1998, leading to identification of melioidosis cases in 1999 (Limmathurotsakul et al., 
2013a). Environmental sampling (soil and/or water) is essential for determining the presence 
of the organism in the natural environment and creating a melioidosis risk map.  
1.5.2 Soil sampling for the detection of B. pseudomallei 
Obtaining a false negative for the presence of B. pseudomallei provides improper 
assurance of absence of risk to the population in the affected areas. Because B. pseudomallei 
unevenly distributes in the soil, poor study design and conduct of soil sampling may lead to 
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a false negative result (Limmathurotsakul et al., 2010c). For example, a study may collect 
an insufficient number of soil samples, collect insufficient sampling sites, collect low 
amounts of soil per sample, select sampling sites unsystematically, poorly handle samples, 
and poorly select culture techniques. Choices of study design and site selection should be 
based on the study objectives. Several sampling strategies should be considered during study 
design, including the total number of sampling sites, the total number of samples per site, 
distance between sampling points, sampling seasons, depth of soil sampling, amount 
(weight) of soil collected, conditions of sample transportation, and methods for isolation of 
B. pseudomallei (Limmathurotsakul et al., 2013a).  
1.5.2.1 Sampling site selection, number of samples and distance between sampling 
points 
A previous study using spatial statistics shows that soil samples taken from sampling 
points adjacent to sampling points culture positive for the organism are more likely to yield 
a positive culture (Limmathurotsakul et al., 2010c). Likewise, soil samples taken from 
sampling points adjacent to sampling points culture negative for the organism are also more 
likely to yield a negative culture (Limmathurotsakul et al., 2010c). To lower the risk of false 
negative results, it is recommended to use a sample size calculation to derive the total 
number of sites. In Thailand, it is recommended to collect at least 100 sampling points per 
site, with a distance between sampling points of 2.5 to 3.5 meters (Limmathurotsakul et al., 
2010c). The strategy is in line with the consensus guideline for soil sampling developed by 
the “Detection of Environmental Burkholderia Pseudoamallei Working Party (DEBWorP)” 
(Limmathurotsakul et al., 2013a) (Table 1-1). 
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Table 1-1 Published and recommended soil sampling strategies and recommended 
methodologies of isolation of B. pseudomallei from Soil by DEBWorP 
(Limmathurotsakul et al., 2013a) 
 
1.5.2.2 Seasons of soil sampling 
The presence of B. pseudomallei in the soil during the wet season is speculated to be 
higher than during the dry season. Therefore, the probability of detecting the pathogen by 
soil sampling during the wet season may also be higher than during the dry season. An 
observational study observed that positivity for B. pseudomallei in the soil in wet season 
was higher than during the dry season (Thanapat et al., 2013). However, this study was 
conducted with a small number of soil samples per sampling site (4 samples per site), which 
may limit the generalisability of this result. A recent review shows that the difference in 
positivity rate for B. pseudomallei between two sampling seasons is still uncertain 
(Limmathurotsakul et al., 2013a). This implies that positivity rates are also associated with 
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other contributing factors (e.g. land usages and presence of animals) which can change over 
the time and the locations of sampling. Hence, it is important to take study objectives and 
all available information about the sampling areas into account when shaping sampling 
strategies. 
1.5.2.3 Soil sampling depth and condition of sample transportation 
A depth of 30 cm from the soil surface is the depth for soil sampling recommended by 
DEBWorP (Limmathurotsakul et al., 2013a). This choice of sampling depth is based on 
published evidence that the proportion of samples that are culture positive for B. 
pseudomallei is higher at 30 cm than at the surface (Thomas et al., 1979), but comparable 
to samples taken deeper than 30 cm (Knappik et al., 2015). 
A laboratory study shows that environmental B. pseudomallei survives optimally at a 
temperature between 24℃ and 32℃, and that the organism is killed by ultraviolet rays at 
465 µW/cm2 (Tong et al., 1996). Therefore, soil samples should be stored in a container at 
this optimal temperature range and protected from direct sun light or heat during 
transportation.  
1.5.2.4 Extraction, detection, and isolation methods of B. pseudomallei from soil  
A summary of a comprehensive review and details of the consensus culture guidelines 
is reproduced in Table 1-2. Methods used for differentiation of environmental B. 
pseudomallei are similar to those used for isolates obtained from clinical specimens.   
Any colony suggestive of B. pseudomallei can be initially differentiated by Gram stain, 
oxidase test, arabinose assimilation test, and antimicrobial drug susceptibility testing 
(resistant to gentamicin and colistin but sensitive to amoxicillin-clavulanic acid). Then the 
organisms should be tested by a few confirmatory tests including latex agglutination, PCR 
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assay and API20NE (Limmathurotsakul et al., 2013a). Multilocus sequence typing (MLST) 
can be used as a confirmatory test and as a tool to determine genetics relatedness between 
isolates from different geographical regions reported in the public database. 
Laboratory studies and one environmental study show that PCR-based methods 
(targeting TSS1) have a higher sensitivity to detect B. pseudomallei in the soil than bacterial 
culture (Brook et al., 1997, Trung et al., 2011, Kaestli et al., 2007, Knappik et al., 2015, 
Gohler et al., 2017). However, PCR-based methods alone will not be able to obtain bacterial 
isolates for confirmation and genetic studies. Therefore, PCR-based methods can be used 
together with culture, if available. Also, large studies to properly evaluate the sensitivity and 
specificity of PCR-based methods in the real environmental settings are still required.  
Table 1-2 Published and recommended methodologies for the isolation of B. 
pseudomallei from Soil by DEBWorP (Limmathurotsakul et al., 2013a). 
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1.5.3 Ecological factors associated with environmental B. pseudomallei  
B. pseudomallei is a saprophytic beta-proteobacteria, a facultative aerobe that uses 
respiration to harvest energy through oxidization of organic compounds, utilizing oxygen 
and nitrate in aerobic and anaerobic condition, respectively (Ian L. Pepper, 2009). 
Knowledge of environmental factors associated with the presence of the organism in the 
natural setting is limited and conflicting. Notable findings from both laboratory studies and 
environmental studies are summarized below. 
1.5.3.1 Soil texture and water content/ moisture level 
The persistence and survival of B. pseudomallei is influenced by soil type and by the 
level of soil moisture (Kaestli et al., 2015, Palasatien et al., 2008). This is because soil type 
is associated with the ability to hold water, oxygen, and nutrients which are essentials to the 
survival of soil microorganisms. For example, clayey soil holds water better than sandy soil 
(Ian L. Pepper, 2009). Soil studies have shown that the presence of B. pseudomallei is 
associated with clayey soil, due to its superior ability to hold water (thus higher moisture 
level) and support growth of the organism (Thomas et al., 1979). Findings from both 
laboratory studies and environmental surveys support this suggestion. Laboratory studies 
show that soil with water content less than 15% inhibits growth of the organism by 60 days 
(Chen et al., 2003) and soil with water less than 10% can lead to death of the bacterium by 
70 days (Tong et al., 1996). Experimental studies show that adding water to the soil yields 
3 times higher odds of detecting B. pseudomallei compared to control soil (Kaestli et al., 
2015), and that an environmental B. pseudomallei strain can survive in intermittently 
irrigated soil for at least 113 days (after which the experiment was terminated) while the 
strain survived only 91 days in desiccated soil (Larsen et al., 2013). A number of 
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environmental studies in Australia (Kaestli et al., 2009, Larsen et al., 2013), in Thailand 
(Palasatien et al., 2008), and Gabon in Africa (Wiersinga et al., 2015) also found that soil 
samples culture positive for B. pseudomallei had higher water content or moisture than the 
soil samples negative for the organism. 
However, B. pseudomallei can also be isolated from sandy soils (Smith et al., 1995, 
Palasatien et al., 2008, Baker et al., 2015, Larsen et al., 2013), which naturally contain lower 
water content and moisture level. B. pseudomallei can also be isolated from soil in harsh 
and desert-like environments in Central Australia (Yip et al., 2015). Laboratory experiments 
also confirm that B. pseudomallei can survive in desiccated environments (soil with 0% 
water content) for 30 days (Tong et al., 1996).  
1.5.3.2 pH and acidic environment 
An acidic environment is reported to be a preferable environment for B. pseudomallei. 
The organism can grow in an experimental broth at pH 4.5, in which B. cepacia and B. 
aeruginosa can not survive (Dejsirilert et al., 1991). In a number of laboratory studies, pH 
4-8 is an optimal range for B. pseudomallei growth and survival (Tong et al., 1996, Wang-
Ngarm et al., 2014, Chen et al., 2003, Kaestli et al., 2015). A laboratory experiment done in 
Thailand observed that growth of B. pseudomallei declines at pH 8, while the organism 
grows well at pH 4-7 (Wang-Ngarm et al., 2014). In another two studies, pH 9 was inhibitory 
to the survival of B. pseudomallei in normal saline after 26 days (Tong et al., 1996) and in 
soil after 2 days (Wang-Ngarm et al., 2014). In an environmental study, B. pseudomallei 
wass isolated from soil with a low pH ranging from 4 to 6 (Ngamsang et al., 2015, Palasatien 
et al., 2008). In another environmental study in Australia, the pH of soil samples positive 
for B. pseudomallei had a lower pH than the soil samples negative for the organism (range 
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of pH 5.2-5.8 vs. 6-7, respectively) (Kaestli et al., 2009). Multiple soil surveys from 
Thailand reported no difference in pH between soil positive and negative for B. 
pseudomallei (Sermswan et al., 2015, Thanapat et al., 2013, Ngamsang et al., 2015). For 
example, a soil survey observed pH range of 4.77-7.65 versus 5.35-7.7 in soil positive and 
negative for the organism, respectively (Sermswan et al., 2015).  
1.5.3.3 Salinity and osmotic stress 
 B. pseudomallei grows well in a soil microcosm with a concentration of sodium chloride 
between 0% and 0.7% (Wang-Ngarm et al., 2014). As salinity increases up to >2.5%, growth 
of the organism decreases to below detectable level (Wang-Ngarm et al., 2014, Inglis and 
Sagripanti, 2006). The possible explanation for this is that the high salinity of 2.5% imposes 
physiological stress to B. pseudomallei. As a result, the organism goes into a viable but non-
culturable state (VBNC) (Inglis and Sagripanti, 2006).  
The salinity of natural soil is determined by measuring the electrical conductivity level 
(EC; ds/m). EC reflects the concentration of soluble salts in soil, including sodium, choline, 
magnesium, calcium, potassium and nitrate. A previous soil survey from Thailand did not 
find a difference of salinity level between soil culture positive and negative for B. 
pseudomallei (EC 0.03-0.93 vs. 0.03-0.17 ds/m, respectively) (Thanapat et al., 2013). An 
experimental study from Australia observed that the concentration of B. pseudomallei 
detected is negatively associated with the level of EC in the soil samples, and that garden 
soil with EC of 0.7 ds/m inhibits persistence of B. pseudomallei beyond 4 weeks after 
inoculation (Kaestli et al., 2015). 
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1.5.3.4 Soil nutrients 
Nitrogen is an essential nutrient for microorganisms and plants (Ian L. Pepper, 2009). B. 
pseudomallei has an ability to change nitrate to nitrites during anaerobic respiration. Soils 
with presence of B. pseudomallei have significantly higher levels of nitrogen compared to 
soils negative for the organism (Palasatien et al., 2008). An experimental study shows that 
soils treated with high nitrate fertilizer enhance growth of the organism (Kaestli et al., 2015).  
Iron is also important for microbial metabolism. In an experimental study, soils treated 
with iron ranging from 75 to 150 mg/kg improve growth of B. pseudomallei (Wang-Ngarm 
et al., 2014). This is consistent with a finding from an environmental survey which shows 
that soils positive for B. pseudomallei have higher levels of iron than negative soil; 
45.4±18.4 vs. 17.9±7.2 mg/kg, respectively (Ngamsang et al., 2015). However, an 
Australian soil survey shows that sampled sites with high prevalence of B. pseudomallei 
have lower levels of iron than sampled sites with low prevalence of B. pseudomallei; 8-12 
mg/kg vs. 160-180 mg/kg, respectively (Baker et al., 2015). Both environmental studies 
were restricted to two sampling sites. In an environmental study carried out in Thailand, soil 
samples which were culture positive for B. pseudomallei had a wide range of iron content 
from as low as 6.17 mg/kg to as high as 288.48 mg/kg (Thanapat et al., 2013). 
Apart from nitrogen and iron, total organic carbon was found positively related to 
presence of B. pseudomallei (Palasatien et al., 2008, Wang-Ngarm et al., 2014). However, 
soils with low total carbon and high prevalence of B. pseudomallei were also observed in a 
soil survey in Australia (Baker et al., 2015). 
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1.5.4 Environmental B. pseudomallei in Thailand 
In Thailand, little is known about the distribution of B. pseudomallei (Figure 1-8). Most 
of the environmental studies for B. pseudomallei have been limited to Khon Kaen 
(Palasatien et al., 2008) and Ubon Ratchathani provinces (Wuthiekanun et al., 1995a, Smith 
et al., 1995).  
The very first large environmental survey to identify B. pseudomallei in Thailand was 
conducted between 1964-1967 (Finkelstein et al., 2000). Soils or water culture positive for 
the organism were found in Northeastern and the Southern regions (Finkelstein et al., 2000). 
A recent large soil survey was conducted in 1999. The highest B. pseudomallei positivity 
rates were reported in the Northeast (50.1%), followed by the Central (24.5%), the South 
(18.4%), and the North (13.8%) (Vuddhakul et al., 1999). Although soil culture positive for 
B. pseudomallei in the Central region was second after the Northeast, clinical cases had been 
rarely reported in the Central region. In fact, the majority of B. pseudomallei reported in this 
study in the Central region assimilated arabinose, suggesting that they were actually non-
pathogenic B. thailandensis (Brett et al., 1998). In addition, this study was not conducted in 
the East region, where human melioidosis is reported. The sampling areas were limited to 
roadsides along the highway (Vuddhakul et al., 1999), which may not represent the risk 
areas where the rice farming population is normally exposed to the organism. Considering 
the incidence of melioidosis in the East region (Bhengsri et al., 2011a), it is predicted that 
B. pseudomallei is present in the soil in that area. A pilot study conducted by Vanaporn 
Wuthiekanun found that B. pseudomallei is occasionally found in the East region but less 
common than in the Northeast (personal communication, unpublished data).  
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To understand the factors associated with the presence of B. pseudomallei in rice fields, 
surveys for organism positivity and evaluation of soil characteristics should be carried out 
simultaneously. In Thailand, the sole analytical study of this type was performed in Khon 
Kaen province, northeast Thailand (Palasatien et al., 2008). The investigators reported that 
soil physiochemical properties associated with presence of the organism were pH 5-6, a 
moisture content >10%, higher chemical oxygen demand (COD) and higher nitrogen 
concentration (Palasatien et al., 2008). Nonetheless, this study cannot explain the presence 
or absence of B. pseudomallei in different regions outside northeast Thailand. 
Understanding the factors associated with presence of B. pseudomallei may provide useful 
information on how to eradicate or reduce the high concentration of B. pseudomallei present 
in the soil in Northeast Thailand.   
The presence of other Burkholderia species may also be positively or negatively 
associated with the presence of B. pseudomallei. The non-pathogenic Gram-negative 
bacterium B. thailandensis has colony morphologies and antigenicities similar to those of 
B. pseudomallei, except that B. thailandensis can assimilate L(+) arabinose and B. 
thailandensis lacks the B. pseudomallei-like CPS. Other Burkholderia spp. that have been 
reported from other countries include B. vietnamensis, B. ubonensis and B. oklahomensis 
(Wiersinga et al., 2012). Nikolakakis et al. recently showed that Burkholderia species 
contained functional contact-dependent growth inhibition (CDI) systems, which may confer 
a competitive advantage on these bacteria over other species (Nikolakakis et al., 2012). An 
experimental study found that there is mutual inhibition between B. pseudomallei and B. 
thailandensis in culture medium (Ngamdee et al., 2015). Nonetheless, there is currently a 
lack of evidence supporting this finding in the natural environment. Therefore, the presence 
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of other Burkholderia species should be evaluated in the environmental survey as one factor 
potentially associated with the presence of B. pseudomallei.  
Figure 1-8 Distribution of environmental B. pseudomallei in Thailand 
(www.melioidosis.info) 
 
1.6 Surveillance and global burden of melioidosis 
Infectious disease surveillance plays a crucial role for public health, as it can be used to 
guide resource allocation for diseases prevention, control and treatment programs developed 
by health policy makers. A disease surveillance system can also be used to monitor changes 
in disease frequency and in levels of risk factors. A disease surveillance system usually 
requires three integrated systems: data collection (e.g. case reports); data analysis; and 
timely information dissemination to guide interventions and policies (M'ikanatha et al., 
2013, WHO, 2018). The main indicators for burden of disease are morbidity and mortality.  
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In addition, surveillance can also be used to assess changes in levels of environmental 
risk factors for the diseases. Such monitoring may forewarn of possible rises in rates of 
diseases associated with that environmental agent. Thus, surveillance for changes in either 
disease rates or levels of environment risk factors inform possible directions for reducing 
health threats in the future.  
Active surveillance systems intensively determine the  incidence and epidemiological 
characteristics of specific conditions within defined areas, and require dedicated extensive 
resources. Therefore, this type of surveillance is rarely applied in either resource-limited or 
developed countries.  National surveillance system in most countries is based on passive 
surveillance systems, in which patients diagnosed with notifiable diseases are reported by 
the healthcare provider or by district health authorities (Gordis, 2013, M'ikanatha et al., 
2013).  
Melioidosis is not listed as a notifiable disease in many endemic countries, including 
Malaysia, Vietnam, Cambodia, Lao PDR, India, Sri Lanka, and the Phillipines. However, 
melioidosis is listed in the national surveillance systems in Singapore, Taiwan, Japan, 
Australia (Queensland, the Northern Territory and Western Australia) and Thailand. 
Melioidosis is not listed as a notifiable disease in the US; nevertheless, the US Centers for 
Disease Control and Prevention (CDC) has an additional surveillance system for agents 
considered to have bioterrorism potential and has classified B. pseudomallei as a Tier 1 
select agent (agents that present the greatest risk of deliberate misuse with significant 
potential for mass casualties and pose a severe threat to public health and safety (CDC)). 
Figure 1-9 illustrates melioidosis cases reported in scientific publications according to a 
previous review using data from 1917 to 2013 (Limmathurotsakul et al., 2016).  
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Figure 1-9 Distribution of human melioidosis, which were reported in scientific 
publiactions from 1917 to 2013 (www.melioidosis.info) 
 
Using mathematic modelling, Limmathurotsakul et al. predicted 165,000 melioidosis 
cases worldwide (Limmathurotsakul et al., 2016). However, only about 1,300 melioidosis 
cases were reported per year worldwide since 2010 (Limmathurotsakul et al., 2016). 
Underreporting of melioidosis may be associated with low awareness of the disease, lack of 
capacity or expertise in identifying the causative pathogen, and a lack of formal or inefficient 
reporting or surveillance system.  
Awareness of melioidosis plays a critical role in disease recognition at all levels. 
Because awareness of the disease is usually very low among patients and clinicians, 
melioidosis is often not included as a possible cause of illnesses. Consequently, clinical 
specimens may not be collected for culture, and laboratory technicians may not be notified 
that an isolate should be suspected of being B. pseudomallei. This reduces the chance of 
detecting the pathogen tremendously, particularly in samples with mixed culture. As a result, 
melioidosis patients are rarely diagnosed – as depicted in the surveillance iceberg below 
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(Figure 1-10). Although awareness of melioidosis is relatively higher in well-known 
melioidosis-endemic areas (e.g. Thailand), reported cases are also believed to be just the tip 
of the iceberg and not representative of the true incidence of melioidosis (Dance, 1991). 
Figure 1-10 Surveillance iceberg (Ketheesan , N. editor 2012) 
 
Underreporting of melioidosis from all levels is a major contributing factor to unknown 
burden of melioidosis. As a result, melioidosis is not set as a priority disease that requires 
resource allocation for enhancing diagnosis, treatment, prevention and surveillance. This is 
happening in most, if not all, developing countries where melioidosis is known to be highly 
endemic. 
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1.7 Surveillance and burden of melioidosis in Thailand 
1.7.1 National surveillance system in Thailand 
In Thailand, communicable diseases legislation was established in 1934 and has been 
regularly updated since, and the National Communicable Disease Surveillance system was 
established in 1968. The first Communicable Disease Surveillance system covered 14 
infectious diseases, and this has been expanded since to cover 81 diseases including, since 
2002, melioidosis.  
The system is managed by the Bureau of Epidemiology (BOE), Ministry of Public 
Health (MoPH), Thailand. The list of notifiable diseases, case definitions, report forms, and 
the data system are defined by the BOE, MoPH. The flow of national surveillance data is 
depicted in Figure 1-11. In brief, first, local healthcare providers such as community 
hospitals, general and regional hospitals under MoPH, and hospitals under other ministry 
send case reports (a report form called “Report 506”) to the district health office (DHO). 
The DHO then sends the data to the provincial public health office (PPHO) (Figure 1-11). 
Then, PPHO retrieves and validates the data from hospitals under its jurisdiction, and sends 
the validated reports to the main database located in the BOE. Data from hospitals located 
in 77 provinces nationwide are analyzed, and an annual epidemiological report of all 
notifiable diseases is written by the BOE and submited to the Department of Diseases 
Control (DDC), MoPH. Policy makers regularly use the annual epidemiological reports as 
a main reference for resource allocation for disease diagnosis, treatment, prevention and 
control programs. 
Prior to 2016, the notifiable disease system in Thailand was not mandatory. Since June 
2016, reporting of culture-confirmed melioidosis cases from every hospital with a 
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microbiology laboratory, together with final outcome, has been mandated under the 
Communicable Diseases Act B.E. 2558 (A.D. 2015). Now, hospitals nationwide need to 
report all probable and confirmed cases of melioidosis. The BOE defined probable and 
confirmed cases of melioidosis as clinically compatible illness with laboratory diagnostics 
results. Probable clinical presentations of melioidosis include fever, septicaemia, single or 
multiple abscesses including cutaneous, splenic or hepatic abscess, septic arthritis, 
osteomyelitis, and abnormality of chest x-ray. Laboratory diagnosis criteria are IHA titer 
≥1:160 from a single blood sample, or four-fold rising of two blood samples, or 
immunofluorescence antibody test (IFA) >1:400, or culture positive for B. pseudomallei. 
Reporting of melioidosis is required for all probable cases (e.g. cases with clinical symptoms 
and IHA ≥1:160). Confirmed melioidosis is defined as having clinical symtoms (mentioned 
above) and one or more laboratory diagnostic result: IHA titer ≥1:160 from a single blood 
sample, or four-fold rising of two blood samples, immunofluorescence antibody test (IFA) 
>1:400, or culture positive for B. pseudomallei from any specimens. 
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Figure 1-11 Flow of national surveillance data (Bureau of Epidemiology, 2016) 
 
Records of Report 506 showed that a total of 39 patients died of melioidosis countrywide 
between 1999 and 2006. However, a retrospective study showed that there were more than 
735 deaths from melioidosis in one regional hospital during the same period 
(Limmathurotsakul et al., 2010b) (Figure 1-12). These discrepancies in the numbers of 
deaths due to meliodosis suggest that the incidence and mortality of melioidosis recorded 
via the Report 506 system is substantially under-reported.  
The BOE, MoPH, Thailand regularly publishes the summary data of notifiable diseases 
from Report 506 in the Annual Epidemiological Surveillance Report of Thailand. As that 
information is regularly used by policy makers, the burden of melioidosis is currently 
neglected. Therefore, the under-reporting of the incidence and mortality of melioidosis via 
the Report 506 system needs to be rectified. 
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Figure 1-12 Discrepancies between deaths of melioidosis in 1999-2006 reported in 
national surveillance system and published data   
 
1.7.2 Burden of melioidosis in Thailand 
In 1955, the first culture-confirmed melioidosis was reported from a province located in 
Central Thailand by Chittivej et al (Chittivej et al., 1995). Up until 1976, a total of 16 culture-
confirmed melioidosis cases had been identified in Bangkok. As a result, melioidosis was 
raised as a threat to public health nationwide (Chayasirisobhon, 1976). With a rising of 
disease awareness among infectious disease physicians, reports of meloidosis cases have 
continued to increase. Up until  1985, over 700 culture-confirmed melioiodisis cases had 
been reported from many provinces in the Northeast (n=585), the North (n=61), the Central 
(n=102), and the South (n=6) (Punyagupta, 1989).  It became clear that the Northeast is the 
most highly endemic region for melioidosis in Thailand. 
Despite the increase in case reporting, improvements in diagnosis, and including 
melioidosis as a notifiable diseases in Thailand, the true burden of melioidosis in the country 
and in each region is still largely unknown. Thailand is divided into six geographical regions 
by the National Geographic Committee in 1977, including Northeast, North, East, West, 
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South, and Central Thailand (Kashino, 2014).  Evidence of melioidosis in each geographical 
region is summarized below. 
1.7.2.1 Northeast Thailand 
Northeast Thailand is recognized as the most highly endemic region for melioidosis 
worldwide. Northeast Thailand is the largest region in Thailand by area (168,854 km2) and 
consists of 20 provinces (The Bureau of registration Administration, 2013).  Most of the 
published melioidosis cases in Thailand are from four provinces: Khon Kaen, Nakhon 
Panom, Udon Thani, and Ubon Ratchathani. These four provinces are where melioidosis 
research institutes are located.  
In 1997, 1,050 culture-confirmed melioidosis were observed in general and regional 
hospitals in Northeast Thailand; however, details of provinces and outcomes of those cases 
were not specified (Vuddhakul et al., 1999). From 1997 to 2006, a study reported that the 
incidences of culture-confirmed melioidosis cases observed at Sunpasitthiprasong Hospital, 
Ubon Ratchathani ranged from 141 to 380 cases per year (Limmathurotsakul et al., 2010b). 
Observed incidence rates of melioidosis in Ubon Ratchathani had substantially increased 
from 8.0 to 21.3 per 100,000 population per year between 2000 and 2006 (Limmathurotsakul 
et al., 2010b), and melioidosis is the third most common cause of death from infectious 
diseases in Northeast Thailand after HIV/AIDS and tuberculosis (Limmathurotsakul et al., 
2010b).  
In a study from Nakhon Panom hospital, the total number of culture-confirmed 
melioidosis cases sharply rose from 130 cases in 2003-2005 to 330 cases in 2006-2008 
because an automated bacterial culture system was fully implemented in 2006 in the hospital 
(Bhengsri et al., 2011b). Incidence rates of meliodosis in Nakhon Panom in 2006-2008 were 
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estimated to be 14.9 cases per 100,000 population per year (95% confidence interval [CI], 
13.3-16.6) (Bhengsri et al., 2011b). The increase in reported incidences of meliodosis in this 
region could also be due to increases in disease awareness, increases in diagnostic capacity, 
and increases in the population susceptible to B. pseudomallei infection due to changing 
demographics (more elderly people) and increasing diabetes mellitus prevalence (White, 
1994). Information on the incidence of melioidosis in other provinces in Northeast Thailand 
is limited (Figure 1-13).  
Figure 1-13 Evidence and distribution of melioidosis in Thailand from 1910 to 2015 
(Hinjoy et al., 2018) 
Red icons represent geolocated records of culture-confirmed human cases (1a), culture-confirmed animal 
cases and (1b). Green, orange, pink, rose, blue and yellow colors represent Northeast, North, East, West, 
South and Central Thailand, respectively. Interactive data is available at www.melioidosis.info/map.aspx 
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1.7.2.2 North Thailand 
North Thailand covers 9 provinces (93,691 km2), some of which share a border with 
Myanmar and Laos. Most meliodosis cases reported in this region are from Chiang Mai 
province. From 2001 to 2003, 26 culture confirmed melioidosis cases with a case fatality 
rate of 42% were reported from one hospital in Chang Mai (Chaiwarith, 2005). In 1997, 110 
culture-confirmed melioidosis cases were observed in general and regional hospitals in the 
region; however, details of provinces were not specified (Vuddhakul et al., 1999). 
Knowledge of the epidemiology of human melioidosis in this region is limited, and it is 
possible that melioidosis is seldom suspected as a cause of illness in this region (Figure 
1-13). 
1.7.2.3 West Thailand 
West Thailand is a long mountainous region, covers 5 provinces (53,679 km2) running 
parallel to the border with Myanmar. Reports of human melioidosis cases from this region 
are rare. From 2006 to 2010, culture-confirmed meliodosis cases were reported from two 
provinces; Ratchaburi (n=50) and Phetchaburi (n=8) (Limmathurotsakul et al., 2012a). The 
estimated incidence rates were 1.20 and 0.35 per 100,000 population per year 
(Limmathurotsakul et al., 2012a). Animal melioidosis was also reported from Ratchaburi 
province (Kongkaew, 2017) (Figure 1-13), and B. pseudomallei has been isolated from soil 
in Prachuap Kiri Khan province (Finkelstein et al., 2000).  
1.7.2.4 East Thailand 
East Thailand consist of 7 provinces and covers an area of 34,381 km2 (The Bureau of 
registration Administration, 2013). East Thailand was previously perceived to be a non-
endemic area for melioidosis. In 2011, Bhengsri et al reported that B. pseudomallei caused 
 Chapter 1—53 
bacteraemia in Sa Kaeo province with an incidence rate of 4.9 cases per 100,000 population 
(95% CI =3.9-6.1) between 2006 and 2008 (Bhengsri et al., 2011b). The CFR of melioidosis 
in the province was 44%, which was higher than that in Nakhon Panom province (CFR of 
34%) reported in the same study (Bhengsri et al., 2011b). In 2012, more human melioidosis 
cases were reported from another two provinces in the region; Chachoengsao and Chonburi. 
The study reported incidence rates of melioidosis of 24.1 and 1.2 per 100,000 population 
per year in Chachoengsao and Chonburi, respectively; however, the CFR was not specified 
(Limmathurotsakul et al., 2012a). Observed incidences of meliodosis in goats from these 
two provinces were 27.9 and 9.5 per 100,000 goat population per year, respectively 
(Limmathurotsakul et al., 2012a) (Figure 1-13).   
The incidence rate of melioidosis reported from Chachoengsao province was as high as 
that observed in the Northeast (Limmathurotsakul et al., 2010b), suggesting that the East 
Thailand might be another area highly endemic for melioidosis. In addition, an 
environmental survey for the organism has never been conducted in the region. 
1.7.2.5 South Thailand 
South Thailand consists of 14 provinces, covering an area of 70,716 km2 (The Bureau of 
registration Administration, 2013). The region has two long coastlines connecting to 
Andaman sea on the western side, and to the Gulf of Thailand on the eastern side. Sporadic 
culture confirmed cases have been reported from Phangnga (total of six cases) after the west 
coast was devastated by the 2004 tsunami (Chierakul et al., 2005b) (Figure 1-13). Suggested 
routes of infection were aspiration and laceration (Chierakul et al., 2005b). In 2013 one 
culture confirmed meliodosis case was reported from France, with a history of travel to Koh 
Samui (Rossi et al., 2013). In the following year, a melioidosis outbreak of 11 cases was 
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reported on Phangan island (Thaipadungpanit et al., 2014), which led to an environmental 
investigation for B. pseudomallei in water sources on the island. B. pseudomallei were 
isolated from multiple sources of water from the island (Thaipadungpanit et al., 2014).  Both 
Koh Samui and Phangan island are located in Surat Thani province, where B. pseudomallei 
was isolated from soil and water in the very first environmental survey conducted in 
Thailand in 1964-1967 by Finkelstein et al. (Finkelstein et al., 2000). In this survey the 
organism was found in all 14 provinces in South Thailand (Finkelstein et al., 2000). This 
implies that the population of the South are at risk of melioidosis, and that incidences of 
melioidosis might be largely under-diagnosed and under-reported in all 14 provinces.  
1.7.2.6 Central Thailand 
Central Thailand consists of 21 provinces, covering an area of 93,005 km2 (The Bureau 
of registration Administration, 2013). The region possess nutrient-rich soils and water 
sources, and agriculture such as rice farming can be performed in the region all year round. 
Although the first Thai culture-confirmed melioidosis case was reported from the Central 
region (Chittivej et al., 1995), and many cases were also reported in Bangkok 
(Chayasirisobhon, 1976) (Figure 1-13), most of these cases are believed to have acquired B. 
pseudomallei in the Northeast.  
All soil and water samples from five provinces in Central region were negative for B. 
pseudomallei in an environmental survey in 1964-1967 (Finkelstein et al., 2000). However, 
Vuddhakul et al. reported a total of 127 culture-confirmed melioidosis cases in Central 
Thailand (Vuddhakul et al., 1999). In addition, B. pseudomallei has been isolated from soil 
in the Central region (Vuddhakul et al., 1999). Furthermore, melioidosis has been reported 
in goats in Bangkok, suggesting that the animals may have acquired B. pseudomallei from 
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the environment in Central Thailand (Tonpitak et al., 2014). This published evidence 
suggests that Central Thailand could also be endemic for melioidosis, and melioidosis might 
be under-diagnosed and under-reported in the region.  
In summary, the current information ofnenvironmental B. pseudomallei does not 
represent the risk areas where the rice farming rural population may be exposed to the 
organism.  A soil survey has never been conducted in East Thailand, where melioidosis is 
potentially also endemic. Knowledge about factors associated with the presence of 
environmental B. pseudomallei is limited to the Northeast, and cannot explain the presence 
or absence of B. pseudomallei in different regions outside Northeast Thailand. The presence 
of other Burkholderia species may be associated with the presence of B. pseudomallei, but 
this has never been evaluated systematically. Understanding factors associated with the 
presence of B. pseudomallei may also provide useful information on how to eradicate or 
reduce the high density of B. pseudomallei present in the soil in Northeast Thailand.    
The true burden of melioisosis in Thailand is not known. There is a large discrepancy 
between numbers of cases and deaths of melioidosis reported in the national surveillance 
system and published data, indicating that the incidence of and mortality from melioidosis 
is severely under-reported in the country. This has led to my dissertation which aims to 
evaluate where in Thailand melioidosis is a threat to public health and an important health 
burden. My dissertation addresses four research questions listed in the following section. 
1.8 Scope of this dissertation  
My four research questions are:  
(1) What is the geographical distribution of B. pseudomallei in Northeast, East and Central 
Thailand? 
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(2) What are the ecological factors associated with presence of environmental B. 
pseudomallei?  
(3) What are the serological responses in people exposed to environmental B. pseudomallei 
and other neighbouring species?  
(4) What is the incidence of meliodosis nationwide?.  
1.8.1 What is the geographically distribution of  B. pseudomallei in Northeast, East 
and Central Thailand? 
With the aim of describing the geographical distribution of B. pseudomallei in multiple 
regions of Thailand and explaining the presence or absence of B. pseudomallei in different 
regions outside northeast Thailand, a large environmental survey was conducted 
simultaneously with an evaluation of soil physicochemical factors in the East, Central and 
Northeast Thailand. A total of 20 provinces were included in the study covering the East (6 
provinces), Central (7 provinces) and Northeast (7 provinces) regions of Thailand (Figure 
1-14). A total of 60 rice fields were evaluated (3 fields per province). Provinces in Northeast, 
East and Central Thailand were selected because they represent adjacent areas with different 
incidence rates of melioidosis. The consensus guidelines for the detection of environmental 
B. pseudomallei were used (Limmathurotsakul et al., 2013a).  
 Chapter 1—57 
Figure 1-14 Map of 20 provinces from Central, East and Northeast Thailand aimed 
to be sampled for presence of B. pseudomallei.  
 
Central (7 provinces):  
(1) Phitsanulok, (2) Phetchabun, (3) Lop Buri,  
(4) Saraburi, (5) Nakhon Nayok, (6) Pathum Thani, 
(7) Bangkok.  
East (6 provinces):  
(8) Prachin Buri, (9) Chacoengsao, (10) Chon Buri, 
(11) Rayong, (12) Sa Kaeo, (13) Chanthabu. 
Northeast (7 provinces):  
(14) Loei, (15) Chaiyaphum, (16) Nakhon 
Ratchasima (17) Nong Bua Lamphu, (18) Udon 
Thani, (19) Khon Kaen, (20) Buri Ram. 
1.8.2 What are the ecological factors associated with presence of environmental B. 
pseudomallei? 
The soil chemical properties play important roles for survival of B. pseudomallei, but 
these are rarely evaluated in the real environmental setting (Inglis and Sagripanti, 2006). 
Identifying ecological factors associated with the presence of B. pseudomallei could have 
important implications for developing a public health program to control or reduce the 
prevalence of the organism in the environment. A study from a single province in Northeast 
Thailand reported that the soil physiochemical properties associated with the presence of B. 
pseudomallei were soil pH 5-8, a moisture content >10%, high chemical oxygen demand 
(COD) and high nitrogen concentration (Palasatien et al., 2008). A study from Laos shows 
that the presence of B. pseudomallei is associated with the elevation above sea level 
(Rattanavong et al., 2011). A study from Australia shows that the presence of exotics 
grasses, high moisture level, acidic soil, road drainage and soil colours (reddish grey and 
reddish yellow) are associated with the presence of B. pseudomallei (Kaestli et al., 2012). It 
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is unclear whether these factors are associated with the presence of B. pseudomallei in 
different regions in Thailand.  
During the soil sampling study conducted to answer Question 1, an evaluation of soil 
physiochemical properties from each study field was performed to determine ecological 
factors associated with the presence of B. pseudomallei in different regions. Soil was 
analyzed by iLab Asia Co., Ltd. and Central Laboratory (Thailand) Co., Ltd. Soil 
characteristics evaluated included soil texture, pH, lime requirement, organic matter, 
electrical conductivity, total nitrogen, phosphorus, potassium, calcium, magnesium, sulfur, 
sodium, cation exchange capacity, moisture, carbon:nitrogen ratio, cadmium and iron. The 
evaluation of correlation between B. pseudomallei positivity in rice fields and the level of 
each soil characteristic were performed. 
1.8.3 What are the serological responses in people exposed to environmental B. 
pseudomallei? 
Serological response has been used to determine exposure to B. pseudomallei in endemic 
areas. The indirect hemagglutination assay (IHA) is commonly used with titers of 1:40 or 
greater being considered reactive and indicating exposure to B. pseudomallei (Alexander et 
al., 1970a, Appassakij et al., 1990, Ashdown and Guard, 1984). Populations in northeast 
Thailand are often found to have high serological positivity by the IHA test (Kanaphun et 
al., 1993, Tiyawisutsri et al., 2005, Maude et al., 2012, Wuthiekanun et al., 2006a, Cheng et 
al., 2006, Wuthiekanun et al., 2006b). Systematic studies of the human immune response 
associated with presence of environmental B. pseudomallei and other closely related species 
(B. thailandedsis) in different regions have never been conducted. This knowledge will be 
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important to demonstrate the background sero-positivity to B. pseudomallei in different 
regions in Thailand.  
During the soil sampling study conducted in Question 1, serological response of the rice 
farmers, family members and workers who are exposed to the sampled rice fields were 
evaluated. Five milliliters of blood was collected from the study participants after informed 
consent was obtained and level of antibody against B. pseudomallei using IHA evaluated as 
described previously (Chantratita et al., 2007b). Associations between presence of B. 
pseudomallei and other closely related species (B. thailandedsis) in rice fields and level of 
serological response were evaluated. 
1.8.4 What is the incidence of meliodosis nationwide?  
Melioidosis is one of 81 notifiable diseases in Thailand. There is a large discrepancy 
between the numbers of cases and deaths of melioidosis reported in the national surveillance 
system and in the research literature, indicating that incidence and mortality of melioidosis 
are severely under-reported in the country. There are many problems with the current 
national reporting systems; including delayed culture positivity of B. pseudomallei, rapid 
mortality of melioidosis, and the workload of the hospitals. However, identifying the true 
incidence of meloidosis nationwide is crucial for informing policy makers, which could lead 
to an improvement in diagnosis, treatment and prevention of melioidosis in the country.  
Under a collaboration with BOE MoPH, Thailand, a cross-sectional retrospective, 
multicentre surveillance study in all 96 regional hospitals and general hospitals in Thailand 
was conducted. Data from the microbiology laboratory and hospital database (2012-2015) 
from each hospital, and from the national death registry held by the Ministry of Interior, 
Thailand, for the year 2012 were obtained. The study population were all patients who 
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admited to the study hospitals, and the hospital database was used. The incidence rate, 30-
day mortality, in-hospital mortality of melioidosis in 2012-2015 was estimated in patients 
with culture positive for B. pseudomallei from any clinical specimens using the 
microbiology laboratory database. The mortality rate from melioidosis in 2012-2015 was 
evaluated using the national death registry data. 
1.9 Outline of the five chapters of dissertation 
The first chapter presents general background on B. pseudomallei and the overall 
epidemiology of melioidosis. The second chapter consists of background, study design and 
findings regarding the distribution of and factors associated with presence of B. 
pseudomallei in the soil. The third chapter consists of background, study design and findings 
regarding associations between the presence of B. pseudomaleli and another closely related 
species; B. thailandensis. This chapter also includes the association between presence of 
those organisms and serological responses in healthy rice farmers working in those rice 
fields. The fourth chapter provides the information of background, study design and findings 
regarding nationwide incidence and in-hospital mortality of culture-confirmed meliodosis. 
Finally, the fifth chapter is where implications and suggestions drawn from the findings are 
discussed.  
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Chapter 2: Geographically distribution of B. pseudomallei in rice 
fields in East, Central, and Northeast Thailand and ecological 
factors associated with presence of environmental  
B. pseudomallei 
Published: 
Hantrakun V, Rongkard P, Oyuchua M, Amornchai P, Lim C, Wuthiekanun V, Day 
NP, Peacock SJ, Limmathurotsakul D: Soil Nutrient Depletion Is Associated with the 
Presence of Burkholderia pseudomallei. Appl Environ Microbiol 2016, 82(24):7086-7092. 
2.1 Abstract 
Burkholderia pseudomallei is a soil-dwelling bacterium and the cause of melioidosis, 
which kills an estimated 89,000 people per year worldwide. Agricultural workers are at high 
risk of infection due to repeated exposure. Little is known about soil physicochemical 
properties associated with presence or absence of the organism. Here, we evaluated the soil 
physicochemical properties and presence of B. pseudomallei in 6,100 soil samples collected 
from 61 rice fields in Thailand. The presence of B. pseudomallei was negatively associated 
with the proportion of clay, proportion of moisture, level of salinity, percentage of organic 
matter, presence of cadmium, and nutrient levels (phosphorous, potassium, calcium, 
magnesium and iron). The presence of B. pseudomallei was not associated with the level of 
soil acidity (p=0.54). In a multivariable logistic regression model, presence of B. 
pseudomallei was negatively associated with the percentage of organic matter (OR=0.06; 
95%CI 0.01-0.47, p=0.007), level of salinity (OR=0.06; 95%CI 0.01-0.74, p=0.03), and 
percentage of soil moisture (OR=0.81; 95%CI 0.66-1.00, p=0.05). Our study suggests that 
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in rice fields, B. pseudomallei thrives in those that are nutrient-depleted. Some agricultural 
practices result in a decline in soil nutrients, which may impact on the presence and amount 
of B. pseudomallei in affected areas. 
2.2 Author summary 
Burkholderia pseudomallei is an environmental Gram-negative bacillus and the cause 
of melioidosis. Humans acquire the disease following skin inoculation, inhalation or 
ingestion of the bacterium in the environment. The presence of B. pseudomallei in soil 
defines geographic regions where humans and livestock are at risk of melioidosis, yet little 
is known about soil properties associated with presence of the organism. We evaluated the 
soil properties and presence of B. pseudomallei in 61 rice fields in East, Central and 
Northeast Thailand. We demonstrated that the organism was more commonly found in soils 
with lower levels of organic matter and nutrients including phosphorus, potassium, calcium, 
magnesium and iron. We also demonstrated that crop residue burning after harvest, which 
can reduce soil nutrients, was not uncommon. Some agricultural practices result in a decline 
in soil nutrients, which may impact on the presence and amount of B. pseudomallei in 
affected areas. 
2.3 Introduction 
Melioidosis, an infectious disease caused by the Gram-negative bacterium Burkholderia 
pseudomallei, is an important global public health threat. An estimated 165,000 cases of 
human melioidosis occur each year worldwide, of which 89,000 (54%) die 
(Limmathurotsakul et al., 2016). The disease is highly endemic in Southeast Asia and 
Northern Australia (Wiersinga et al., 2012), and is predicted to be endemic but is grossly 
under-reported in many tropical and sub-tropical countries (Currie et al., 2008, 
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Limmathurotsakul et al., 2016). The crude case fatality rate for melioidosis ranges from 14% 
to 40% and may be as high as 70% in cases given sub-optimal antibiotic therapy (Chierakul 
et al., 2005a, Limmathurotsakul et al., 2010b, White et al., 1989). No licensed vaccine for 
melioidosis is currently available. 
B. pseudomallei is a free-living organism found in soil and water (Wiersinga et al., 
2012), and humans acquire the disease following skin inoculation, inhalation or ingestion of 
the bacterium in the environment (Limmathurotsakul et al., 2013b). In tropical developing 
countries, most patients are agricultural workers (typically rice farmers) with frequent 
contact with soil and water. Evidence-based guidelines for the prevention of melioidosis 
recommend that residents and visitors to melioidosis-endemic areas avoid direct contact 
with soil and water, and wear protective gear such as boots and gloves when in direct contact 
with soil and environmental water (Faa and Holt, 2002, Limmathurotsakul et al., 2013b). 
However, rubber boots are hot and make walking difficult in muddy rice fields, and rubber 
gloves are also hot and difficult to use while planting rice (Suntornsut et al., 2016). As a 
result, many rice farmers continue to work in rice fields without protective gear and are at 
high risk of melioidosis.  
The presence of B. pseudomallei in soil defines geographic regions where humans and 
livestock are at risk of melioidosis, but knowledge of environmental factors associated with 
the presence of the organism in the natural setting is poor and conflicting. Laboratory studies 
using sterile soil shows that B. pseudomallei grows well in soil with a high percentage of 
moisture (Tong et al., 1996, Chen et al., 2003, Kaestli et al., 2015), high level of iron (Wang-
Ngarm et al., 2014), optimal acidity (pH 4-8) (Chen et al., 2003, Wang-Ngarm et al., 2014), 
and high salinity (up to 4.2 dS/m) (Wang-Ngarm et al., 2014). By contrast, two cross-
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sectional studies in the natural environment in Northern Australia and Northeast Thailand 
found that the presence of B. pseudomallei was negatively associated with the level of iron 
in soil (Thanapat et al., 2013, Baker et al., 2015), and a recent modelling study and an 
experimental field study suggested that the presence of B. pseudomallei was not associated 
with soil acidity (Limmathurotsakul et al., 2016, Kaestli et al., 2015). Furthermore, both 
negative and positive correlations between the presence of B. pseudomallei and soil salinity 
have been reported (Limmathurotsakul et al., 2016, Kaestli et al., 2015, Baker et al., 2015). 
Land use can affect the biodiversity of organisms in soil (Newbold et al., 2015), but there is 
currently no information on the association between the presence of B. pseudomallei and 
agricultural practices.  
Here, we report the findings of a large cross-sectional environmental survey to determine 
the physicochemical characteristics of soil associated with the presence of B. pseudomallei 
in three regions in Thailand where melioidosis is considered to be highly endemic (Northeast 
and East) or non-endemic (Central). Our findings extend the understanding of soil properties 
related to environmental B. pseudomallei.  
2.4   Materials and Methods 
2.4.1 Study area 
East, Central and Northeast Thailand consist of 7, 21 and 20 provinces that cover 34,381, 
93,005 and 168,854 km2, and have an estimated population in 2013 of 3.9, 18.7 and 23.3 
million, respectively (The Bureau of registration Administration, 2013). Northeast Thailand 
is a plateau surrounded by mountain ranges, and most of the arable land consists of tropical 
sandy soil. East Thailand is characterized by short mountain ranges alternating with alluvial 
plains. Central Thailand is a large plain consisting of clay soil. Rice farming is the 
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predominant form of agriculture in all three regions. In Thailand, for administrative purposes 
each province is sub-divided into districts, sub-districts, communes and villages. The 
majority of the population in all three regions live in rural settings and most adults are 
engaged in agriculture, particularly rice farming. In 2013, land used for agriculture was 57%, 
48% and 60% in East, Central and Northeast Thailand, respectively (Office of Agricultural 
Economics, 2013).  
To evaluate environmental factors associated with the presence of B. pseudomallei, we 
selected six, seven and seven adjacent provinces in each of East, Central and Northeast 
Thailand, respectively (Figure 2-1). Three villages per province were randomly selected. 
Randomization was performed using Stata version 14.0 (StataCorp LP, College station, 
Texas). Soil sampling was performed in one rice field per one village. Rice fields were 
selected as sampling sites since rice farming is a major risk factor for melioidosis 
(Suntornsut et al., 2016). The sampled fields were those that had been used for rice farming 
for at least 12 months prior to the sampling date. Written, informed permission was obtained 
from land owners prior to sampling.  
2.4.2 Ethical approvals 
The study protocol was approved by the Ethics Committee of the Faculty of Tropical 
Medicine, Mahidol University (MUTM 2013-021-01) and the Oxford Tropical Research 
Ethics Committee, University of Oxford (OXTREC 1013-13). 
2.4.3 Soil Sampling 
Soil sampling in East, Central and Northeast Thailand was performed during the dry 
season (from April to June) in 2013, 2014 and 2015, respectively. We used the consensus 
guidelines for environmental sampling described by the Detection of Environmental B. 
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pseudomallei Working Party (DEBWorP) (Limmathurotsakul et al., 2013a). In brief, each 
rice field was divided into a grid system, in which 100 sampling points (10 by 10) were 
plotted 2.5 meters apart. At each sampling point, around 30 grams of soil was removed from 
the base of a 30-cm hole, placed in a zip bag, and kept at ambient temperature and protected 
from sunlight. We recorded the location of sampled fields using the EpiCollect application 
(www.epicollect.net, Imperial College, London) (Aanensen et al., 2009). All soil samples 
were processed within 48 hours of collection for the identification of B. pseudomallei and 
for soil physicochemical properties. 
2.4.4 Identification of B. pseudomallei 
Ten grams of soil from each sampling point was mixed with 10 ml of enrichment broth 
consisting of threonine-basal salt solution plus colistin (TBSS-C50 broth) and incubated at 
40C in air for 48 hours. Ten microliters of surface liquid was then sub-cultured onto 
Ashdown agar and incubated at 40C in air and examined every 24 hours for 4 days for 
bacterial colonies suggestive of B. pseudomallei, which were initially identified on the basis 
of colony morphotype. This included the characteristic colony morphology (purple, flat, dry 
and wrinkled) together with six additional colony morphotypes, as described previously 
(Chantratita et al., 2007a). Presumptive colonies were picked from each sample and tested 
immediately using a specific latex agglutination test for B. pseudomallei-specific CPS, as 
previously described (Anuntagool et al., 2000a, Anuntagool et al., 2000b, Wuthiekanun et 
al., 2002). For positive colonies, susceptibility to amoxicillin/clavulanic acid and arabinose 
assimilation were determined as previously described (Wuthiekanun et al., 1996). B. 
pseudomallei was defined based on the combination of colony morphology, positive latex 
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agglutination test, susceptibility to amoxicillin/clavulanic acid and negative arabinose 
assimilation (Wuthiekanun et al., 1996). 
2.4.5 Soil properties 
One kilogram of soil from each sampling field was made by aggregating 100 soil 
samples (10 g per each sampling point) and evaluated for four main properties (Table 2-1), 
as follows. (1) Physical properties: texture (proportion of sand, silt and clay) and moisture 
(% weight for weight [%w/w]). (2) Acidity and salinity: pH, lime requirement (to adjust soil 
acidity; kg/100sqm) and electrical conductivity (deciSiements/meter [dS/m]). (3) Chemical 
properties: total nitrogen (mg/kg), available phosphorous (mg/kg), exchangeable potassium 
(mg/kg), exchangeable calcium (mg/kg), available magnesium (mg/kg), extractable sulphur 
(mg/kg), total iron (g/kg), total cadmium (mg/kg), exchangeable sodium (mg/kg) and cation 
exchange capacity (cmol/mg). (4) Biological related factors: organic matter (%w/w) and 
carbon to nitrogen ratio (C:N ratio).  
2.4.6 Agricultural practices 
A closed-end interviewee-based questionnaire was used to collect the information about 
agricultural practices (Appendix 1). For illiterate participants, the questionnaire was read to 
the participant and completed by trained research staff in accordance with their responses. 
Questions included fertilizer used and rice field management (before planting and after 
harvest) in the 12 months before the sampling date. 
2.4.7 Sample size calculation 
To determine the optimal sample size, we performed a pilot study of soil sampling in 
four rice fields in Chachoengsao province, East Thailand. Three of four rice fields (75%) 
were culture positive for B. pseudomallei. We calculated that 60 rice fields (3 rice fields per 
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province) were needed to determine environmental factors associated with B. pseudomallei 
with a power of 80% at an alpha error of 5%.  
2.4.8 Statistical analysis 
The outcomes of interest were positivity of B. pseudomallei in rice fields and its 
association with soil properties. Binary and continuous variables were compared by using 
the Fisher’s exact test and Mann-Whitney test, respectively. Soil properties associated with 
the presence of B. pseudomallei were evaluated using univariable and multivariable logistic 
regression. The final multivariable logistic regression models were developed using a 
purposeful selection method (Bursac et al., 2008). Sensitivity analysis was conducted using 
region-stratified analysis.  We also used ordered logistic regression to evaluate the 
association between soil properties and quantity of B. pseudomallei. The number of positive 
sampling points for B. pseudomallei within a rice field was used to represent the quantity of 
B. pseudomallei distribution in the field. The Spearman correlation coefficient was used to 
evaluate the correlation between soil properties. All statistical tests were performed using 
Stata version 14.0 (StataCorp LP, College station, Texas). The final database with the data 
dictionary are publicly available online (https://figshare.com/s/b44c335a9b321ab19325).  
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Table 2-1 Soil physicochemical properties methods used and normal range 
Soil physicochemical characteristics Method & Definition Normal range  
Physical factors   
 Percentage of sand, silt and clay  Hydrometer method classified by particles size: 
sand (0.05– 2 mm), silt (0.002 – 0.05 mm) and 
clay (<0.002 mm) 
Combination of sand, silt and 
clay is 100% 
 Moisture (%w/w) Gravimetric method Not available 
Acidity and salinity factors   
 pH pH meter method: Acidity and alkalinity of the 
soil 
Extremely acid <4.5,  
Very acid soil 4.5-5.5,  
Mild acid 5.6-6.5, 
Neutral 6.6–7.3, 
Mild alkaline 7.4-7.8, 
Alkaline 7.9-8.4, 
Very alkaline 8.5-9.0, 
Extremely alkaline 9.02 
 Electrical conductivity (dS/m) EC meter method: soluble salt content in the soil Very low (non-saline) 0-2,  
Mild salinity 2-4,  
saline soil 4-8,  
high 8-16,  
very high ≥162 
 Lime requirement (kg/100sqm) Woodruff  buffer method Not available 
Chemical factors   
 Total nitrogen (mg/kg) Kjeldahl method Not available 
 Available phosphorous (mg/kg) Bray II method Very low <6,  
low 6-12,  
average 13-25,  
high 26-50,  
very high >50 mg/kg2 
 Exchangeable potassium (mg/kg) Automated Flame photometric method Very low <16,  
low 16-30,  
average 31-60,  
high 60-120,  
very high >120 mg/kg2 
 Exchangeable calcium (mg/kg) Flame photometic method Not available 
 Available magnesium (mg/kg) Flame photometic method Not available 
 Extractable sulphur (mg/kg) Turbidimetric method Not available 
 Exchangeable sodium (mg/kg) Flame photometic method 6020 Not available 
 Total iron (Fe; g/kg)3 Based on US EPA method 6101B Not available 
 Total cadmium (mg/kg) 3 Based on US EPA method 6020 <37 mg/kg1 
 Cation exchange capacity 
(cmol/kg) 
Filtration method: The number of 
exchangeable cations per dry weight that a soil is 
capable of holding, at a given pH value, and 
available for exchange with the soil water 
solution. 
>15 cmol/kg2  
Biological related factors   
 Organic matter (%w/w) Walkley and black method.  very low <0.5%,  
low 0.5-1.5%,  
average 1.5-2.5%,  
somewhat high 2.5-3.5%,   
high 3.5-4.5%, 
very high >4.5%2 
 Carbon to nitrogen ratio Walkley and black method/Kjeldahl method: A 
ratio of the mass of carbon to the mass of 
nitrogen in a substance. 
Not available 
1 Pollution Control Department (PCD), Ministry of Science Technology and Environment, Thailand 
2 Land Development Department (LDD), Ministry of Agriculture and Cooperatives, Thailand 
3 Iron and cadmium were tested by Central Laboratory (Bangkok, Thailand).  
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2.5  Results 
2.5.1 Distribution of B. pseudomallei in Northeast, East and Central Thailand 
Of 6,100 soil samples collected from 61 rice fields (100 soil samples per rice field), 
1,046 were culture positive for B. pseudomallei (Figure 2-1). A total of 30 of 61 rice fields 
(49%) had at least one sampling point that was culture positive for the organism. Percentages 
of rice field culture-positive for B. pseudomallei were 57% (12 of 21 rice fields), 68% (13 
of 19 rice fields) and 24% (5 of 21 rice fields) in Northeast, East and Central Thailand, 
respectively. The percentage of rice fields culture-positive for B. pseudomallei in the 
Northeast and East were higher than that in Central Thailand (57% vs. 24%, p=0.06 and 
68% vs. 24%, p=0.01), while the percentage was not significantly different between the 
Northeast and East (57% vs. 68%, p=0.53).  
For the rice fields that were culture-positive for B. pseudomallei, the median number of 
positive sampling points were 53 (range 2 to 98), 16 (range 1 to 81) and 1 (range 1 to 63) in 
Northeast, East and Central Thailand, respectively (Table 2-2). The median number of 
positive sampling points in the Northeast and East were both higher than that in Central 
Thailand (p=0.01 and p=0.002), while the number was not significantly different between 
the East and Northeast (p=0.61).  
2.5.2 Characteristics of soil and agricultural practices 
Overall comparison of soil properties among the three regions studied shows that soils 
from Central Thailand have the highest median percentage of clay (53%), followed by the 
Northeast (45%) and East (32%). Soil acidity (pH) varied considerably, ranging from very 
acid (pH=4.9) to carbonate-rich soil (pH=8.1), but was not significantly different between 
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the three regions (p=0.68). Soil salinity, as determined by electrical conductivity and 
expressed in dS/m, was very low in all fields sampled (<2.0 dS/m).  
Farmers were interviewed about land management before and after rice planting 
(including the fertilizer used, and crop residue burning before and after harvest) in the 12 
months before the sampling date. Of 61 rice fields evaluated, 54 (89%) were treated with 
chemical fertilizer, 17 (28%) with organic fertilizer made from plant material, 22 (36%) with 
organic fertilizer made from animal dung, and 39 (64%) with biological fertilizer such as 
“Effective Microorganisms”. Owners of 24 (39%) rice fields burned their fields between 
rice planting seasons. The median percentage of organic matter in fields with a history of 
burning was not significantly lower than that of others (0.81 vs. 0.84 %w/w, p=0.82). 
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Table 2-2 Number of culture positive samples for B. pseudomallei in 61 rice fields 
Region Province Number of sampling points culture positive for B. 
pseudomallei per 100 sampling points (sampled rice fields1) 
Rice field 
no. 1 
Rice field 
no. 2 
Rice field 
no. 3 
Rice field 
no.4 
Northeast Burirum 87 (NE1-1) 0 (NE1-2) 97 (NE1-3) - 
 Chaiyaphum 0 (NE2-1) 98 (NE2-2) 0 (NE2-3) - 
 Khon Kaen 72 (NE3-1) 94 (NE3-2) 35 (NE3-3) - 
 Udon Thani 40 (NE4-1) 0 (NE4-2) 28 (NE4-3) - 
 Nong Bua Lam 
Phu 
58 (NE5-1) 0 (NE5-2) 48 (NE5-3) - 
 Loei 4 (NE6-1) 0 (NE6-2) 0 (NE6-3) - 
 Nakhon 
Ratchasima 
2 (NE7-1) 0 (NE7-2) 0 (NE7-3) - 
East Chachoengsao2 39 (E1-1) 8 (E1-2) 43 (E1-3) 0 (E1-4) 
 Prachinburi 10 (E2-1) 6 (E2-2) 0 (E2-3) - 
 Sa Kaeo 17 (E3-1) 0 (E3-2) 81 (E3-3) - 
 Chanthaburi 16 (E4-1) 1 (E4-2) 0 (E4-3) - 
 Chonburi 3 (E5-1) 32 (E5-2) 0 (E5-3) - 
 Rayong 1 (E6-1) 0 (E6-2) 57 (E6-3) - 
Central Phetchabun 0 (C1-1) 0 (C1-2) 3 (C1-3) - 
 Phitsanulok 1 (C2-1) 1 (C2-2) 0 (C2-3) - 
 Pathum Thani 0 (C3-1) 0 (C3-2) 0 (C3-3) - 
 Saraburi 0 (C4-1) 0 (C4-2) 0 (C4-3) - 
 Lopburi 0 (C5-1) 0 (C5-2) 0 (C5-3) - 
 Nakhon Nayok 63 (C6-1) 1 (C6-2) 0 (C6-3) - 
 Bangkok 0 (C7-1) 0 (C7-2) 0 (C7-3) - 
1 Each rice field was divided into a grid system, in which 100 sampling points (10 by 10) were plotted 2.5 
m apart. At each sampling point, 10 g of soil at 30 cm depth was collected and cultured for B. pseudomallei.  
2A pilot study of soil sampling were performed in four rice fields in Chachoengsao province, East Thailand. 
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Figure 2-1 Distribution of B. pseudomallei in Central, East and Northeast Thailand. 
(a) Map of Thailand. (b) Location of the 61 rice fields evaluated. Red and white circles, culture positive 
and negative for B. pseudomallei, respectively. Province codes represent Phetchabun (C1),  Phitsanulok 
(C2), Pathum Thani (C3), Saraburi (C4), Lopburi (C5), Nakhon Nayok (C6) and Bangkok (C7) in Central 
Thailand, Chachoengsao (E1), Prachinburi (E2), Sa Kaeo (E3), Chanthaburi (E4), Chonburi (E5) and 
Rayong (E6) in the East, and Burirum (NE1), Chaiyaphum (NE2), Khon Kaen (NE3), Udon Thani (NE4), 
Nong Bua Lam Phu (NE5), Loei (NE6) and Nakhon Ratchasima (NE7) in the Northeast. 
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2.5.3 Association between soil physicochemical properties and B. pseudomallei  
We found that the presence of B. pseudomallei was associated with nutrient-depleted 
soil (Table 2-3, Figure 2-2). Presence of the organism was negatively associated with the 
percentage of soil moisture (p<0.001), the level of soil salinity (p=0.001), presence of 
cadmium (p<0.001) and levels of multiple nutrients including available phosphorous 
(p=0.03), exchangeable potassium (p<0.001), exchangeable calcium (p=0.001), available 
magnesium (p=0.002) and total iron (p=0.002). Levels of overall nutrients and total nutrient 
fixing capacity of soil determined by organic matter and cation exchange capacity, 
respectively, were also negatively associated with the presence of B. pseudomallei (both p 
values<0.001). The carbon to nitrogen ratio, which is used to determine how easily bacteria 
can decompose organic material in soil, was also negatively associated with the presence of 
B. pseudomallei (p=0.01). Presence of the organism was positively associated with the 
proportion of sand (p=0.02), negatively associated with the proportion of clay (p=0.002), 
and not associated with the proportion of silt (p=0.68). Presence of B. pseudomallei was not 
associated with soil acidity (p=0.54), or agricultural practices. Many soil physicochemical 
properties were strongly correlated (Table 2-4). 
We used multivariable logistic regression analysis and found that the presence of B. 
pseudomallei was negatively associated with the percentage of organic matter (OR=0.06; 
95%CI 0.01-0.47, p=0.007), level of salinity (OR=0.06; 95%CI 0.01-0.74, p=0.03), and 
level of soil moisture (OR=0.81; 95%CI 0.66-1.00, p=0.05) (Table 2-5). A sensitivity 
analysis was conducted by including region as a stratification variable, which gave 
comparable results. 
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In addition, we also used ordered logistic regression to further evaluate the association 
between the quantity of B. pseudomallei distribution in rice fields and soil physicochemical 
factors. We observed that the number of sampling points culture positive for B. pseudomallei 
was also negatively associated with the percentage of organic matter (OR=0.06; 95%CI 
0.01-0.32, p=0.001), level of soil moisture (OR=0.78; 95%CI 0.66-0.91, p=0.002) and level 
of salinity (OR=0.07; 95%CI 0.01-0.53, p=0.01) (Table 2-6).   
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Table 2-3 Soil physicochemical properties associated with the presence of B. 
pseudomallei 
Soil physicochemical 
characteristics 
Rice fields 
positive for B. 
pseudomallei1 
(n=30) 
Rice fields negative 
for B. pseudomallei1 
(n=31) 
Crude odds ratio  
(95% CI) 
p value 
Physical factors     
 Sand (%) 22.4 (4.3-78.8) 12.0 (7.8-81.0) 1.04 (1.01-1.07) 0.02 
 Silt (%) 32.2 (9.7-57.2) 34.5 (11.7-53.2) 0.99 (0.95-1.03) 0.68 
 Clay (%) 34.1 (11.5-57.6) 51.9 (7.3-58.6) 0.93 (0.88-0.97) 0.002 
 Moisture (%w/w) 9.9 (2.5-19.5) 16.1 (7.9-31.8) 0.78 (0.67-0.90) <0.001 
Acidity and salinity factors     
 pH 6.8 (4.9-8.1) 6.6 (5.0-7.8) 1.23 (0.63-2.40) 0.54 
 Electrical conductivity 
(dS/m) 0.3 (0.04-1.4) 0.5 (0.1-1.5) 0.22 (0.09-0.53) 0.001 
 Lime requirement 
(kg/100sqm) 7.5 (0-30) 6.2 (0-22.5) 1.00 (1.00-1.01) 0.10 
Chemical factors     
 Total nitrogen (mg/kg) 598 (175-2,442) 731 (278-1,601) 0.99 (0.98-1.01) 2 0.41 
 Available phosphorous 
(mg/kg) 5 (0.2-23) 10 (0.4-38) 0.35 (0.15-0.83) 2 0.02 
 Exchangeable 
potassium (mg/kg) 45 (11-115) 93 (32-252) 0.52 (0.37-0.74) 2 <0.001 
 Exchangeable calcium 
(mg/kg) 673 (272-1,289) 1474 (602-4,326) 0.93 (0.90-0.97) 2 0.001 
 Available magnesium 
(mg/kg) 134 (44-498) 255 (93-823) 0.92 (0.87-0.97) 2 0.003 
 Extractable  sulphur 
(mg/kg) 12 (0-114) 24 (0-88) 0.94 (0.77-1.15) 2 0.55 
 Exchangeable sodium 
(mg/kg) 144 (89-217) 161 (98-241) 0.87 (0.75-1.01)2 0.07 
 Total iron (Fe; g/kg) 12 (0.6-96) 36 (4- 79) 0.95 (0.92-0.98) 0.002 
 Total cadmium 
o not detected 
o detected 
25 fields (83%) 
5 fields (17%) 
11 fields (35%) 
20 fields (65%) 
1.0 
0.11 (0.03-0.37)3 <0.001 
 Cation exchange 
capacity (cmol/mg) 6.7 (2.0-28.5) 24.4 (0.6-47.9) 0.89 (0.84-0.95) <0.001 
Biological related factors     
 Organic matter 
(%w/w) 0.6 (0.2-1.5) 1.5 (0.6-2.8) 0.02 (0.003-0.17) <0.001 
 Carbon to nitrogen 
ratio 5.4 (2.0-19.3) 11.0 (3.6-42.6) 0.81 (0.70-0.94) 0.01 
1 Median (range) unless other are specified. 
2 Odds ratio for any increase of 100 mg/kg in nutrient.  
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Figure 2-2 Soil physicochemical properties associated with the presence of B. pseudomallei 
Box–whisker plots indicate median, interquartile range and distribution of the data. Dots indicate the outliers (data located outside 1.5 times of 
interquartile range) (Tukey, 1977). 
 
Red and grey boxes represent rice fields culture positive (Pos) and negative (Neg) for B. pseudomallei, respectively. *P≤0.05, **P≤0.01, ***P≤0.001 
and NS=Not Significant. 
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Table 2-4 Correlation coefficients among soil physicochemical properties in the East, Central and Northeast Thailand 
 Sand Silt Clay pH LR1 OM1 EC1 TotalN1 AvailP1 ExchK1 
Sand 1          
Silt -0.74*** 1         
Clay -0.77*** 0.13 1        
pH 0.12 -0.03 -0.15 1       
LR1 0.22 -0.29* -0.05 -0.49*** 1      
OM1 -0.25* -0.01 0.38** -0.10 -0.18 1     
EC1 -0.14 -0.09 0.29* -0.10 -0.11 0.35** 1    
TotalN1 -0.13 -0.08 0.27* -0.15 0.14 0.35** 0.18 1   
AvailP1 -0.17 0.16 0.11 -0.04 -0.01 0.37** 0.11 0.28* 1  
ExchK1 -0.27* -0.11 0.51*** -0.26* -0.16 0.63*** 0.44*** 0.31* 0.40** 1 
ExchCa1 -0.19 -0.07 0.35** -0.06 -0.36** 0.57*** 0.29* 0.10 0.17 0.64*** 
AvailMg1 -0.27* 0.02 0.38** -0.14 -0.28* 0.47*** 0.19 0.16 0.003 0.47*** 
ExtrS1 -0.20 0.17 0.14 -0.20 -0.01 0.14 0.21 0.14 0.16 0.17 
ExchNa1 -0.38** 0.26* 0.32* -0.23 0.03 0.26* 0.12 0.16 0.24 0.29* 
CEC1 -0.31* -0.06 0.51*** -0.25 -0.12 0.76*** 0.34** 0.27* 0.18 0.69*** 
Moisture -0.46*** 0.16 0.53*** -0.27* -0.18 0.55*** 0.23 0.26* 0.20 0.60*** 
CNRatio1 0.003 0.001 -0.01 0.05 -0.24 0.57*** 0.04 -0.36** 0.28* 0.27* 
CD1 -0.25* 0.12 0.26* 0.07 -0.13 0.63*** 0.15 0.09 0.24 0.32* 
Iron1 -0.38** 0.08 0.48*** -0.16 0.004 0.63*** 0.11 0.21 0.27* 0.42*** 
Statistically significant *p≤0.05, **p≤0.01 and ***p≤0.001 
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Table 2-5 Soil physicochemical properties associated with the presence of B. 
pseudomallei in a multivariable logistic regression model 
Soil physicochemical characteristics Adjusted odds ratio (95% CI) p value 
Organic matter (%w/w) 0.06 (0.01-0.47) 0.007 
Electrical conductivity (dS/m) 0.06 (0.01-0.74) 0.03 
Moisture (%) 0.81 (0.66-1.00) 0.05 
 
Table 2-6  Association between soil physicochemical properties and quantity of B. 
pseudomallei distribution in rice field determined by ordered logistic regression  
Soil physicochemical characteristics Adjusted odds ratio (95% CI) p value 
Organic matter (%w/w) 0.06 (0.01-0.32) 0.001 
Moisture (%) 0.78 (0.66-0.91) 0.002 
Electrical conductivity (dS/m) 0.07 (0.01-0.53) 0.01 
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2.6 Discussion 
The results of our large environmental study demonstrated an association between the 
presence of B. pseudomallei and nutrient-depleted soil in rice fields in Thailand. Negative 
associations between the presence of B. pseudomallei and nutrient levels in the soil were 
observed for each of the nutrients evaluated (with the exception of total nitrogen, 
exchangeable sodium and extractable sulphur) and for organic matter and cation exchange 
capacity, which represent levels of overall nutrients and total nutrient fixing capacity of 
soil, respectively. This is also supported by the negative association between the presence 
of B. pseudomallei and the level of salinity, which could also represent the level of soil 
nutrients in the environment (Kaestli et al., 2015). Our findings are important because 
nutrients in the soil are effected by agricultural practices, and crop residue burning after 
harvest is not uncommon in Thailand and many other tropical countries. There is strong 
evidence to show that burning can reduce soil nutrients by eliminating crop residues and 
soil organisms present on the soil surface (FAO, 2005). Poor agricultural practices could 
impact on the presence and amount of B. pseudomallei. This suggests that changes in 
agricultural practice and improvement of soil nutrient content might also be essential to 
reduce the distribution of B. pseudomallei and incidence of melioidosis.   
Our study also highlights the difference between findings from experimental soil 
inoculated with B. pseudomallei, environmental studies in small areas where melioidosis 
is endemic, and this large environmental study. For example, soil moisture was positively 
associated with presence of B. pseudomallei in experimental soil studies (Tong et al., 1996, 
Chen et al., 2003, Kaestli et al., 2015), and environmental studies of small areas where 
melioidosis is endemic (Kaestli et al., 2009, Sermswan et al., 2015). It has been postulated 
that B. pseudomallei can move from deeper soil layers to the surface during the rainy 
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season and rising water table where it may then multiply (Thomas et al., 1979). Our study 
shows that soil in Northeast Thailand (where B. pseudomallei is abundant in soil) is mostly 
sandy soil with a low level of organic matter and moisture, while soil in Central Thailand 
(where B. pseudomallei is less abundant), is mostly clay soil with high level of organic 
matter and moisture. This is also supported by a recent finding of the presence of B. 
pseudomallei in a desert region outside the wet tropics in Northern Australia (Yip et al., 
2015).  
Organic matter in soil contains vital nutrients and influences the diversity and 
biological activity of soil organisms (FAO, 2005). The negative association between soil 
organic matter and the presence of B. pseudomallei is consistent with two previous 
environmental studies in Northern Australia (Baker et al., 2015) and Northeast Thailand 
(Ngamsang et al., 2015), which show that the level of organic carbon is negatively 
associated with presence of B. pseudomallei. The level of organic carbon is a measure of 
the carbon contained within the soil organic matter. It is possible that soils with high 
organic matter have high biotic stress because abundant soil microorganisms are 
competing for substrates, water or growth factors (Ian L. Pepper, 2009), which may inhibit 
the survival or growth of B. pseudomallei. This is supported by an environmental study 
showing that low microbial density in soil is associated with the presence of B. 
pseudomallei (Sermswan et al., 2015, Potisap et al., 2018) and that Bacillus 
amyloliquefaciens extracted from soil samples can inhibit the growth of B. pseudomallei 
(Chotima et al., 2016). It is also possible that depletion of individual nutrients such as iron 
supports the growth of B. pseudomallei, which has a range of mechanisms to persist in low 
iron environments (Ribolzi et al., 2016). An additional possibility is that environmental 
stress selects for persister cells of B. pseudomallei, as has been recently shown for 
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Pseudomonas aeruginosa in nutrient-limited conditions and in biofilm (Nguyen et al., 
2011). B. pseudomallei are taken up by amoebae,  which in vitro are associated with 
survival  in the presence of disinfecting agents and antimicrobial drugs (Inglis et al., 2004, 
Howard and Inglis, 2005), and may represent an additional survival advantage for B. 
pseudomallei in nutrient-depleted soil. 
Our findings suggest that extremely low levels of salinity (such as <0.1 dS/m) may be 
an indirect measure of nutrient depletion in rice fields. This is because soil salinity as 
estimated by measuring electrical conductivity represents soluble salts of soil nutrients, 
including sodium, chloride, magnesium, calcium, potassium and nitrate. Our finding is 
consistent with an experimental study in Northern Australia (Kaestli et al., 2015), which 
shows that B. pseudomallei grows well in soil with low electrical conductivity (0.1 dS/m) 
but could not survive in commercial soil, which has a high level of organic based compost 
and high electrical conductivity (0.7 dS/m). Although a recent modelling study proposed 
a positive association between salinity level and presence of B. pseudomallei, this 
estimation was based on soil salinity for all land (undisturbed land, agricultural land, sports 
fields, etc) with an electrical conductivity ranging from 0 to >20 dS/m (Limmathurotsakul 
et al., 2016). It is also possible that the effect of salinity in rice fields may be different from 
non-rice fields; for example, garden and unused land. For example, rice fields may be 
intentionally flooded and drained repeatedly to reduce salinity to a very low level (<2.0 
dS/m) (FAO, UN), and this could lead to the loss of water-soluble nutrients from the soil 
(Inthong et al., 2005, Stoate et al., 2001, Pathak et al., 2004).  
B. pseudomallei can survive well in soil under laboratory condition with pH ranging 
from 4 to 8 (Wang-Ngarm et al., 2014), and our study supports the lack of association 
between presence of B. pseudomallei and pH.  
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A limitation of our study is that soil sampling was only performed during the dry 
season over a period of three years. We chose to sample during the dry season to control 
for variation in the presence of B. pseudomallei and soil physicochemical properties 
associated with seasonal changes. Recent environmental studies showed that soil 
properties are not different between the dry and wet season (Thanapat et al., 2013), and 
that changes in the presence of B. pseudomallei in the soil with very low salinity level 
(<2.0 dS/m) measured over three years were minimal (Kaestli et al., 2015). It is possible 
that the presence of B. pseudomallei in rice fields would have been generally higher if the 
study was conducted during the rainy season. Although the difference in percentage of 
organic matter between fields with and without a history of burning was not observed in 
our study, this could be because of the cross-sectional study design or other confounding 
factors. For example, some fields were burned more than 12 months before the study was 
conducted.  
In summary, our large cross-sectional environmental survey has shown that the 
presence of the important human pathogen B. pseudomallei is associated with nutrient-
depleted rice fields. Further investigations are required to evaluate whether changes in 
agricultural practices could effectively enhance soil nutrients, and whether these could 
reduce the distribution of B. pseudomallei in rice fields. 
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Chapter 3: Serological responses in people who are exposed to 
environmental B. pseudomallei and closely related species 
Published: 
Hantrakun V, Thaipadungpanit J, Rongkard P, Srilohasin P, Amornchai P, Langla S, 
Mukaka M, Chantratita N, Wuthiekanun V, Dance DAB et al: Presence of B. thailandensis 
and B. thailandensis expressing B. pseudomallei-like capsular polysaccharide in Thailand, 
and their associations with serological response to B. pseudomallei. PLoS Negl Trop Dis 
2018, 12(1):e0006193. 
3.1 Abstract 
Burkholderia pseudomallei is an environmental Gram-negative bacillus and the cause 
of melioidosis. B. thailandensis, some strains of which express a B. pseudomallei-like 
capsular polysaccharide (BTCV), is also commonly found in the environment in Southeast 
Asia but is considered non-pathogenic. The aim of the study was to determine the 
distribution of B. thailandensis and its capsular variant in Thailand and investigate whether 
its presence is associated with a serological response to B. pseudomallei. We evaluated the 
presence of B. pseudomallei and B. thailandensis in 61 rice fields in Northeast (n=21), 
East (n=19) and Central (n=21) Thailand. We found BTCV in rice fields in East and 
Central but not Northeast Thailand. Fourteen fields were culture positive for B. 
pseudomallei alone, 8 for B. thailandensis alone, 11 for both B. pseudomallei and B. 
thailandensis, 6 for both B. thailandensis and BTCV, and 5 for B. pseudomallei, B. 
thailandensis and BTCV. Serological testing using the indirect hemagglutination assay 
(IHA) of 96 farmers who worked in the study fields demonstrated that farmers who worked 
in B. pseudomallei-positive fields had higher IHA titers than those who worked in B. 
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pseudomallei-negative fields (median 1:40 [range: <1:10-1:640] vs. <1:10 [range: <1:10-
1:320],  p=0.002). In a multivariable ordered logistic regression model, IHA titers were 
significantly associated with the presence of B. pseudomallei (aOR=3.7; 95% CI 1.8-7.8, 
p=0.001) but were not associated with presence of B. thailandensis (p=0.32) or BTCV 
(p=0.32). One sequence type (696) was identified for the 27 BTCV isolates tested.  This 
is the first report of BTCV in Thailand. The presence of B. pseudomallei and B. 
thailandensis in the same field was not uncommon. Our findings suggest that IHA 
positivity of healthy rice farmers in Thailand is associated with the presence of B. 
pseudomallei in rice fields rather than B. thailandensis or BTCV. 
3.2 Author summary   
Burkholderia thailandensis is a non-pathogenic soil-dwelling bacterium and is 
genetically closely related to Burkholderia pseudomallei, the cause of melioidosis. In 
mouse models, inoculation of a variant of B. thailandensis which express a B. 
pseudomallei-like capsular polysaccharide (BTCV) induces antibodies and partial 
protection against melioidosis. Here, we evaluated the presence of B. pseudomallei, B. 
thailandensis, and BTCV in 61 rice fields in Northeast, East and Central Thailand, 
determined whether they co-existed, and if their presence was associated with a serological 
response in farmers. We report the presence of BTCV in Thailand for the first time and 
describe the distribution of the three organisms. Co-localization between these organisms 
in the same rice fields was not uncommon. Our findings suggested that serological 
positivity based on the indirect hemagglutination assay (a test commonly used to detect 
antibodies to B. pseudomallei) in healthy rice farmers in Thailand was associated with 
exposure to B. pseudomallei, but not exposure to B. thailandensis or BTCV. 
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3.3 Introduction  
Burkholderia pseudomallei is a soil-dwelling Gram-negative bacterium and the cause 
of melioidosis, a frequently fatal infectious disease of humans and animals. Humans 
acquire the disease following skin inoculation, inhalation or ingestion of the bacterium 
from the environment. The disease is highly endemic in Southeast Asia and Northern 
Australia (Wiersinga et al., 2012), and is increasingly being reported in South Asia, Africa 
and Central and South America (Redondo et al., 2011, Currie et al., 2008). A recent 
modeling study estimated that there are about 165,000 human melioidosis cases per year 
worldwide, of whom 89,000 (54%) die (Limmathurotsakul et al., 2016). The current 
diagnostic standard for melioidosis is microbiological culture (Hoffmaster et al., 2015). 
However, melioidosis is difficult to diagnose due to its diverse clinical manifestations, the 
inadequacy of conventional bacterial identification methods, and a lack of microbiology 
laboratories in tropical developing countries (Hoffmaster et al., 2015). An indirect 
haemagglutination assay (IHA) is the most frequently used serological test for melioidosis, 
but may be misleading when used for the diagnosis of melioidosis in disease-endemic 
regions (Hoffmaster et al., 2015). This is because the background seropositivity (IHA titers 
≥1:160) ranges from 4% to 32% in healthy individuals living in areas where melioidosis 
is endemic (Maude et al., 2012, Hii et al., 2016, Suttisunhakul et al., 2016). Therefore, 
IHA is recommended as a serological standard to assess exposure to B. pseudomallei 
(Hoffmaster et al., 2015). 
Burkholderia thailandensis was first recognized by Wuthiekanun et al. in 1996 
(Wuthiekanun et al., 1996). The organism is genetically closely related to B. pseudomallei, 
can be isolated from environmental soil and water, and is non-pathogenic (Wuthiekanun 
et al., 1996, Trakulsomboon et al., 1997, Sermswan et al., 2015). The colony morphology 
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of B. thailandensis and B. pseudomallei are very similar, but B. thailandensis can 
assimilate L-arabinose (Smith et al., 1997, Brett et al., 1998). In addition, B. thailandensis 
has polysaccharide-related genes that are distinct from B. pseudomallei (74.8% and 72.8% 
nucleotide and protein similarity, respectively) and  usually lacks the virulence-associated 
capsular polysaccharide (also referred to as CPS or CPS-I) of B. pseudomallei (Reckseidler 
et al., 2001, Smith et al., 1993, Wuthiekanun et al., 2002, Sim et al., 2010). The 
geographical distribution of B. thailandensis is uncertain but the organism has rarely been 
isolated from fields that are culture positive for B. pseudomallei (Vuddhakul et al., 1999, 
Trakulsomboon et al., 1999). It was recently shown that B. pseudomallei can inhibit the 
growth and motility of B. thailandensis in the laboratory (Ngamdee et al., 2015). However, 
previous environmental studies did not systematically evaluate the presence of both 
organisms, so the presence of B. thailandensis and co-localization of both organisms may 
have been underestimated (Vuddhakul et al., 1999, Trakulsomboon et al., 1999). In an 
experimental mouse model, lipopolysaccharide extracted from B. thailandensis induced 
measurable IgG and IgM, and provided partial protection against melioidosis (Ngugi et 
al., 2010). The association between exposure to environmental B. thailandensis and IHA 
seropositivity in humans is still largely unknown.  
A variant of B. thailandensis originally isolated from soil in Cambodia (E555) that 
contained genes encoding a B. pseudomallei-like capsular polysaccharide cluster (BTCV) 
was described in 2010 (Sim et al., 2010). This organism exhibited several B. pseudomallei-
like phenotypes including colony wrinkling, resistance to human complement binding, and 
intracellular macrophage survival. However, in mice E555 was avirulent (Sim et al., 2010), 
induced higher levels of IgG and gave better protection against melioidosis than non-
capsulated B. thailandensis (Scott et al., 2013). The capsular polysaccharide (CPS) 
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biosynthesis gene cluster of E555 and that of B. pseudomallei are highly similar (94.4% 
and 96% nucleotide and protein similarity, respectively) (Sim et al., 2010), and nuclear 
magnetic resonance spectroscopy has shown that the structures of CPS produced by E555 
and that of B. pseudomallei are identical (Bayliss et al., 2017). Previously, BTCV has been 
isolated from human blood in the USA in 2003 (strain CDC3015869; ST101, USA (Glass 
et al., 2006)) and from environmental samples in Cambodia in 2010 (strain E555; ST696 
), Gabon in 2013 (strain D50; ST1126 (Wiersinga et al., 2015)) and Laos in 2015 (strain 
ST_10; ST696 (Knappik et al., 2015)). BTCV has not been reported in Thailand and its 
distribution is unknown.  
We recently reported the presence of B. pseudomallei in 61 rice fields in the Northeast, 
East and Central Thailand, and its association with soil physicochemical properties 
(Hantrakun et al., 2016). Here, we report the presence of B. thailandensis and co-
localization between B. pseudomallei and B. thailandensis in the same rice fields, and 
provide the first report of the BTCV in Thailand. In addition, we explored whether 
exposure to B. thailandensis and BTCV is associated with background seropositivity to B. 
pseudomallei by evaluating IHA levels in healthy adults who worked in the sampled rice 
fields. 
3.4   Materials and Methods 
3.4.1 Study area 
East, Central and Northeast Thailand consist of 7, 21 and 20 provinces, cover 34,381, 
93,005 and 168,854 km2, and had estimated populations in 2013 of 3.9, 18.7 and 23.3 
million, respectively (The Bureau of Registration Administration, 2013). Northeast 
Thailand is a plateau surrounded by mountain ranges, and most of the arable land consists 
of tropical sandy soil. East Thailand is characterized by short mountain ranges alternating 
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with alluvial plains. Central Thailand is a large plain consisting of clay soil. Rice farming 
is the predominant form of agriculture in all three regions. In Thailand, for administrative 
purposes each province is sub-divided into districts, sub-districts, communes and villages. 
The majority of the population in all three regions live in rural settings and most adults are 
engaged in agriculture, particularly rice farming. In 2013, areas used for agriculture were 
57%, 48% and 60% in East, Central and Northeast Thailand, respectively (Office of 
Agricultural Economics, 2013).  
3.4.2 Study design 
We conducted a cross-sectional environmental survey as described previously 
(Hantrakun et al., 2016). All B. pseudomallei, B. thailandensis and BTCV reported in this 
work were from the same environmental survey (Hantrakun et al., 2016). In brief, we 
collected soil from randomly-selected rice fields in the East, Central and Northeast regions 
during the dry season (from April – June) in 2013, 2014 and 2015, respectively. We 
sampled rice fields that had been used for rice farming in the 12 months prior to the 
sampling date. We collected the blood from farmers who were exposed to the sampled rice 
fields in the 12 months prior to the blood collection date. 
3.4.3 Ethics statement 
Written, informed consent was obtained from land owners and farmers prior to soil 
sampling and blood collection, respectively. The study protocol was approved by the 
Ethics Committee of the Faculty of Tropical Medicine, Mahidol University (MUTM 2013-
021-01) and the Oxford Tropical Research Ethics Committee, University of Oxford 
(OXTREC 1013-13). 
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3.4.4 Soil sampling and soil properties 
The method used for soil sampling was described previously (Limmathurotsakul et al., 
2013a, Hantrakun et al., 2016). In brief, each rice field was divided into a 10x10 grid 
system to generate 100 sampling points per field. At each sampling point, around 30 grams 
of soil was removed from the base of a 30-cm hole. All soil samples were processed within 
48 hours of collection for the identification of B. pseudomallei and B. thailandensis, and 
for soil physicochemical properties. One kilogram of soil from each sampling field was 
made by aggregating 100 soil samples (10 g per each sampling point) and evaluated for 
soil physicochemical properties as described previously (Hantrakun et al., 2016). 
3.4.5 Identification of B. pseudomallei and B. thailandensis 
Ten grams of soil from each sampling point was mixed with 10 ml of enrichment broth 
consisting of threonine-basal salt solution plus colistin 50mg/L (TBSS-C50 broth) and 
incubated at 40C in air for 48 hours. Ten microliters of surface liquid was then streaked 
onto Ashdown agar containing gentamicin 8mg/L and crystal violet 5mg/L using a 
calibrated loop, incubated at 40C in air, and examined every day for 4 days for bacterial 
colonies suggestive of B. pseudomallei or B. thailandensis (Limmathurotsakul et al., 
2012b, Chantratita et al., 2007a). B. pseudomallei can have seven colony morphotypes on 
Ashdown agar  (Chantratita et al., 2007a), and cannot readily be distinguished from the 
colonies of B. thailandensis (Wuthiekanun et al., 1996, Brett et al., 1998, Smith et al., 
1997).  For each soil specimen, a total of up to five presumptive colonies of B. 
pseudomallei or B. thailandensis were picked and evaluated by a latex agglutination test 
that is highly specific for B. pseudomallei CPS (Wuthiekanun et al., 2002, Anuntagool et 
al., 2000b, Anuntagool et al., 2000a), and the L-arabinose assimilation test. B. 
pseudomallei was defined based on a positive latex agglutination test and negative L-
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arabinose assimilation. B. thailandensis was defined based on a negative latex 
agglutination test and positive L-arabinose assimilation (Wuthiekanun et al., 2002, 
Wuthiekanun et al., 1996, Sim et al., 2010). Colonies which had positive results for both 
the latex agglutination and L-arabinose assimilation tests were defined as BTCV, as 
previously described (Sim et al., 2010). The monoclonal antibody used in the latex 
agglutination test has been shown to be positive for B. pseudomallei and BTCV (strains 
E555 and CDC3015869), and negative for B. thailandensis (Duval et al., 2014, Nualnoi et 
al., 2017). 
3.4.6 Genotyping of BTCV 
Because BTCV was found in rice fields in East and Central Thailand, we randomly 
selected three isolates of BTCV from each culture positive field and genotyped these using 
multilocus sequence typing (MLST) (Godoy et al., 2003). The alleles at each of the seven 
loci were assigned by comparing the sequences to those on the B. pseudomallei MLST 
website (https://pubmlst.org/bpseudomallei/). 
Information and the sequence type of BTCV reported in this work has been deposited 
in the global MLST database (https://pubmlst.org/bpseudomallei/). 
3.4.7 Serological response 
Blood samples were collected from rice farmers who had worked in the sampled rice 
fields in the 12 months prior to the sampling date. The detection of antibodies against B. 
pseudomallei was performed using the IHA, as described previously (Ileri, 1965, 
Alexander et al., 1970b). The antigen used in the IHA was derived from a pool of two 
clinical B. pseudomallei isolates, 199a and 207a, obtained from melioidosis patients in 
Ubon Ratchathani, Thailand. The negative control was pooled sera from three patients 
with no detectable IHA titers. The positive control was pooled sera from three patients 
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with known positive IHA. In this study, for binary comparisons, an IHA titer of <1:80 was 
defined as negative based on the previous report that healthy US donor could have IHA 
titers up to 1:40 (Suttisunhakul et al., 2015). 
3.4.8 Sample size calculation 
To determine the optimal sample size, we performed a pilot study of soil sampling in 
four rice fields in Chachoengsao province, East Thailand. Three and four rice fields were 
culture positive for B. pseudomallei (75%; 3 of 4) and B. thailandensis (100%; 4 of 4), 
respectively. We calculated that 60 rice fields (3 rice fields per province) and 60 rice 
farmers were needed to determine environmental factors associated with presence of B. 
pseudomallei and B. thailandensis, and evaluate the association between IHA titers and 
presence of both organisms, respectively, with a power of 80% at an alpha error of 5%.  
3.4.9 Statistical analysis 
We evaluated (1) positivity of B. thailandensis and BTCV in the rice fields, (2) co-
localization and correlation between B. pseudomallei, B. thailandensis and BTCV in the 
rice fields, (3) soil properties associated with presence of B. thailandensis and BTCV, and 
(4) association between IHA levels and presence of those organisms in the rice fields. 
Fisher’s exact test and Mann-Whitney test were performed to compare binary and ordinal 
variables, respectively. McNemar’s test was used to compare the presence of two 
organisms. We assessed co-localization between organisms in the rice fields by using 
Kappa value. The Kappa value was used to describe the agreement of presence and absence 
of the organism in rice fields, beyond that caused by chance, as follows: 0.00–0.20, slight; 
0.21–0.40, fair; 0.41–0.60, moderate; 0.61–0.80, substantial; 0.81–1.00, high (Viera and 
Garrett, 2005). A Spearman rank correlation coefficient (Spearman’s rho) was used to 
assess correlations among the total number of sampling points culture-positive for B. 
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pseudomallei, B. thailandensis and BTCV in the rice fields. Spearman’s rho close to 0 
indicates no correlation, while Spearman’s rho close to 1 (or -1) indicates a strong positive 
(or negative) correlation between the organisms (Mukaka, 2012). We used ordered logistic 
regression to determine the associations between IHA level and presence of the three 
organisms. As we sampled more than one rice farmer per field, the analysis was stratified 
by rice field. Multivariable ordered logistic regression models were developed using a 
purposeful selection method (Bursac et al., 2008). In brief, a univariable ordered logistic 
regression model was used to preliminarily evaluate the crude association between 
presence of B. pseudomallei, B. thailandensis and BTCV and IHA titers. We decided a 
priori to evaluate their independent associations in a multivariable ordered logistic 
regression model, and presence of B. pseudomallei, B. thailandensis and BTCV were all 
included in the final multivariable model. Sensitivity analysis was conducted by  
grouping B. thailandensis and BTCV as B. thailandensis. All statistical tests were 
performed using STATA version 14.0 (StataCorp LP, College Station, Texas).  
The final database with the data dictionary are publicly available online 
(https://doi.org/10.6084/m9.figshare.4928993). 
3.5 Results  
3.5.1 Distribution of B. thailandensis and BTCV 
Of 6,100 soil samples collected from 61 rice fields, 826 (14%) were culture positive 
for B. thailandensis. The percentages of rice fields that were culture-positive for B. 
thailandensis were 29% (6 of 21 rice fields), 63% (12 of 19 rice fields) and 57% (12 of 21 
rice fields) in Northeast, East and Central Thailand, respectively (Figure 3-1). There was 
borderline evidence that culture-positivity for B. thailandensis was higher in the East than 
the Northeast (63% vs. 29%, p=0.055), while there was no significant difference between 
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East and Central (63% vs. 57%, p=0.76) or Northeast and Central regions (29% vs. 57%, 
p=0.12). 
For the rice fields that were culture-positive for B. thailandensis, the median numbers 
of positive sampling points were 6.5 (range 1 to 27), 26.5 (range 1 to 100) and 10.5 (range 
1 to 85) in Northeast, East and Central Thailand, respectively (Table 3-1). There was a 
trend towards the median number of positive sampling points for B. thailandensis being 
lower in the Northeast than the East (p=0.08), while there was no significant difference 
between Central versus Northeast or East Thailand (p=0.40 and 0.52, respectively). 
BTCV was isolated from 11 of 61 (18%) rice fields in the East (7 fields) and Central 
(4 fields) regions but it was not isolated from rice fields in Northeast Thailand (Figure 
3-1). Overall, the proportion of fields positive for the BTCV was lower than that for B. 
thailandensis (18% vs. 49%, p<0.001). The percentage of rice fields that were culture 
positive for BTCV in the East and Central regions was not significantly different (37% 
[7/19] vs. 19% [4/21], p=0.29). The median numbers of positive sampling points in the 
East and Central regions were also not significantly different (3 [range 1 to 24] vs. 4 [range 
1 to 8], p= 0.45). 
3.5.2 Co-localization and correlation between presence of B. pseudomallei, B. 
thailandensis and BTCV in the same rice fields 
We previously reported the isolation of B. pseudomallei from 30 of 61 rice fields 
included in this study (Hantrakun et al., 2016). Figure 3-2 shows the number of rice fields 
from which B. pseudomallei, B. thailandensis and BTCV were isolated. Of 61 rice fields, 
14 (23%) were positive for B. pseudomallei alone, 8 (13%) positive for B. thailandensis 
alone, 11 (18%) positive for both B. pseudomallei and B. thailandensis, 6 (10%) positive 
for B. thailandensis and BTCV, and 5 (8%) positive for B. pseudomallei, B. thailandensis 
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and BTCV. Co-localization of B. pseudomallei and B. thailandensis in the same rice field 
was not more frequent than expected by chance (Kappa value 0.08, p=0.26). The numbers 
of sampling points per rice field that were culture positive for B. pseudomallei and for B. 
thailandensis were not correlated (Spearman’s rho -0.02, 95%CI -0.27 to 0.23, p=0.89). A 
sensitivity analysis was conducted by considering BTCV as B. thailandensis, which gave 
a comparable result (Spearman’s rho -0.02, 95%CI -0.27 to 0.23, p=0.87). All eleven fields 
culture positive for BTCV were also culture positive for B. thailandensis (Figure 3-2). 
There was a fair agreement between presence of B. thailandensis and BTCV (Kappa value 
0.37, p<0.001), and a strong correlation between the total number of sampling points 
culture positive for the two organisms (Spearman’s rho 0.68, 95% CI 0.51 to 0.79, 
p<0.001). 
3.5.3 Co-localization and correlation between presence of B. pseudomallei, B. 
thailandensis and BTCV in the same sampling points 
Of 6,100 soil samples collected, 975 (16%) were positive for B. pseudomallei alone, 
706 (12%) positive for B. thailandensis alone, 24 (0.4%) positive for BTCV alone, 69 (1%) 
positive for both B. pseudomallei and B. thailandensis, 1 (0.02%) positive for B. 
pseudomallei and BTCV, 50 (0.8%) positive for B. thailandensis and BTCV, and 1 
(0.02%) positive for B. pseudomallei, B. thailandensis and BTCV. There was a slight 
agreement between presence of B. thailandensis and BTCV in the same soil sample 
(Kappa value 0.09, p<0.001). Co-localization of B. pseudomallei and B. thailandensis in 
the same soil sample was also not greater than that expected by chance (p>0.99). 
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3.5.4 Soil physicochemical properties associated with presence of B. thailandensis 
and BTCV 
Associations between soil physicochemical properties and the presence of B. 
thailandensis were not observed (Table 3-2). Presence of BTCV was negatively associated 
with cation exchange capacity, which represents the total nutrient fixing capacity of soil 
(p=0.05), and associated with the level of total nitrogen (p=0.04; Table 3-3). The 
associations were also observed in the multivariable model (Table 3-4). 
3.5.5 Genetic diversity of BTCV 
A total of 27 isolates of BTCV from 76 culture positive sampling points for BTCV in 
11 rice fields in East and Central Thailand were randomly selected for MLST (Table 3-5). 
All 27 isolates belonged to sequence type (ST) 696, which was identical to the ST of BTCV 
strain E555 reported from soil in Cambodia (Sim et al., 2010). We had previously reported 
a single B. pseudomallei isolate (strain A-330-05-1-04) from drinking water in Ubon 
Ratchathani, northeast Thailand, as ST696 (Limmathurotsakul et al., 2014). The isolate 
was re-evaluated. The isolate was found to be positive for both latex agglutination and L-
arabinose assimilation and was thus re-classified as BTCV.  
 Chapter 3—98 
 
Figure 3-1 Map of the presence of B. pseudomallei, B. thailandensis and B. 
thailandensis expressing B. pseudomallei-like capsular polysaccharide (BTCV) in 61 
rice fields in Northeast (n=21), East (n=19) and Central (n=21) Thailand 
(a) Map of Thailand. (b) Location of the 61 rice fields evaluated. Red, green and yellow pies represent 
rice fields that were culture positive and negative for B. pseudomallei, B. thailandensis, and BTCV, 
respectively. Province codes represent Burirum (NE1), Chaiyaphum (NE2), Khon Kaen (NE3), Udon 
Thani (NE4), Nong Bua Lam Phu (NE5), Loei (NE6) and Nakhon Ratchasima (NE7) in the Northeast, 
Chachoengsao (E1), Prachinburi (E2), Sa Kaeo (E3), Chanthaburi (E4), Chonburi (E5) and Rayong (E6) 
in the East, Phetchabun (C1),  Phitsanulok (C2), Pathum Thani (C3), Saraburi (C4), Lopburi (C5), Nakhon 
Nayok (C6) and Bangkok (C7) in Central Thailand. ArcGis Version 10.2 (ESRI, Redlands, CA, USA) 
was used to map the sampled rice fields. The location of sampled rice fields was recorded by using the 
EpiCollect application (www.epicollect.net, Imperial College, London). 
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Table 3-1 Number of culture-positive sampling points for B. pseudomallei (B. ps), B. 
thailandensis (B. th) and B. thailandensis expressing B. pseudomallei-like capsular 
polysaccharide variant (BTCV) in 61 rice fields in the Northeast (n=21), East (n=19) 
and Central (n=21) Thailand 
Regions Provinces Field1 
Number of sampling points  
culture positive for 
B. ps B. th BTCV 
Northeast Buri Rum NE1-1 87 0 0 
  NE1-2 0 0 0 
  NE1-3 97 1 0 
 Chaiyaphum NE2-1 0 0 0 
  NE2-2 98 0 0 
  NE2-3 0 0 0 
 Khonkaen NE3-1 72 0 0 
  NE3-2 94 0 0 
  NE3-3 35 0 0 
 Udonthani NE4-1 40 20 0 
  NE4-2 0 27 0 
  NE4-3 28 0 0 
 Nong Bua Lamphu NE5-1 58 0 0 
  NE5-2 0 6 0 
  NE5-3 48 7 0 
 Loei NE6-1 4 6 0 
  NE6-2 0 0 0 
  NE6-3 0 0 0 
 Nakhon Ratchasima NE7-1 2 0 0 
  NE7-2 0 0 0 
  NE7-3 0 0 0 
East Chachoengsao2 E1-1 39 29 0 
  E1-2 8 70 1 
  E1-3 43 33 16 
  E1-4 0 24 3 
 Prachin Buri E2-1 10 2 0 
  E2-2 6 0 0 
  E2-3 0 16 10 
 Sa Kaeo E3-1 17 0 0 
  E3-2 0 0 0 
  E3-3 81 1 0 
 Chanthaburi E4-1 16 0 0 
  E4-2 1 16 0 
  E4-3 0 0 0 
 Chon Buri E5-1 3 0 0 
  E5-2 32 0 0 
  E5-3 0 44 3 
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Regions Provinces Field1 
Number of sampling points  
culture positive for 
B. ps B. th BTCV 
 Rayong E6-1 1 11 0 
  E6-2 0 100 24 
  E6-3 57 54 2 
Central Phetchabun C1-1 0 0 0 
  C1-2 0 0 0 
  C1-3 3 7 0 
 Phitsanulok C2-1 1 74 2 
  C2-2 1 70 8 
  C2-3 0 0 0 
 Pathum Thani C3-1 0 0 0 
  C3-2 0 2 0 
  C3-3 0 2 0 
 Saraburi C4-1 0 85 6 
  C4-2 0 1 0 
  C4-3 0 26 1 
 Lop Buri C5-1 0 0 0 
  C5-2 0 0 0 
  C5-3 0 0 0 
 Nakhon Nayok C6-1 63 0 0 
  C6-2 1 65 0 
  C6-3 0 0 0 
 Bangkok C7-1 0 6 0 
  C7-2 0 13 0 
  C7-3 0 8 0 
1Each rice field was divided into a grid system, in which 100 sampling points (10 by 10) were plotted 2.5 m apart. At 
each sampling point, 10 g of soil at 30 cm depth was collected and cultured for B. pseudomallei, B. thailandensis and 
BTCV. 2A pilot study of soil sampling were performed in four rice fields in Chachoengsao province, East Thailand. 
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Figure 3-2 Overlap between presence of B. pseudomallei (B. ps; red), B. 
thailandensis (B. th; green) and B. thailandensis expressing B. pseudomallei-like 
capsular polysaccharide (BTCV; yellow) in 61 sampled rice fields 
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Table 3-2 Soil physicochemical properties associated with the presence of B. 
thailandensis in univariable logistic regression models 
Soil physicochemical 
characteristics 
Rice fields 
positive for  
B. thailandensis1 
(n=30) 
Rice fields 
negative for  
B. thailandensis1 
(n=31) 
Crude odds 
ratio (95% 
confidence 
interval) 
p 
value 
Physical factors 
    
 Sand (%) 13.2 (4.3-78.8) 18.2 (7.8-81.0) 0.98 (0.96-1.01) 0.19 
 Silt (%) 34.8 (9.7-56.3) 33.1 (11.1-57.2) 1.03 (0.99-1.07) 0.16 
 Clay (%) 46.7 (11.5-58.6) 45.2 (7.3-57.6) 1.01 (0.97-1.05) 0.54 
 Moisture (%w/w) 14.6 (2.5-28.3) 12.8 (4.0-0.0) 1.05 (0.96-1.15) 0.32 
Acidity and salinity factors 
    
 pH 6.6 (4.9-7.8) 6.8 (5.0-8.1) 0.54 (0.27-1.09) 0.09 
 Electrical conductivity 
(dS/m) 
0.3 (0.0-1.5) 0.4 (0.0-1.2) 1.14 (0.28-4.59) 0.85 
 Lime requirement 
(kg/100sqm) 
7.5 (0.0-30.0) 5.4 (0.0-23.0) 1.01 (0.95-1.08) 0.73 
Chemical factors 
    
 Total nitrogen (mg/kg) 682 (330-2442) 643 (175-1,380) 1.01 (0.99-1.03)2 0.10 
 Available phosphorous 
(mg/kg) 
8.1 (0.6-28) 5.6 (0.2-38) 1.11 (0.60-2.04)2 0.75 
 Exchangeable 
potassium (mg/kg) 
57.5 (13.5-184) 58.2 (10.5-252) 0.98 (0.87-1.09)2 0.65 
 Exchangeable calcium 
(mg/kg) 
808 (494-2,182) 945 (272-4,326) 0.99 (0.99-1.00)2 0.11 
 Available magnesium 
(mg/kg) 
212 (44-616) 169 (47-823) 1.00 (0.97-1.03)2 0.85 
 Extractable  sulphur 
(mg/kg) 
19 (2.2-114) 12 (0-74) 1.19 (0.96-1.48)2 0.12 
 Exchangeable sodium 
(mg/kg) 
144 (94-241) 161 (88.5-241) 0.91 (0.79-1.05)2 0.21 
 Total iron (Fe; g/kg) 24 (1.9-96) 33 (0.6-79.6) 0.98 (0.77-1.24)2 0.87 
 Total cadmium   
  
o    not detected 19 fields (63%) 17 fields (55%) 1.0 
 
o    detected 11 fields (37%) 14 fields (45%) 0.70 (0.27-1.84) 0.50 
 Cation exchange 
capacity (cmol/mg) 
7.6 (0.6-44) 12 (2-48) 0.99 (0.95-1.04) 0.75 
Biological related factors 
    
 Organic matter 
(%w/w) 
0.8 (0.2-2.4) 0.9 (0.2-2.8) 0.78 (0.35-1.72) 0.53 
 Carbon to nitrogen 
ratio 
6.3 (2.0-22.6) 9.5 (2.3-42.6) 0.92 (0.83-1.02) 0.10 
1 Median (range) unless otherwise specified. 
2 Odds ratio for an increase of 100 mg/kg in nutrient.  
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Table 3-3 Soil physicochemical properties associated with the presence of B. 
thailandensis expressing B. pseudomallei-like capsular polysaccharide (BTCV) in 
univariable logistic regression models 
Soil physicochemical 
characteristics 
Rice fields 
positive for 
BTCV1 (n=11) 
Rice fields 
negative for 
BTCV1 (n=50) 
Crude odds ratio 
(95% confidence 
interval) 
p value 
Physical factors     
 Sand (%) 14.7 (9.8-42.1) 15.1 (4.3-81.0) 0.97 (0.93-1.02) 0.22 
 Silt (%) 32.3 (29.3-56.3) 34.6 (9.7-57.2) 1.03 (0.98-1.09) 0.27 
 Clay (%) 45.5 (27.3-58.6) 45.6 (7.3-57.6) 1.02 (0.97-1.08) 0.41 
 Moisture (%w/w) 15.4 (10.4-19.5) 12.9 (2.5-0.0) 1.05 (0.94-1.18) 0.35 
Acidity and salinity 
factors     
 pH 6.6 (5.1-7.8) 6.7 (4.9-8.1) 0.67 (0.29-1.57) 0.35 
 Electrical 
conductivity (dS/m) 0.2 (0.1-1.5) 0.4 (0.0-1.4) 0.71 (0.11-4.76) 0.72 
 Lime requirement 
(kg/100sqm) 7.6 (5.8-22.5) 6.0 (0.0-30.0) 1.05 (0.97-1.14) 0.22 
Chemical factors     
 Total nitrogen 
(mg/kg) 792.0 (330-2,442) 599.9 (175-1,601) 1.02 (1.00-1.03)2 0.04 
 Available 
phosphorous 
(mg/kg) 12.2 (4-28) 6.1 (0.2-38) 1.95 (0.95-4.00) 2 0.07 
 Exchangeable 
potassium (mg/kg) 57 (31.7-114.8) 58 (10.5-252) 0.93 (0.79-1.10) 2 0.41 
 Exchangeable 
calcium (mg/kg) 841 (696-1,680) 822 (272-4,326) 0.99 (0.98-1.00) 2 0.28 
 Available 
magnesium (mg/kg) 193 (123-292) 174 (44-823) 0.98 (0.94-1.03) 2 0.42 
 Extractable  sulphur 
(mg/kg) 18 (4.3-75) 18 (0-114) 1.01 (0.78-1.31) 2 0.95 
 Exchangeable 
sodium (mg/kg) 144 (108-241) 151 (88.5-241) 1.02 (0.85-1.22) 2 0.83 
 Total iron (Fe; g/kg) 3 (0.4-5.9) 2.8 (0.1-9.6) 0.97 (0.71-1.33) 0.85 
 Total cadmium     
o    not detected 6 fields (55%) 30 fields (60%) 1.0  
o    detected 5 fields (45%) 20 fields (40%) 1.25 (0.34-4.65) 0.74 
 Cation exchange 
capacity (cmol/mg) 4.7 (0.6-21.9) 13 (2-48) 0.92 (0.85-1.00) 0.05 
Biological related factors     
 Organic matter 
(%w/w) 0.8 (0.3-1.5) 0.9 (0.2-2.8) 0.47 (0.13-1.61) 0.23 
 Carbon to nitrogen 
ratio 5.6 (2.0-11.7) 9.1 (2.3-42.6) 0.81 (0.65-1.00) 0.05 
1 Median (range) unless otherwise specified. 
2 Odds ratio for an increase of 100 mg/kg in nutrient.  
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Table 3-4 Soil physicochemical properties associated with the presence of B. 
thailandensis expressing B. pseudomallei-like capsular polysaccharide in a 
multivariable logistic regression model 
Soil physicochemical characteristics 
Adjusted odds ratio 
(95% confidence interval) 
p value 
Total nitrogen (mg/kg) 1.04 (1.01 - 1.07) 1 0.01 
Cation exchange capacity (cmol/mg) 0.86 (0.76 - 0.97) 0.01 
1 Odds ratio for an increase of 100 mg/kg in nutrient. 
Table 3-5 Reports of B. thailandensis expressing B. pseudomallei-like capsular 
polysaccharide worldwide from 1921 to 2016. 
Year Strains 
Sequence type  
(allele profile)1 
Sources References 
2003 CDC3015869 
101 
(6-5-9-11-14-20-
14) 
Blood of a 2-year-old male 
presenting with drowning, 
post-cardiac arrest, 
pneumonia and septicemia 
in Texas, USA 
(Glass et al., 2006) 
2008 E555 
696 
(6-5-9-11-7-20-
14) 
Soil in Cambodia  (Sim et al., 2010) 
2012 A-330-05-1-04 
696 
 
Water (tap water) in Ubon 
Ratchathani, northeast 
Thailand 2  
(Limmathurotsakul 
et al., 2014) 
2012-
2013 
D50 
1126 
(6-5-9-5-7-7-5) 
Soil in Gabon 
(Wiersinga et al., 
2015) 
2013 ST_10 696 Water in Laos 
(Knappik et al., 
2015) and personal 
communication: 
DABD and Dr 
Sabine Dittrich 
2013-
2014 
SBXCB001a, SBXCB002a, 
SBXCB003a, SBXCC001a, 
SBXCC002a, SBXCC005a, 
SBXCC008a, SBXCC014b, 
SBXCC019a, SBXCC020a, 
SBXPL001a, SBXPL002a, 
SBXPL005a, SBXPL007a, 
SBXPL010a, SBXPR001a, 
SBXPR002a, SBXPR005a, 
SBXRY001a, SBXRY017a, 
SBXRY019a, SBXRY030a, 
SBXRY031a, SBXSR003a, 
SBXSR004a,     SBXSR005a,        
SBXSR007a 
696 
 
Soil in East and Central 
Thailand 
This study 
1 The B. pseudomallei MLST allele profile corresponds to the gene order ace-gltB-gmhD-lepA-lipA-narK-
ndh . 2 Previously reported as B. pseudomallei.  
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3.5.6 IHA titers and their association with presence of B. pseudomallei, B. thailandensis and 
BTCV 
Of 96 rice farmers included in the analysis, 29, 35 and 32 were from Northeast, East and 
Central Thailand, respectively. The median number of farmers per rice field was 1 (range 1 to 5). 
Sixty-two farmers (65%) were male and median age was 51 years (range 23-75 years). Six farmers 
(6%) had a known diagnosis of diabetes. Overall, 27 (28%) farmers had a positive IHA (IHA titers 
≥1:80). Forty eight farmers who worked in rice fields culture-positive for B. pseudomallei had 
higher IHA titers than the 48 farmers who worked in rice fields culture-negative for the organism 
(median 1:40 [range: <1:10-1:640] vs. <1:10 [range: <1:10-1:320], p=0.002) (Figure 3-3). 
Proportion of farmers who had positive IHA (IHA ≥1:80) was also significantly higher in rice field 
culture-positive for B. pseudomallei than the farmers who work in rice field culture-negative for 
B. pseudomallei (44% vs. 13%, p=0.001).  
In the univariable ordered logistic regression model, IHA titers were associated with the 
presence of B. pseudomallei (OR=3.39; 95% CI 1.66-6.90, p=0.001) but not with presence of B. 
thailandensis (OR=0.92; 95% CI 0.44-1.90, p=0.82) or BTCV (OR=1.04; 95% CI 0.60-1.80, 
p=0.89). A multivariable ordered logistic regression model was used to evaluate independent 
association between IHA titers of rice farmers and presence of each organism. IHA titers were 
independently associated with the presence of B. pseudomallei (aOR=3.72; 95% CI 1.76-7.84, 
p=0.001) but not associated with the presence of B. thailandensis (p=0.32) or BTCV (p=0.32, 
Table 3-6). 
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Figure 3-3 IHA titers associated with the presence of B. pseudomallei, B. 
thailandensis and B. thailandensis expressing B. pseudomallei-like capsular 
polysaccharide (BTCV) in the rice fields, respective 
Box-and-whisker plots indicate median, interquartile range and distribution of IHA titers. Dots indicate 
outliers (data located outside 1.5 times of interquartile range). (a) IHA titers of farmers whose rice 
fields were culture positive for B. pseudomallei alone (22 farmers). (b) IHA titers of farmers whose 
rice fields were culture positive for B. pseudomallei and either B. thailandensis or BTCV (26 farmers), 
(c) IHA titers of farmers whose rice fields culture positive for either B. thailandensis or BTCV (22 
farmers), and (d) IHA titers of farmers whose rice fields culture negative for B. pseudomallei, B. 
thailandensis and BTCV (26 farmers). 
 
 
Table 3-6 Factors associated with indirect hemagglutination assay (IHA) results in 96 
healthy rice farmers 
Organisms 
cultured from rice 
fields 
IHA results 
Odds Ratios  
(95% confidence interval)1 
IHA positive2 
(n=27 famers) 
IHA negative2 
(n=69 farmers) 
Univariable 
analysis 
Multivariable 
analysis 
B. pseudomallei 21/27 (78%) 27/69 (39%) 
3.3 (1.66-6.90), 
p=0.001 
3.72 (1.76-7.84),  
p=0.001 
B. thailandensis 12/27 (44%) 36/69 (52%) 
0.92 (0.44-1.91), 
p=0.82 
0.63 (0.25-1.57),  
p=0.32 
BTCV 4/27 (15%) 17/69 (25%) 
1.04 (0.60-1.80), 
p=0.89 
1.62 (0.63-4.17),  
p=0.32 
1 Estimated by ordered logistic regression models stratified by sampled rice field.  
2 IHA titers ≥ 1:80 is defined as positive; IHA titers <1:80 is defined as negative.  
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3.6 Discussion 
Here, we present data on the spatial distribution of B. pseudomallei, B. thailandensis and 
BTCV in Northeast, East and Central Thailand. This is the first study to report the isolation of 
BTCV from soil in Thailand, although we did find that a Thai water isolate previously identified 
as B. pseudomallei was actually an example of BTCV (Limmathurotsakul et al., 2014). B. 
thailandensis was commonly isolated in all three regions, while BTCV was less common but 
associated with B. thailandensis. Co-localization of B. thailandensis and B. pseudomallei was not 
uncommon. Our findings also suggest that IHA positivity of healthy rice farmers was associated 
with exposure to B. pseudomallei rather than to B. thailandensis or BTCV. This supports the 
recommendation that IHA could be used to measure exposure to environmental B. pseudomallei 
(Hoffmaster et al., 2015), even in areas containing other closely related Burkholderia species.  
Our finding of co-localization of B. pseudomallei and B. thailandensis is consistent with a 
previous environmental study in Khon Kaen, northeast Thailand (Sermswan et al., 2015). B. 
thailandensis has been reported from many melioidosis-endemic countries; including Thailand, 
Laos, Vietnam (Godoy et al., 2003), Cambodia (https://pubmlst.org/bpseudomallei/), Australia 
(Levy et al., 2008), Papua New Guinea (Warner et al., 2008), Kenya (Godoy et al., 2003) and 
Gabon (Wiersinga et al., 2015). This is probably highly influenced by the locations of melioidosis 
research groups. B. thailandensis has also been reported in two non melioidosis-endemic countries; 
France and the United States (Godoy et al., 2003, Glass et al., 2006). B. thailandensis strain 82172 
(ST73) was isolated from the intestine of a foal in France in 1982, while B. thailandensis strain 
CDC2721121 (ST73) was isolated from the pleural wound of a 76 year old male from Louisiana, 
USA, in 1997 (Godoy et al., 2003, Glass et al., 2006). As strain CDC2721121 was isolated from a 
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wound sample its pathogenicity in humans cannot be assumed and this strain was avirulent in a 
mouse model (Scott et al., 2013). 
Although BTCV was common in both Central and East Thailand, its prevalence is lower than 
that of wild-type B. thailandensis. Our analysis suggested that BTCV was associated with soil with 
low cation exchange capacity and high levels of total nitrogen. Although Sim et al. raised the 
possibility that acquisition of the B. pseudomallei-like CPS in E555 might improve its 
environmental fitness (Sim et al., 2010), this is not supported by our findings. It is also possible 
that the environment we studied is not representative of the environmental niche which induced B. 
thailandensis to acquire the B. pseudomallei-like gene cluster. 
The finding that all BTCV isolates obtained from different geographical areas in Thailand, 
Laos and Cambodia were ST696 suggests that these may have arisen from a single ancestor. BTCV 
isolates in USA (ST101) (Glass et al., 2006) and Gabon (ST1126) (Wiersinga et al., 2015) are 
single- and triple-locus variants of ST696, respectively (TableS5). Previous phylogenetic analysis 
suggested that ST101 and ST696 are closely related and possibly share the same ancestor (Sim et 
al., 2010). Studies using whole genome sequencing of BTCV and B. thailandensis from different 
regions are required to further understand the genetic diversity and evolution of this organism. 
Our results suggest that exposure to environmental B. thailandensis and BTCV makes a limited 
contribution to IHA seropositivity in farmers. In animal models, antibodies can be detected after 
intraperitoneal inoculation of B. thailandensis and BTCV (Scott et al., 2013). Intraperitoneal 
inoculation can lead to rapid dissemination of B. thailandensis or BTCV by bypassing natural host 
defenses (Scott et al., 2013), and induces a serological response. Nonetheless, human exposure to 
B. thailandensis and BTCV in the natural environment rarely if ever leads to infection, unlike 
exposure to B. pseudomallei. This is also supported by the finding that intra-nasal inoculation of 
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high dose B. thailandensis or BTCV (106 colony forming unit [CFU]) did not cause death in 
BALB/c mice with rapid bacterial clearance and no visible abscess formation in sacrificed mice, 
whilst the LD50 of B. pseudomallei was less than 300 CFU in the same experiment (Sim et al., 
2010). 
Our study has several limitations. Soil sampling was performed during the dry season over a 
period of three years. We chose to sample during the dry season to control the variation in presence 
of the three organisms, human exposure and soil physicochemical properties associated with 
seasonal changes. It is possible that the presence of B. thailandensis and BTCV could vary 
according to the season. Farmers may work in multiple rice fields, and be exposed to B. 
pseudomallei in untested fields. Our study may have also detected more positive samples for B. 
thailandensis and BTCV if more than five colonies had been tested from each sampling point or 
using other identification methods such as PCR.  
In summary, our large cross-sectional environmental survey has defined the distribution of B. 
thailandensis and BTCV in Thailand. This is the first report of BTCV in Thailand, which appears 
to be less common than wild-type B. thailandensis. Our findings also suggest that exposure to B. 
thailandensis or BTCV in the environment makes a limited contribution to IHA positivity amongst 
healthy farmers. 
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4.1 Abstract 
Melioidosis, an infectious disease caused by Gram-negative bacillus Burkholderia 
pseudomallei, is an important cause of death in Thailand. However, only about 10 melioidosis 
deaths are formally reported to the National Notifiable Disease Surveillance System (Report 506) 
of Ministry of Public Health (MoPH), Thailand, yearly. Therefore, priority setting for melioidosis 
is limited.   
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We conducted a large retrospective study to examine incidence and mortality of melioidosis 
cases already diagnosed by clinical microbiology laboratories in Thailand. Information was 
obtained from the microbiology and hospital database of large public hospitals in Thailand, and 
the Report 506 from 2012 to 2015. The national death registry in 2012 was obtained from the 
Ministry of Interior, Thailand to evaluate 30-day mortality. 
Of 96 regional or general hospitals in Thailand, 71 (74%) participated in the study. A total of 
1735, 1757, 1932 and 1702 culture-confirmed melioidosis cases were diagnosed in 2012, 2013, 
2014 and 2015, respectively. The incidence rate was highest in Northeast, followed by East, North, 
Central, South and West Thailand. In 2012, 30-day mortality of melioidosis was 40% (696/1,735), 
while only 4 fatal cases of melioidosis were reported from the study hospitals through the Report 
506 reporting system of MoPH. Age distribution, proportions of patients presenting with 
bacteraemia and pneumonia, and proportion of patients with diabetes were different by region (all 
p values<0.001).  
Melioidosis is an important cause of death in Thailand, but not officially reported to MoPH. 
Clinical presentations of melioidosis may be different by region. Data from the national notifiable 
disease-surveillance system in resource-limited settings needs to be verified and supplemented by 
integrating information from readily available databases. 
4.2 Introduction 
Melioidosis is an infectious disease caused by Gram-negative environmental bacterium 
Burkholderia pseudomalei (Wiersinga et al., 2018). The disease is considered highly endemic in 
northeast Thailand and northern Australia, where B. pseudomallei is commonly found in soil and 
surface water. Skin inoculation, ingestion and inhalation are important routes of B. pseudomallei 
infection. Diabetes is the most common risk factor. The majority of patients present with sepsis 
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with or without pneumonia or localized abscesses. The case fatality rate (CFR) for melioidosis 
ranges from 14% to 40% and may be as high as 70% in cases given sub-optimal antibiotic therapy 
(Chierakul et al., 2005a, Limmathurotsakul et al., 2010b, White et al., 1989). A modelling study 
estimated that there are about 165,000 melioidosis cases per year worldwide, of which 89,000 
(54%) die (Limmathurotsakul et al., 2016). 
 Melioidosis is difficult to diagnose due to a lack of specific clinical manifestations and of 
diagnostic microbiological laboratories in tropical developing countries, where the disease is 
endemic (Wiersinga et al., 2018). The gold standard for the diagnosis of melioidosis is culture.  B. 
pseudomallei is not part of the normal human flora, and its isolation from any clinical sample is 
regarded as diagnostic of melioidosis. However, even with good microbiological laboratories, B. 
pseudomallei could initially be discarded as a contaminant or misidentified as other organisms 
such as Pseudomonas spp. The most widely used serological test for melioidosis is an indirect 
haemagglutination assay (IHA), which detects crude antibodies raised against B. pseudomallei. 
Nonetheless, the international concensus guideline recommends that the IHA should not be used 
to diagnose melioidosis as the test is neither sensitive nor specific in the disease-endemic regions 
(Hoffmaster et al., 2015). A positive result of IHA can be used to imply an exposure to 
environmental B. pseudomallei (Hoffmaster et al., 2015).  
Although capacity and utilization of microbiological laboratories in Thailand is high 
(Teerawattanasook et al., 2017), burden and epidemiology of melioidosis in the country remain 
poorly understood. The National Communicable Disease Surveillance system (Report 506) was 
established in Thailand in 1968, and melioidosis has been one of the diseases for notification since 
2002. However, only about 10 melioidosis deaths were formally reported to the Report 506 each 
year, thus limiting priority setting by the Ministry of Public Health (MoPH), Thailand (Hinjoy et 
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al., 2018). Publications on melioidosis in Thailand are mostly from few research centers in 
northeast Thailand (Limmathurotsakul et al., 2016). Recent environmental studies show that B. 
pseudomallei is present in the environment in other regions in Thailand; including Central, East 
and South Thailand, (Finkelstein et al., 2000, Vuddhakul et al., 1999, Limmathurotsakul et al., 
2014, Thaipadungpanit et al., 2014, Sermswan et al., 2015, Thanapat et al., 2013, Hantrakun et al., 
2018), suggesting that melioidosis might be endemic in those regions but under-reported. In this 
study, our objectives were to determine incidence and mortality of melioidosis cases already 
diagnosed by clinical microbiological laboratories in Thailand using multiple sources of data 
including routine microbiology and hospital admission databases from all regional and provincial 
hospitals, and to compare these with the national death registry from the Ministry of Interior and 
the Report 506 of MoPH, Thailand.   
4.3 Materials and methods 
4.3.1 Study area 
In 2012, Thailand had a population of 64.4 million, consisted of 77 provinces and covered 
513,120 km2. The country can be divided into six regions: Northeast (21.6 million population; 20 
provinces); North (6.1 million population; 9 provinces); East (4.4 million population; 7 provinces); 
West (3.2 million population; 5 provinces), South (9.0 million population; 14 provinces); and 
Central (19.8 million population; 21 provinces), based on geographical and scientific purposes 
(Kashino, 2014). The MoPH is responsible for health care service delivery and finance, and disease 
prevention and control. In March 2001, the Thai health care system was majorly reformed by 
introducing a universal coverage (UC), to improve equity of healthcare accessibility to all Thai 
citizens (NHSO, 2010). There are multiple levels of health care facilities in Thailand. In each 
province, there are primary care units (PCU) located in sub-districts, district hospitals, and at least 
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one general or regional hospital. These health care units deliver health care services to people 
living within their catchment areas. In 2012, there were a total of 28 regional hospitals and 68 
general hospitals in Thailand (MoPH, 2012). These general and regional hospitals act as referral 
hospitals for smaller PCUs and district hospitals for severely ill patients. These hospitals, unlike 
PCUs and district hospitals, are equipped with a microbiology laboratory capable of performing 
bacterial culture using standard methodologies for bacterial identification and susceptibility testing 
provided by the Bureau of Laboratory Quality and Standards, MoPH, Thailand (Opartkiattikul and 
Bejrachandra, 2002). 
4.3.2 Study design 
We conducted a retrospective, multicentre surveillance study in all general and regional 
hospitals in Thailand. From the hospitals that agreed to participate, data were collected from 
microbiology and hospital databases between January 2012 and December 2015. Hospital number 
(HN) and admission number (AN) were used as a record linkage between the two databases and 
to identify individuals who had repeat admissions. The death registry of Thailand in 2012 was 
obtained from the Ministry of Interior (MoI), Thailand, and used to identify patients who were 
discharged from hospital but died at home shortly after, which is a common practice in Thailand 
(Kanoksil et al., 2013, Hongsuwan et al., 2014). 
4.3.3 Ethical approvals 
Ethical permission for this study was obtained from Institute for the Development of Human 
Research Protection, Ministry of Public Health (IHRP 2334/2556), the Ethics Committee of the 
Faculty of Tropical Medicine, Mahidol University (MUTM 2014-017-01) and the Oxford Tropical 
Research Ethics Committee, University of Oxford (OXTREC 521-13). Written consent was given 
by the directors of the hospitals to use their routine hospital database for research. Consent was 
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not sought from the patients as this was a retrospective study, and the Ethical and Scientific Review 
Committees approved the process.  
4.3.4 Data collection  
The microbiology laboratory data collected included hospital number (HN), admission number 
(AN), specimen type, specimen date and culture result. Hospital admission data were collected 
from the routine in-patient discharge report, which is regularly completed by attending physicians 
and reported to the MoPH, Thailand, as part of the national morbidity and mortality reporting 
system. The data collected included HN, AN, national identification 13-digit number, admission 
date, discharge date and diagnosis. Diagnosis in the hospital admission data were recorded using 
the 10th revision Thai Modification (Edition 2012) of the International Classification of Disease 
(ICD-10-TM) codes (Thai Health Coding Center, MoPH., 2012). Date of death was also extracted 
from this data. We consulted with study hospitals when the data were unclear. Data collected from 
the national death registry obtained from the MoI included the national identification 13-digit 
number and the date of death. The Report 506 data was obtained from the BOE, MoPH. The data 
variables include total number of cases, total number of deaths, type of healthcare facilities and 
provinces.  
4.3.5 Definitions 
Melioidosis was defined as culture positive for B. pseudomallei from any type of clinical 
specimens. Comorbidities, including diabetes mellitus, hypertension, chronic renal failure, chronic 
obstructive pulmonary disease (COPD), chronic liver disease, human immunodeficiency virus 
(HIV), tuberculosis, thalassemia, and malignancy were determined using ICD-10 codes Thailand 
modified version (Table 4-1). Bacteraemia was defined as blood culture positive for B. 
pseudomallei. Pneumonia was determined using ICD-10 codes or sputum culture positive for the 
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organism. Urinary tract infection was defined as urine culture positive for B. pseudomallei. 
Hepatosplenic abscess, septic arthritis and osteomyelitis were determined using ICD-10 codes. 
30-day mortality was determined on the basis of a record of death within 30 days of the 
admission as recorded in the hospital admission data or by a record of death in the national death 
registry. In-hospital mortality was determined by using discharge status recorded in the hospital 
admission data. In the event that a patient had more than one episode of admission due to culture-
confirmed melioidosis, only the first episode was included in the study.  
4.3.6 Statistical analysis 
The outcomes of interest were incidence and 30-day mortality, and their associations with 
regions, comorbidities and clinical manifestations. Binary and continuous variables were 
compared by using the Chi-square test and Kruskal-Wallis test, respectively. Risk factors 
associated with mortality were evaluated using univariable and multivariable logistic regression. 
The final multivariable logistic regression models were developed using a purposeful selection 
method (Bursac et al., 2008). Poisson regression models were used to assess change of incidence 
rates over time and to compare mortality rate among six regions. The models were stratified by 
hospitals. A sensitivity analysis was done by evaluating factors associated with in-hospital 
mortality. All statistical analyses were performed using Stata version 15.0 (StataCorp LP, College 
station, Texas).  
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Table 4-1 List of ICD-10 codes used to determine co-morbidities and clinical manifestations  
Factors ICD10 codes 
Comorbidities:  
 Diabetes mellitus E10-14 
 Hypertension I10, I15.8-I15.9 
 Chronic kidney disease N18.1-N18.5, 189 
 COPD J42, J43, J44.0-J44.1, J44.8-J44.9, J47 
 Liver disease  K70, K72-K74, K75.1-K76, K77, B18.0, B18.10, B18.19, B18.2, B18.8, 
B18.9 
 HIV B20-B23, B24 
 Pulmonary tuberculosis  A15.0-A15.9, A16.0-A16.9, O98.0, P37.0, B90.9 
 Thalassemia D56.0-D56.4, D56.8-D56.9 
 Malignancy  C00-C75, C81-C96, C76-C80, C97 
Clinical manifestations:  
 Pneumonia  
 
B01.2, B05.2, B20.6, J10.0, J11.0, J12.0-J12.2, J12.8-J12.9, J13-J14, J15.0-
J15.7, J15.81, J15.88, J16.8, J17.0-J17.3, J17.8, J18.0-J18.2, J18.8-J18.9, 
J22, J44.0,  J85.1-J85.2, P23.0-P23.6, and P23.8-P23.9 
 Hepatosplenic abscesses A06.4, D73.3 and K75.0 
 Septic arthritis M00.0-M00.2 and M00.8-M01.0   
 Ostomyelitis M46.2, M86.0, M86.1-M86.6 and M86.8-M86.9 
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4.4 Results 
Of 96 regional or general hospitals in Thailand, 95 hospitals (99%) agreed to participate in the 
study (Figure 4-1). Data of 24 hospitals (24%) were excluded from analysis because either 
microbiological laboratory data or hospital admission data obtained was incomplete. The 71 
hospitals included in the analysis were located in 62 provinces (Figure 4-2). Of 71 hospitals, 50 
(70%) had data for 4 years, 2 (3%) had data for 3 years, 9 (13%) had data for 2 years, and 10 (14%) 
had data for 1 year (Table 4-2). 
A total of 8,113,051 admission records from 6,240,514 patients were evaluated. Total of 7,626 
admission records had at least one clinical sample culture positive for B. pseudomallei. Multiple 
admissions with culture positive for B. pseudomallei were noted in 421 patients. Only the first 
episode of culture-confirmed melioidosis in 7,126 patients were included in further analysis. 
4.4.1 Incidence of melioidosis 
The average incidence rate of melioidosis during the 4-year study period was 4.06 per 100,000 
population per year (Figure 4-3, Table 4-3). The total number of cases diagnosed in Northeast, 
Central, South, East, North, and West Thailand were 5,475, 536, 374, 364, 358 and 19 cases, 
respectively. The incidence rate was significantly different by region (p<0.001). The incidence 
rate was highest in Northeast Thailand (8.73 per 100,000 population per year) and lowest in West 
Thailand (0.18 per 100,000 population per year) (Table 4-3). The number of cases diagnosed in 
2012, 2013, 2014 and 2015 were 1,735, 1,757, 1,932, and 1,702 cases, respctively (Table 4-4), and 
a temporal trend in incidence rates was not observed (p=0.58).  
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Figure 4-1 Flow chart of study  
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Figure 4-2 Distribution of 95 regional and general hospitals provided hospital data in 
Thailand. 
(a) Map of Thailand. (b) Location of the 95 general and regional hospitals partitipated in the study. Navy blue and 
green circles represent 71 hospitals and 24 hospitals, of which were included and excluded from the analysis, 
respectively. 
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Table 4-2 Incidence and in-hospital mortality of culture-confirmed melioidosis cases 
diagnosed at 71 hospitals in Thailand from 2012 to 2015 
No Hospital Province Region 
Year of 
data 
included 
No. of 
culture-
confirmed 
melioidosis 
cases 
No. of 
cases 
died in 
the 
hospital 
In-
hospital 
mortality 
(%) 
1 Ang Thong hospital Angthong Central 2012 1 1 100% 
2 
Phanakorn Si Ayutthaya 
hospital 
Ayutthaya Central 2013,2015 3 1 33% 
3 Kamphaeng Phet hospital Kamphaengphet Central 2012-2015 66 26 39% 
4 Ban Mi hospital Lopburi Central 2014-2015 5 3 60% 
5 Kingnarai hospital Lopburi Central 2012 1 1 100% 
6 Nakhon Nayok hospital Nakhonnayok Central 2012,2014 24 9 38% 
7 Nakhon Pathom hospital Nakhonpathom Central 2012-2015 12 2 17% 
8 Sawan Pracha Rak hospital Nakhonsawan Central 2012-2015 100 42 42% 
9 Pranangklao hospital Nonthaburi Central 2012-2015 0 0 0% 
10 Pathum Thani hospital Pathumthani Central 2012 1 1 100% 
11 Phetchabun hospital Phetchabun Central 2012-2015 53 19 36% 
12 Phichit hospital Phichit Central 2015 2 1 50% 
13 Buddhachinaraj hospital Phitsanulok Central 2012-2015 186 61 33% 
14 Samut Sakhon hospital Samutsakhon Central 2012 1 0 0% 
15 Phra Phutthabat hospital Saraburi Central 2015 3 2 67% 
16 Saraburi hospital Saraburi Central 2012-2015 42 12 29% 
17 Inburi Hospital Singburi Central 2012-2015 0 0 0% 
18 Singburi hospital Singburi Central 2013 1 1 100% 
19 Srisangworn hospital Sukhothai Central 2012-2015 10 4 40% 
20 
Chao Phaya Yommarat 
hospital 
Suphan Buri Central 2012-2015 22 10 45% 
21 
Somdejprasangkharach 
XVII hospital 
Suphan Buri Central 2012,2015 3 0 0% 
22 Bhuda Sothon hospital Chachoengsao East 2012-2015 113 47 42% 
23 Chon Buri hospital Chonburi East 2012-2015 107 59 55% 
24 Prapokkloa hospital Chanthaburi East 2012-2015 68 19 28% 
25 Rayong hospital Rayong East 2012-2015 76 36 47% 
26 Trat hospital Trat East 2012-2015 0 0 0% 
27 Nakornping hospital Chiangmai North 2012,2014 3 0 0% 
28 
Chiang Rai Prachanukroh 
hospital 
Chiangrai North 2012-2015 0 0 0% 
29 Lampang hospital Lampang North 2012-2015 140 24 17% 
30 Lamphun hospital Lamphun North 2012-2015 0 0 0% 
31 Si Sangwan hospital Maehongson North 2012-2015 0 0 0% 
32 Nan hospital Nan North 2012-2015 90 24 27% 
33 Chiangkhum hospital Phayao North 2012-2015 44 12 27% 
34 Phayao hospital Phayao North 2012-2015 62 13 21% 
35 Phrae hospital Phrae North 2014-2015 19 3 16% 
36 Amnat Charoen hospital Amnat Charoen Northeast 2012 69 8 12% 
37 Buengkan Hospital Buengkan Northeast 2014-2015 28 9 32% 
38 Buri Ram hospital Buriram Northeast 2012-2015 372 105 28% 
39 Chaiyaphum hospital Chaiyaphum Northeast 2012 63 24 38% 
40 Kalasin  hospital Kalasin Northeast 2012-2015 289 79 27% 
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No Hospital Province Region 
Year of 
data 
included 
No. of 
culture-
confirmed 
melioidosis 
cases 
No. of 
cases 
died in 
the 
hospital 
In-
hospital 
mortality 
(%) 
41 Khon Kaen hospital Khon Kaen Northeast 2012-2015 506 58 11% 
42 Loei hospital Loei Northeast 2012-2015 61 18 30% 
43 Maha Sarakham hospital Mahasarakham Northeast 2012-2015 258 54 21% 
44 Mukdahan hospital Mukdahan Northeast 2012-2015 125 19 15% 
45 Nakhon Phanom hospital Nakhonphanom Northeast 2012-2015 358 78 22% 
46 Nong Bua Lamphu hospital Nongbualamphu Northeast 2013-2015 35 6 17% 
47 Nong Khai hospital Nongkhai Northeast 2012-2015 108 14 13% 
48 Roi Et hospital Roiet Northeast 2012-2015 496 104 21% 
49 Sakonnakhon hospital Sakonnakhon Northeast 2012-2015 708 197 28% 
50 Sappasitthiprasong hospital Ubonratchathani Northeast 2012-2015 1219 234 19% 
51 Surin hospital Surin Northeast 2012-2015 124 31 25% 
52 Udon Thani hospital Udonthani Northeast 2012-2015 656 158 24% 
53 
Chumphonkhetudomsakdi 
hospital 
Chumphon South 2012-2015 33 13 39% 
54 Krabi hospital Krabi South 2012-2015 18 3 17% 
55 
Maharaj 
Nakhonsithammarat 
hospital 
Nakhonsithammarat South 2012-2015 58 25 43% 
56 Su-ngai Kolok hospital Narathiwat South 2012-2015 0 0 0% 
57 Pattani hospital Pattani South 2014-2015 8 1 13% 
58 Phang Nga hospital Phang Nga South 2012,2013, 3 1 33% 
59 Takuapa hospital Phang Nga South 
2012, 2014-
2015 
15 5 33% 
60 Vachira Phuket hospital Phuket South 2012-2015 79 22 28% 
61 Hatyai hospital Songkhla South 2012-2015 59 20 34% 
62 Songkhla hospital Songkhla South 2012-2015 29 11 38% 
63 Surat Thani hospital Suratthani South 2012-2015 13 2 15% 
64 Trang hospital Trang South 2012-2015 39 3 8% 
65 Yala hospital Yala South 2012-2015 20 4 20% 
66 
Phaholpolpayuhasaena 
hospital 
Kanchanaburi West 2012-2015 0 0 0% 
67 
King Mongkut Memorial 
hospital 
Phetchaburi West 2012-2015 0 0 0% 
68 Ban Pong hospital Ratchaburi West 2012-2015 0 0 0% 
69 Damnoen Saduak hospital Ratchaburi West 2012-2015 0 0 0% 
70 Photharam hospital Ratchaburi West 2015 1 0 0% 
71 
King Taksinmaharaj 
Memorial hospital 
Tak West 2012-2015 18 3 17% 
        Total 7,126  1,742  24% 
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Figure 4-3 Incidence rates of culture confirmed melioidosis in Thailand from 2012 to 2015 
Provinces are categorized based on incidence rates of culture-confirmed melioidosis observed (dark red,  
>5 cases per 100,000 population per year; red, >1 to 5 cases per 100,000 population per year;  
yellow, >0 to 1 case per 100,000 population per year; green, no cases observed; grey, no data obtained). 
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Table 4-3 Incidence rates of culture-confirmed melioidosis from 2012 to 2015 in Thailand, 
by region 
Regions 
Number of 
hospitals 
Number of 
provinces 
Melioidosis 
cases from 2012 
to 2015 
Total 
number of 
population 
at risk in 
2012 
Total 
number of 
population-
year at risk 
Incidence rate 
(per 100,000 
population per 
year) 
Central 21 17  536  10,753,504 38,455,625  1.39  
East 5 5  364  3,419,147 13,959,934  2.61  
North 9 8  358  5,220,558 18,491,803  1.94  
Northeast 17 17  5,475  16,139,661 62,745,784  8.73  
South 13 11  374  7,348,772 31,143,881  1.20  
West 6 4  19  2,679,256 10,756,160  0.18  
Overall 71 62  7,126  45,560,898 175,553,187  4.06 
 
Table 4-4 Incidence rates of culture-confirmed melioidosis from 2012 to 2015 in Thailand, 
by year 
 Region 
 Number 
of  
hospitals 
Numbers 
of 
provinces 
Number of cases 
Incidence rate (per 100,000 
population per year) 
20121 20131 20141 20151 20121 20131 20141 20151 
Central 21 17 112 142 155 127 1.04 1.62 1.72 1.28 
East 5 5 85 84 113 82 2.49 2.42 3.21 2.31 
North 9 8 99 93 85 81 1.90 2.60 1.49 2.03 
Northeast 17 17 1332 1359 1481 1303 8.25 8.94 9.45 8.29 
South 13 11 97 75 95 107 1.32 1.01 1.16 1.30 
West 6 4 10 4 3 2 0.37 0.15 0.11 0.07 
Total 711 622 1735 1757 1932 1702 3.81 4.27 4.31 3.86 
1Of 71 hospitals included in  study, distribution of four year data were 2012 from 61 hospitals, 2013 from 54 hospitals, 2014 from 
58 hospitals and 2015 from 61 hospitals. 2Eight provinces had the data from more than one hospital, including Lopburi (2), Phayao 
(2), Ratchaburi (3), Saraburi (2), Singburi (2), Songkhla (2), Phang Nga (2) and Suphanburi (2). 
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4.4.2 Co-morbidities and presentations of melioidosis   
Of 7,126 patients with a first episode of culture-confirmed melioidosis, 4,839 (68%) were male 
and 2,287 (32%) were female (Table 4-5). Median age was 54 years (IQR 45-63 years, range <1-
100 years). The most common co-morbidities identified were diabetes mellitus (43%), followed 
by hypertension (15%) and chronic kidnesy disease (11%). Culture positivity for B. pseudomallei 
was observed in blood (n=4,910, 69%), sputum (n=1,555, 22%), urine (n=341, 5%), pleural fluid 
(n=92, 1%), cerebrospinal fluid (n=13, 0.2%) and unidentified pus or fluid (n=1,143, 16%). The 
most common clinical presentations were bacteraemia (69%) and pneumonia (38%). 
Age distribution, number of comorbidities recorded by ICD-10, and clinical presentations 
differed by region (Table 4-5). The median age of patients was highest in North (57 years) and 
lowest in West Thailand (48 years) (p<0.001). Prevalence of diabetes mellitus was highest in South 
(48%) and lowest in North Thailand (21%) (p<0.001). Bacteraemia was identified highest in East 
(79%) and lowest in West Thailand (63%). Pneumonia was identified highest in East (46%) and 
lowest in West Thailand (16%). 
4.4.3 Mortality from melioidosis 
The 30-day mortality of culture-confirmed melioidosis in 2012 was 40% (696/1,735). 58% 
(403/696) of deaths occurred in the hospital, while the remainder occurred after hospital discharge 
with a hospital record of refusal of treatment (76%; 223/293), an improvement in condition (20%; 
59/293), transfer to other hospitals (3%; 10/293) or no record of outcome at time of discharge 
0.3%; 1/293). Death occurred rapidly, with 285 deaths (41%) occurring within the first two days 
of admission, 204 (29%) from day 3 to day 7, and the remaining 207 (30%) after 7 days of 
admission. Among 293 patients who died after hospital discharge, 229 (78%) died within the first 
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two days of hospital discharge, 28 (10%) from day 3 to day 7, and the remaining 36 (12%) after 7 
days of hospital discharge.  
The overall mortality rate of culture-confirmed melioidosis in 2012 was 1.5 per 100,000 
population. The mortality rate was significantly different by region (p<0.001). The mortality rate 
was highest in Northeast (3.4 per 100,000 population) and lowest in West Thailand (0.04 per 
100,000 population).   
In the univariable logistic regression models, 30-day mortality was associated with older age, 
underlying disease of chronic kidney disease, liver disease, malignancy, and presentations with 
bacteraemia, pneumonia and urinary tract infection (Table 4-6). The underlying diseases of 
diabetes and thalassemia, and presentations with hepatosplenic abscess and septic arthritis were 
associated with survival. 30-day mortality was not associated with region (p=0.14).  
In the final multivariable logistic regression models, 30-day mortality was significantly 
associated with chronic kidney disease and liver disease as underlying diseases, and with 
presentations with bacteraemia, pneumonia and urinary tract infection (Table 4-7). Underlying 
disease of diabetes and presentation with hepatosplenic abscesses were significantly associated 
with survival outcome.  
4.4.4 Comparison between observed data and the Report 506  
In 2012, the total number of fatal cases of melioidosis reported to the Report 506 was 13 (Table 
4-8). We found that the 71 regional or general hospitals included in the study reported 1,018 
melioidosis cases to the Report 506, but reported that only 4 of them died. The other 25 regional 
or general hospitals not included in the study reported 259 melioidosis cases and that 7 of them 
died. Primary care units or district hospitals reported another 2,246 melioidosis cases, and that 2 
of them died (<0.1%). The discrepancy between the numbers of fatal melioidosis cases observed 
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and those reported to the Report 506 by the 71 hospitals included in the study in 2012 was more 
than 100 fold (696 vs. 4).  
In 2015, the total number of fatal cases of melioidosis reported to the Report 506 was 111, and 
107 of them (96%) were reported from a single regional hospital, Sunpasitthiprasong Hospital, 
Ubon Ratchathani, in northeast Thailand. Using the hospital admission data, we found that half of 
those deaths occurred after hospital discharge (51%; 55/107).  
4.4.5 Sensitivity analysis 
Using data from the year 2012-2015, we evaluated factors associated with in-hospital mortality 
as an outcome. A temporal trend of in-hospital mortality was not observed (p=0.98). In the 
univariable model, region was associated with in-hospital mortality (p<0.001) (Table 4-9).  
In a multivariable logistic regression model, in-hospital mortality was significantly associated 
with an underlying disease of liver disease, and presentations with bacteraemia, pneumonia and 
urinary tract infection, and region (Table 4-10). The underlying diseases of diabetes and 
thalassaemia, and presentations with hepatosplenic abscesses, and septic arthritis were negatively 
associated with in-hospital mortality.  
As region was associated with in-hospital mortality, we ad hoc evaluated the proportions of 
patients who died after hospital discharge among those who died within 30 days of hospital 
admissions in 2012 by region. We found that the proportion was significantly different by region 
(p<0.001); highest in Northeast (50%: 270/541), followed by South (24%; 8/34), North (18%; 
6/33), Central (12%; 6/50), East (8%; 3/37) and WestThailand (0%: 0/1). 
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Table 4-5 Baseline characteristics of 7,126 culture-confirmed melioidosis cases in Thailand from 2012 to 2015 
Baseline characteristics All cases  Northeast Central East North South West P value 
 (N=7126) (n=5475) (n=536) (n=364) (n=358) (n=374) (n=19)  
Gender         
 Female 2287 (32.1%) 1788 (32.7%) 152 (28.4%) 125 (34.3%) 108 (30.2%) 107 (28.6%) 7 (36.8%) 0.16 
 Male 4839 (67.9%) 3687 (67.3%) 384 (71.6%) 239 (65.7%) 250 (69.8%) 267 (71.4%) 12 (63.2%)  
Age group (years)            
 <1 to 14 264 (3.7%) 219 (4.0%) 13 (2.4%) 12 (3.3%) 4 (1.1%) 16 (4.3%) 0 (0.0%) <0.001 
 15 to 29 253 (3.6%) 176 (3.2%) 20 (3.7%) 18 (4.9%) 9 (2.5%) 28 (7.5%) 2 (10.5%)  
 30 to 45 1263 (17.7%) 972 (17.8%) 91 (17.0%) 74 (20.3%) 31 (8.7%) 89 (23.8%) 6 (31.6%)  
 45 to 64 3874 (54.4%) 3049 (55.7%) 261 (48.7%) 166 (45.6%) 221 (61.7%) 169 (45.2%) 8 (42.1%)  
 >=65 1466 (20.6%) 1053 (19.2%) 151 (28.2%) 94 (25.8%) 93 (26.0%) 72 (19.3%) 3 (15.8%)  
Comorbidities1            
 Diabetes mellitus 3045 (42.7%) 2428 (44.3%) 190 (35.4%) 164 (45.1%) 74 (20.7%) 180 (48.1%) 9 (47.4%) <0.001 
 Hypertension 1063 (14.9%) 764 (14.0%) 88 (16.4%) 93 (25.5%) 51 (14.2%) 64 (17.1%) 3 (15.8%) <0.001 
 Chronic kidney disease 815 (11.4%) 688 (12.6%) 35 (6.5%) 38 (10.4%) 27 (7.5%) 26 (7.0%) 1 (5.3%) <0.001 
 Liver disease 661 (9.3%) 513 (9.4%) 49 (9.1%) 55 (15.1%) 17 (4.7%) 27 (7.2%) 0 (0.0%) <0.001 
 COPD 200 (2.8%) 117 (2.1%) 27 (5.0%) 24 (6.6%) 17 (4.7%) 13 (3.5%) 2 (10.5%) <0.001 
 HIV 67 (0.9%) 44 (0.8%) 7 (1.3%) 7 (1.9%) 2 (0.6%) 6 (1.6%) 1 (5.3%) 0.04 
 Malignancy 196 (2.8%) 128 (2.3%) 28 (5.2%) 20 (5.5%) 9 (2.5%) 9 (2.4%) 2 (10.5%) <0.001 
 Pulmonary tuberculosis 217 (3.0%) 165 (3.0%) 17 (3.2%) 12 (3.3%) 6 (1.7%) 17 (4.5%) 0 (0.0%) 0.32 
 Thalassaemia 151 (2.1%) 117 (2.1%) 10 (1.9%) 6 (1.6%) 7 (2.0%) 11 (2.9%) 0 (0.0%) 0.82 
Clinical manifestations1           
 Bacteraemia2 4910 (68.9%) 3741 (68.3%) 348 (64.9%) 286 (78.6%) 256 (71.5%) 267 (71.4%) 12 (63.2%) <0.001 
 Pneumonia3 2705 (38.0%) 2082 (38.0%) 237 (44.2%) 166 (45.6%) 93 (26.0%) 124 (33.2%) 3 (15.8%) <0.001 
 Urinary tract infection4 341 (4.8%) 252 (4.6%) 31 (5.8%) 14 (3.8%) 26 (7.3%) 15 (4.0%) 3 (15.8%) 0.03 
 Liver/splenic abscess1 580 (8.1%) 491 (9.0%) 31 (5.8%) 20 (5.5%) 13 (3.6%) 24 (6.4%) 1 (5.3%) <0.001 
 Septic arthritis1 385 (5.4%) 318 (5.8%) 27 (5.0%) 13 (3.6%) 12 (3.4%) 14 (3.7%) 1 (5.3%) 0.10 
 Osteomyelitis1 63 (0.9%) 40 (0.7%) 6 (1.1%) 3 (0.8%) 3 (0.8%) 9 (2.4%) 2 (10.5%) <0.001 
1Comorbidities and clinical manifestations identified by using ICD10 diagnostic codes listed in Table 4-1. 2Blood culture positive for B. pseudomallei.  
3Using ICD10 diagnostic codes incorporated with sputum culture positive for B. pseudomallei. 4Urine culture positive for B. pseudomallei
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Table 4-6 Factors associated with 30-day mortality in 1,735 culture-confirmed melioidosis 
cases in 2012 
Baseline 
characteristics 
All cases  Died  Survived Crude odds 
ratio 
(95% CI) 
P value 
(N=1735) (n=696) (n=1039) 
Gender      
 Female 565 (32.6%) 220 (31.6%) 345 (33.2%) 1.08 (0.87-1.33) 0.49 
 Male 1170 (67.4%) 476 (68.4%) 694 (66.8%) 
  
Age group (years) 
     
 <1to14 75 (4.3%) 11 (1.6%) 64 (6.2%) 1 <0.001 
 15-29 53 (3.1%) 18 (2.6%) 35 (3.4%) 2.97 (1.25-7.05)  
 30-45 334 (19.3%) 122 (17.5%) 212 (20.4%) 3.31 (1.67-6.57)  
 45-64 930 (53.6%) 373 (53.6%) 557 (53.6%) 3.88 (2.01-7.52)  
 65-115 343 (19.8%) 172 (24.7%) 171 (16.5%) 5.90 (2.99-11.66)  
Comorbidities1 
     
 Diabetes mellitus 717 (41.3%) 243 (34.9%) 474 (45.6%) 0.66 (0.54-0.81) <0.001 
 Hypertension 236 (13.6%) 85 (12.2%) 151 (14.5%) 0.87 (0.65-1.16) 0.34 
 Chronic kidney 
disease 
196 (11.3%) 99 (14.2%) 97 (9.3%) 1.73 (1.27-2.36) <0.001 
 COPD 55 (3.2%) 26 (3.7%) 29 (2.8%) 1.45 (0.84-2.51) 0.18 
 Pulmonary 
tuberculosis 
59 (3.4%) 28 (4.0%) 31 (3.0%) 1.38 (0.81-2.34) 0.23 
 HIV 14 (0.8%) 6 (0.9%) 8 (0.8%) 1.10 (0.38-3.23) 0.89 
 Liver disease 138 (8.0%) 82 (11.8%) 56 (5.4%) 2.49 (1.74-3.58) <0.001 
 Malignancy 40 (2.3%) 22 (3.2%) 18 (1.7%) 1.94 (1.02-3.68) 0.04 
 Thalassaemia 27 (1.6%) 5 (0.7%) 22 (2.1%) 0.35 (0.13-0.94) 0.04 
Clinical manifestations1      
 Bacteraemia2 1181 (68.1%) 587 (84.3%) 594 (57.2%) 4.12 (3.23-5.26) <0.001 
 Pneumonia3 653 (37.6%) 389 (55.9%) 264 (25.4%) 3.98 (3.22-4.92) <0.001 
 Urinary tract 
infection4 
104 (6.0%) 63 (9.1%) 41 (3.9%) 2.59 (1.71-3.92) <0.001 
 Liver/splenic 
abscess1 
151 (8.7%) 33 (4.7%) 118 (11.4%) 0.38 (0.25-0.57) <0.001 
 Septic arthritis1 89 (5.1%) 23 (3.3%) 66 (6.4%) 0.50 (0.30-0.81) 0.005 
 Osteomyelitis1 13 (0.7%) 2 (0.3%) 11 (1.1%) 0.26 (0.06-1.18) 0.08 
Region  
  
  
 Northeast 1332 (76.8%) 541 (77.7%) 791 (76.1%) 1 0.32 
 Central 112 (6.5%) 50 (7.2%) 62 (6.0%) 1.27 (0.77-2.08)  
 East 85 (4.9%) 37 (5.3%) 48 (4.6%) 1.20 (0.68-2.11)  
 North 99 (5.7%) 33 (4.7%) 66 (6.4%) 0.83 (0.47-1.45)  
 South 97 (5.6%) 34 (4.9%) 63 (6.1%) 0.86 (0.51-1.44)  
 West 10 (0.6%) 1 (0.1%) 9 (0.9%) 0.17 (0.02-1.52)  
1Comorbidities and clinical manifestations identified by using ICD10 diagnostic codes listed in Table 4-1. 2Blood culture positive 
for B. pseudomallei. 3Using ICD10 diagnostic codes incorporated with sputum culture positive for B. pseudomallei. 4Urine 
culture positive for B. pseudomallei. 
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Table 4-7 Factors associated with 30-day mortality by a multivariable logistic regression 
model stratified by hospitals 
Baseline characteristics 
Adjusted odds ratio 
(95%CI) 
P value 
Gender (male) 0.76 (0.60-0.98) 0.03 
Age (years) 1.01 (1.01-1.02) <0.001 
Comorbidities1   
 Liver disease 2.55 (1.69-3.85) <0.001 
 Chronic kidney disease 1.74 (1.22-2.49) 0.002 
 Diabetes mellitus 0.49 (0.38-0.63) <0.001 
Clinical manifestations1  
 Bacteraemia2 6.96 (5.22-9.28) <0.001 
 Pneumonia3 5.83 (4.53-7.52) <0.001 
 Urinary tract infection4 3.56 (2.15-5.88) <0.001 
 Liver/splenic abscess1 0.46 (0.29-0.73) 0.001 
1Comorbidities and clinical manifestations identified by using ICD10 diagnostic codes listed in Table 4-1. 2Blood culture positive 
for B. pseudomallei. 3Using ICD10 diagnostic codes incorporated with sputum culture positive for B. pseudomallei. 4Urine 
culture positive for  
B. pseudomallei. 
Table 4-8 Incidences and mortalities of melioidosis cases diagnosed by microbiology 
laboratories in regional or general hospitals compared with those officially reported to the 
Report 506 from 2012 to 2015 
 Year  Type of hospital 
Culture-confirmed 
melioidosis1 
Report 5062 
Number of 
cases1 
Number of 
fatal cases1 
Number of 
cases3 
Number of 
fatal cases3 
2012 Primary care Not availble Not availble 2426 2 
 
Regional or general hospital 1,735 696 1,277 (1,018) 3 11 (4) 3 
2013 Primary care Not availble Not availble 1,821 0  
Regional or general hospital 1,757 459 1,009 (799) 3 4 (3) 3 
2014 Primary care Not availble Not availble 1,677 3  
Regional or general hospital 1,932 482 869 (695) 3 9 (8) 3 
2015 Primary care Not availble Not availble 2,042 1  
Regional or general hospital 1,702 382 1,184 (967) 3 111 (111) 3 
 
Total 7,126 1,742 12,305 (3,479) 3 141 (126) 3 
1From 71 hospitals participating in the study (data of this study). Fatal cases in 2012 were based on 30-day mortality, while fatal 
cases in 2013, 2014 and 2015 were based on in-hospital mortality. 2Reported melioidosis are either probable cases or confirmed 
cases of melioidosis. Probable cases defined as clinically compatible illness and IHA titer ≥1:160 or IFA >1:400. Confirmed 
melioidosis defined as clinically compatible illness and IHA titer ≥1:160 or IFA >1:400 or culture positive for B. pseudomallei. 
3Numbers of cases and deaths in parenthesis were from participating general and regional hospitals in this study.    
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Table 4-9 Factors associated with in-hospital mortality 
Baseline characteristics 
All cases 
(N=7,126) 
In-hospital 
mortality 
(n=1,742) 
Discharged 
with 
survival 
outcomes 
(n=5384) 
Crude odds ratio 
(95%CI) 
P value 
Gender      
 Female 2287 (32.1%) 577 (33.1%) 1710 (31.8%) 0.94 (0.83-1.05) 0.27 
 Male 4839 (67.9%) 1165 (66.9%) 3674 (68.2%) 
 
 
Age group (years)    
 
 
 <1 to 14 264 (3.7%) 24 (1.4%) 240 (4.5%) 1 <0.001 
 15 to 29 253 (3.6%) 54 (3.1%) 199 (3.7%) 2.70 (1.60-4.55)  
 30 to 45 1263 (17.7%) 309 (17.7%) 954 (17.7%) 3.34 (2.14-5.20)  
 45 to 64 3874 (54.4%) 946 (54.3%) 2928 (54.4%) 3.48 (2.26-5.36)  
 >=65 1466 (20.6%) 409 (23.5%) 1057 (19.6%) 4.03 (2.59-6.26)  
Comorbidities1      
 Diabetes mellitus 3045 (42.7%) 654 (37.5%) 2391 (44.4%) 0.74 (0.66-0.84) <0.001 
 Hypertension 1063 (14.9%) 256 (14.7%) 807 (15.0%) 0.92 (0.78-1.07) 0.28 
 Chronic kidney disease 815 (11.4%) 212 (12.2%) 603 (11.2%) 1.13 (0.95-1.34) 0.17 
 COPD 200 (2.8%) 64 (3.7%) 136 (2.5%) 1.35 (0.99-1.84) 0.06 
 Pulmonary tuberculosis 217 (3.0%) 62 (3.6%) 155 (2.9%) 1.22 (0.90-1.66) 0.20 
 HIV 67 (0.9%) 19 (1.1%) 48 (0.9%) 1.15 (0.67-1.99) 0.61 
 Liver disease 661 (9.3%) 231 (13.3%) 430 (8.0%) 1.75 (1.47-2.08) <0.001 
 Malignancy 196 (2.8%) 42 (2.4%) 154 (2.9%) 0.80 (0.56-1.14) 0.22 
 Thalassaemia 151 (2.1%) 20 (1.1%) 131 (2.4%) 0.46 (0.29-0.75) 0.002 
Clinical manifestations1      
 Bacteraemia2 4910 (68.9%) 1478 (84.8%) 3432 (63.7%) 3.40 (2.93-3.94) <0.001 
 Pneumonia3 2705 (38.0%) 1046 (60.0%) 1659 (30.8%) 3.60 (3.20-4.04) <0.001 
 Liver/splenic abscess1 580 (8.1%) 52 (3.0%) 528 (9.8%) 0.29 (0.22-0.39) <0.001 
 Septic  arthritis1 385 (5.4%) 52 (3.0%) 333 (6.2%) 0.48 (0.35-0.65) <0.001 
 Urinary tract infection4 341 (4.8%) 137 (7.9%) 204 (3.8%) 2.18 (1.73-2.74) <0.001 
 Osteomyelitis1 63 (0.9%) 4 (0.2%) 59 (1.1%) 0.21 (0.07-0.58) 0.003 
Regions      
 Northeast 5475 (76.8%) 1196 (68.7%) 4279 (79.5%) 1 <0.001 
 Central 536 (7.5%) 196 (11.3%) 340 (6.3%) 2.15 (1.55-2.99)  
 East 364 (5.1%) 161 (9.2%) 203 (3.8%) 2.75 (1.84-4.12)  
 North 358 (5.0%) 76 (4.4%) 282 (5.2%) 0.97 (0.64-1.47)  
 South 374 (5.2%) 110 (6.3%) 264 (4.9%) 1.41 (0.99-1.99)  
 West 19 (0.3%) 3 (0.2%) 16 (0.3%) 0.65 (0.16-2.56)  
1 Comorbidities and clinical manifestations identified by using ICD10 diagnostic codes listed in Table 4-1. 2 Blood culture 
positive for B. pseudomallei. 3 Using ICD10 diagnostic codes incorporated with sputum culture positive for B. pseudomallei.  
4 Urine culture positive for B. pseudomallei.  
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Table 4-10 Factors associated with in-hospital mortality by a multivariable logistic 
regression model stratified by hospital 
Baseline characteristics 
Adjusted odds ratio 
(95%CI) 
P value 
Gender (male) 0.82 (0.72-0.93) 0.002 
Age group (years)   
 <1 to 14 1 0.02 
 15 to 29 1.91 (1.09-3.36)  
 30 to 45 2.16 (1.34-3.50)  
 45 to 64 2.06 (1.29-3.30)  
 >=65 2.04 (1.27-3.28)  
Comorbidities1   
 Diabetes mellitus 0.67 (0.59-0.76) <0.001 
 Liver disease 1.48 (1.22-1.79) <0.001 
 Thalassaemia 0.54 (0.32-0.91) 0.02 
Clinical manifestations1  
 Bacteraemia2 3.99 (3.41-4.67) <0.001 
 Pneumonia3 3.71 (3.28-4.20) <0.001 
 Urinary tract infection4 2.35 (1.82-3.04) <0.001 
 Septic arthritis1 0.71 (0.52-0.98) 0.04 
 Liver/splenic abscess1 0.36 (0.26-0.49) <0.001 
 Osteomyelitis1 0.40 (0.14-1.18) 0.10 
Regions   
 Northeast 1 <0.001 
 Central 2.26 (1.56-3.29)  
 East 2.52 (1.60-3.98)  
 North 0.93 (0.58-1.48)  
 South 1.54 (1.04-2.28)  
 West 0.92 (0.21-3.98)  
1Comorbidities and clinical manifestations identified by using ICD10 diagnostic codes listed in Table 4-1. 2Blood culture positive 
for B. pseudomallei. 3Using ICD10 diagnostic codes incorporated with sputum culture positive for B. pseudomallei. 4Urine 
culture positive for B. pseudomallei.  
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4.5 Discussion 
Our findings affirm that melioidosis is endemic and an important cause of death in Thailand. 
B. pseudomallei is commonly identified by clinical microbiology laboratories in most regional or 
general hospitals in Thailand. The 30-day mortality of those culture-confirmed melioidosis cases 
is high at 40%. Our findings show that regional and general hospitals rarely report the cases or 
their outcomes through the Report 506 of MoPH. This all suggests that data from the national 
disease surveillance system in resource limited settings (such as Report 506) should not be used 
alone to derive the burden of diseases and prioritize actions, and that an improvement in the 
reporting of melioidosis cases and their outcomes in Thailand is critically needed. Given the high 
burden of melioidosis observed countrywide, policy makers in Thailand should also raise the 
priority afforded to the disease, and consider implementing a large national campaign to raise 
awareness and implement prevention measures.  
Our study systematically estimated incidence rates of culture-confirmed melioidosis cases in 
all six regions in Thailand. The high incidence rates observed in East, North, Central and South 
Thailand was supported by multiple further sources of evidence presented in the latest review 
conducted by the Thailand Melioidosis Network (Hinjoy et al., 2018). Our observed incidence of 
melioidosis in the East is lower than that estimated by an active population-based surveillance 
study (Bhengsri et al., 2011b); 2.6 vs. 4.9 per 100,000 population per year, respectively. This is 
probably because data from Sa Kaeo province was not available for our study, and that our study 
was based on passive surveillance of cases diagnosed by routine microbiology laboratories, while 
Bhengsri et al’s study implemented active blood culture surveillance during their study period. 
Also the incidence rate of melioidosis in the Northeast estimated in this study is lower than that 
reported in a retrospective study conducted in Ubon Ratchathani; 8.7 vs. 12.7 per 100,000 
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population per year (Limmathurotsakul et al., 2010b). This was probably because our data was the 
average of the 20 provinces in Northeast Thailand, while Ubon Ratchathani is equipped with a 
research centre based in the regional hospital focusing on diagnosis of melioidosis. Therefore, our 
observed incidence rates should be considered as a minimum incidence rate based on by routine 
microbiology reports, and the true incidence rate could be higher.   
Culture confirmed melioidosis cases were not found in eight provinces participating in our 
study; three from the North, two from the West Thailand, and one each from the East, Central and 
South. However, high incidences of culture-confirmed melioidosis cases are observed in their 
bordering provinces. It is possible that B. pseudomallei may be actively misidenitified as 
Pseudomomas species, other Burkholderia species or contaminants in laboratories in those eight 
provinces (Podin et al., 2013). This suggests that microbiological training should be provided to 
the microbiological laboratories, and guidelines for the diagnosis and treatment of melioidosis 
issued to the physicians in those provinces. 
Our study suggests that clinical presentations of melioidosis may differ by region. Bacteraemia 
was the most common clinical presentation (69%), highest in East (72%) and lowest in West 
Thailand (63%). Those percentages are higher than the proportion of bacteraemia observed in 
Ubon Ratchathani (55%) (Limmathurotsakul et al., 2010a) and in Darwin, Australia (55%) (Currie 
et al., 2010) in research centres where selective media is routinely used for all non-sterile 
specimens. Bacteraemia is also associated with routes of infection (Lim et al., 2016, Wiersinga et 
al., 2018); inhalation and digestion routes are associated with pneumonia and bacteraemia, 
respectively. Therefore, the difference of bacteraemia and other clinical presentations including 
pneumonia and urinary tract infection could be due to different characteristics of the baseline 
populations, different risk of exposure due to different occupations based on geographical 
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variations, and different practices of physicians and clinical microbiological laboratories in the 
region. Variations in the patterns of clinical presentations and co-mordibidities identified could 
also be due to different practices of converting the final diagnoses into ICD-10 codes by attending 
physicians in each region. 
The high 30-day mortality and rapid death of melioidosis patients in all regions in Thailand is 
concerning. Our observed 30-day mortality (40%) is comparable with those previously reported 
from a large cohort in Thailand; including 36% in Sa Kaeo, East Thailand, and Nakhon Panom, 
Northeast Thailand  (Bhengsri et al., 2011b) and 43% in Ubon Ratchathani, Northeast Thailand 
(Limmathurotsakul et al., 2010b). This could be because the recommended antimicrobials for acute 
melioidosis, including ceftzidime or meropenem, are widely available in Thailand, and all Thai 
citizens are able to seek health care without charges as they are covered by the universal coverage. 
The possible contributing factors to high mortality in Thailand compared to the lower mortality in 
Australia (14%) (Currie et al., 2010) may include lower levels of supportive care and intensive 
care facilities, differences in the infecting organisms, and relatively delayed diagnosis and 
administration of effective antibiotics.  
The mortality of melioidosis is severely underreported by the national surveillance system 
(Report 506). There are a few explanations of the low number of fatal melioidosis cases reported 
via the Report 506 system. First, the general definition of melioidosis used in the Report 506 
system, in which melioidosis could be diagnosed in patients who have relevant clinical symptoms 
and IHA titer ≥1:160. More than sixty percent of melioidosis cases were reported from PCUs or 
district hospitals which do not have a microbiology laboratory to confirm the diagnosis of 
melioidosis. Therefore, most melioidosis cases reported to the Report 506 system probably are 
misdiagnosed cases by IHA. Second, there is a failure in general and regional hospitals to report 
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cases and the final outcomes of culture-confirmed melioidosis cases. Laboratory isolation and 
identification of B. pseudomallei can take up to 7 days; 40% of culture-confirmed cases die within 
3 days of admission or could be discharged, in both cases prior to the final diagnosis making it 
into the medical records. A proportion of cases may have been properly diagnosed while the 
patients are still in hospitals. However, healthcare workers may not report the cases, or report the 
case but not confirm and report the final outcome to the BOE, MoPH, Thailand (Hinjoy et al., 
2018). 
The limitations of this study are that private hospitals, specialized hospitals such as military 
hospitals and psychiatric hospitals, hospitals in Bangkok, and university hospitals were not 
included in the study. It is possible that participating hospitals may still misidentify a proportion 
of the B. pseudomallei isolates, and selective media for B. pseudomallei is not used for non-sterile 
clinical specimens such as sputum. Data of National Death Registry in 2013-2015 was not 
available. Hence, incidence of and deaths from melioidosis in this study are likely to be only a 
proportion of the true burden.  
To date, this study is the largest population-based study carried out in Thailand. The study 
emphasizes that melioidosis is an important cause of death throughout Thailand. With high 
incidence rates and high 30-day mortality, the disease poses a great health burden to people and 
health care providers in the country. This study also demonstrates that data from national notifiable 
disease-surveillance systems in resource-limited settings may need to be verified and 
supplemented retrospectively by integrating information from readily available databases. 
Potential improvements to the national notifiable disease-surveillance data on melioidosis are 
being devised and reported to policy makers. 
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Chapter 5: General discussion and conclusions 
This thesis describes studies performed between 2013-2017 on three important topics: (1) 
distribution of environmental B. pseudomallei and its associated environmental factors in 
Thailand; (2) association between IHA positivity and exposure to B. pseudomallei and B. 
thailandensis in healthy people; and (3) the distribution and burden of human melioidosis in 
Thailand.  
The environmental survey in East, Central and Northeast Thailand defines the risk areas of 
melioidosis in all three regions. B. pseudomallei is widely spread in the East and Northeast, and 
unevenly distributed in Central Thailand. The study also demonstrates that the pathogen is more 
commonly found in soil with lower levels of organic matter and nutrients, suggesting that 
agriculture practices resulting in decline in soil nutrients may impact the presence and amount of 
B. pseudomallei in affected areas. The study is also the first to report the presence of a variant of 
B. thailandensis expressing B. pseudomallei-like capsular polysaccharide (BTCV) in the 
environment in Thailand. The study on serological response against B. pseudomallei in healthy 
rice farmers shows that IHA seropositivity of the farmers in Thailand is associated with presence 
of B. pseudomallei rather than presence of B. thailandensis or BTCV. This supports the utility of 
IHA in evaluating exposure to B. pseudomallei, and suggest that exposure to B. thailandensis and 
BTCV in the environment is not the main factor associated with the IHA seropositivity in healthy 
individuals.  
The extensive descriptive retrospective study affirms the high burden of melioidosis in 
Thailand and highlights the fact that melioidosis is diagnosed regularly in large hospitals with 
microbiology facilities not only in the whole northeast Thailand, but also in Central, East and 
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South Thailand. Furthermore, the study also describes limitations in the national surveillance 
system of Thailand (Report 506) and provides suggested strategies to improve the surveillance of 
melioidosis in Thailand.  
This chapter discusses key findings of this thesis and elaborates on possible future directions 
for research.  
5.1 Distribution of environmental B. pseudomallei and risk of melioidosis 
The overall prevalence of environmental B. pseudomallei in rice fields in the East, Central and 
Northeast are higher than the hypothesized prevalence. Our findings provide the geographical 
setting for preventive measures as well as raising awareness of this disease among healthcare 
workers in affected areas. Our data shows a high prevalence of environmental B. pseudomallei in 
six provinces in the East (57%), suggesting a high risk of infection to people who are living in this 
region (Chapter 2). Our results in Chapter 4 confirm this suggestion as culture confirmed 
melioidosis was commonly found in almost every province in East Thailand. We conclude that 
East Thailand is another highly endemic region for melioidosis in Thailand. In contrast to the East, 
in the Central region B. pseudomallei was isolated from three of seven provinces, and the positivity 
rate was significantly lower than in the East and Northeast (Chapter 2). We also found that those 
three provinces (Phitsanulok, Phetchabun, and Nakhon Nayok) with presence of B. pseudomallei 
in the soil had a high incidence of melioidosis in 2012-2015 (Chapter 4). However, three provinces 
in which the soil samples were culture negative for the organism (Lopburi, Saraburi, and Pathum 
Thani) also had high incidence of melioidosis. Similar discrepancies between findings from the 
soil survey and the hospital data study are observed in two provinces in the Northeast (Loei and 
Chaiyaphum). This may be because our sample size for the environmental study was calculated 
specifically for determining associated factors with presence of the organism; hence, the sample 
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size was not large enough for defining a risk map in all provinces included in the study. Another 
explanation is that the bacterial load of B. pseudomallei in negative rice fields in Central Thailand 
might be lower than the bacterial culture detection limit. In order to define a risk map of 
melioidosis, sample size calculations should correspond with the aims of defining a risk map and 
should proportionally correspond to size of geographical areas of the study. In addition, the wide 
distribution of B. thailandensis and BTCV in the environment (Chapter 2) could make 
differentiation of B. pseudomallei from B. thailandensis and BTCV in environmental samples 
difficult. BTCV possess B. pseudomallei-like CPS, hence using identification methods which are 
specific for CPS alone may give false positives for B. pseudomallei. To ensure accurate 
identification, biochemistry profile for arabinose assimilation or other methods such as PCR assay 
or MALDI-TOF should be used in combination.  
Movement of humans and animals within the country is common (Limmathurotsakul et al., 
2012a). Previously it was unclear whether melioidosis cases found in what were previously 
considered non-endemic regions (such as Central, East, North, South and West Thailand) were 
imported from the northeast or originated in the regions. Our enviromental findings suggested that 
a proportion of human and animal melioidosis observed in both Central and East Thailand were 
locally infected cases.  
Further defining the distribution of environmental B. pseudomallei is important for the 
development of a risk map for melioidosis, since this will inform the geographical areas that will 
benefit from preventive measures, as well as raising awareness of this disease among healthcare 
workers in affected areas. We observed culture-confirmed meliodosis in all provinces in Central, 
North, South, and West Thailand (Chapter 4), where there is still limited information on the 
presence of environmental B. pseudomallei. More environmental sampling studies are indicated to 
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define the risk areas. We also recommend that public health officials should conduct soil or water 
surveys alongside their case surveillance investigations. This will help expand the risk map 
gradually and efficiently over time, and result in better diagnosis, treatment, prevention and control 
of melioidosis in the country. 
5.2 Factors associated with presence of B. pseudomallei 
Conducting an environmental survey and evaluating soil characteristics simultaneously in this 
study expands our understanding of factors associated with the presence of B. pseudomallei in rice 
fields and explains the presence or absence of B. pseudomallei in different regions outside of 
Northeast Thailand. This is important because previous published findings on factors associated 
with the presence of the organism in the natural setting are not consistent.  
The presence of B. pseudomallei is associated with nutrient-depleted soil in rice fields in 
Thailand (Chapter 2). Because nutrient levels in the soil are largely affected and effected by 
agricultural practices, this finding implies that agricultural practice may also affect the burden of 
B. pseudomallei in the soil. Further investigations are required to evaluate whether changes in 
agricultural practices could effectively enhance soil nutrients, and whether these could reduce the 
distribution of B. pseudomallei in rice fields.  
Soil organic matter was negatively associated with the presence of B. pseudomallei, and that 
is consistent with two previous environmental studies in Northern Australia (Baker et al., 2015) 
and Northeast Thailand (Ngamsang et al., 2015). Organic matter contains vital nutrients and 
influences the diversity and biological activity of soil organisms (FAO, 2005). It could be 
speculated that soil physicochemical properties may reflect another causal determinant, which is 
competition among soil microorganisms. This is supported by an environmental study showing 
that low microbial density in soil is associated with the presence of B. pseudomallei (Sermswan et 
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al., 2015, Potisap et al., 2018) and that Bacillus amyloliquefaciens extracted from soil samples can 
inhibit the growth of B. pseudomallei (Potisap et al., 2018).  
We propose that evaluating the diversity of soil microorganisms and soil physicochemical 
properties simultaneously in other regions and worldwide will further expand our understanding 
of factors associated with presence of B. pseudomallei. Conducting longitudinal soil sampling 
studies in a natural experiment would also inform causal relationship between soil characteristics 
and the presence of the organism. 
In addition, co-localization of B. thailandensis and B. pseudomallei in the same rice field is 
not uncommon (Chapter 3), which is in line with a previous environmental study in Khon Kaen, 
northeast Thailand (Sermswan et al., 2015). This finding differs from previous studies that report 
that B. pseudomallei inhibited growth of B. thailandensis. Any inhibitory effect of B. pseudomallei 
on B. thailandensis may influence a lower prevalence of co-localization between the two species. 
However, both species could be isolated from the same soil samples in this study. This could be 
because the two species rarely have direct contact in the real soil environment. Our finding also 
suggests that the presence of B. thailandensis may not be associated with either the presence or 
absence of B. pseudomallei in the environment.    
5.3 Presence of B. thailandensis and its implications for seropositivity in 
humans who are exposed to the organism in environment 
B. thailandensis is commonly isolated in all three regions (Northeast, East and Central 
Thailand), while BTCV is less common but associated with B. thailandensis (Chapter 3). Our 
results suggest that exposure to environmental B. thailandensis and BTCV makes a limited 
contribution to IHA seropositivity in farmers. This supports the recommendation that IHA could 
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be used to measure exposure to environmental B. pseudomallei (Hoffmaster et al., 2015), even in 
areas containing other closely related Burkholderia species.  
Our study is the first report of BTCV in Thailand, and a high prevalence of BTCV is observed 
in East Thailand. In a mouse model, inoculation of BTCV produced protective immunity to 
melioidosis and may be a candidate for an attenuated vaccine for melioidosis (Scott et al., 2013). 
Whether live BTCV has a potential to be a vaccine for melioidosis either in humans or animals 
should be investigated in future. Nonetheless, our study suggests that routine exposure to BTCV 
in the environment may have only limited impact on the increase in the crude seroresponse against 
B. pseudomallei. 
5.4 Burden of human melioidosis in Thailand 
Our findings define the distribution of cultured-confirmed melioidosis nationwide, and 
confirms that melioidosis poses a great threat to public health (Chapter 4). With the evidence 
derived from Chapter 2 (presence of B. pseudomallei) to Chapter 4, this supports an expansion of 
areas considered endemic for melioidosis from the Northeast to the whole country, including 
North, East, Central, West and South Thailand. Our data did not find culture-confirmed 
melioidosis in eight provinces; however, this finding did not indicate the absence of risk for 
melioidosis in those provinces. This is because a number of culture-confirmed melioidosis cases 
were observed in adjacent provinces. The absence of melioidosis cases in these eight provinces 
likely indicates misdiagnosis of melioidosis and misidentification of B. pseudomallei in the 
hospitals due to lack of awareness of the disease and of experience in identification of the organism 
amongst physicians and laboratory staff. 
Diabetes mellitus and older age are the main predisposing factors observed in patients from all 
regions. Changes in the age profile of the population in Thailand toward an aging society and 
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increase in the incidence of diabetes mellitus are expanding the size of the population susceptible 
to B. pseudomallei infection. This suggests that the true incidence of melioidosis may increase in 
Thailand in the future. Improving the awareness of melioidosis in the whole population throughout 
the country would be the fastest and most cost-effective disease prevention and control strategy. 
In addition, the availability of new effective antimicrobials and vaccines are not foreseen in the 
near future. The problem of the high 30-day mortality of about 40% in Thailand has not been 
resolved. This high mortality has been observed for more than 30 years, largely unchanging since 
the change of parenteral antibiotic to ceftazidime influenced by landmark clinical trial in 1989 
which reduced the mortality from about 80% to 40%. Our findings suggests the necessity of 
increasing awareness and strengthening capacity in the diagnosis, treatment and prevention of 
melioidosis nationwide. These could all in themselves lead to an improvement in disease 
outcomes. The defined distribution of human melioidosis derived from our surveillance study 
could be used to prioritize resource allocations for training programs for both clinicians and 
laboratory staff. 
The rapid mortality of melioidosis countrywide, including in the Northeast Thailand where 
awareness of disease is high, may be attributed to a few factors. Although our data were from 
hospitals equipped with microbiology facilities, delay in diagnosis or in providing effective 
treatment could not be ruled out. Communication among attending physicians, collecting adequate 
and a wide range of clinical specimens, and reporting the culture results in a timely fashion are 
still problems observed in many large hospitals countrywide. The other possible contributing factor 
includes a delay in seeking medical care. Patients who present to hospital with fulminant disease 
often have high mortality despite rapid effective treatment.  
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Underreporting cases of notifiable diseases is a common pitfall of passive disease surveillance 
worldwide. This is because reporting cases is an additional burden to the current already 
overloaded health care system. Likewise, reporting melioidosis in Thailand requires hospital staff 
to complete separate Report 506 forms, and submit these to the surveillance system. Thus, the 
incidence of melioidosis reported by the surveillance system depends on the rate of completion of 
Report 506 forms. Form completion rates could vary widely amongst hospitals and regions. For 
example, the hospital that has a dedicated surveillance team is likely to report more cases than 
hospitals that do not have resources for reporting.  
Based on our findings, several recommendations could be made to improve surveillance of 
melioidosis more effectively. First, the national notifiable disease surveillance system and policy 
makers should utilize all laboratory and hospital data from all hospitals in the country when 
determining the incidence and mortality of culture-confirmed melioidiosis and other notifiable 
diseases, as we have performed in this study. They should retrospectively verify and supplement 
the data of the national notifiable disease-surveillance system with the observed laboratory-
confirmed cases. Second, we propose that the case definition of melioidosis for reporting to 
surveillance system  be changed to culture-confirmed melioidosis only. This will increase 
specificity of reported cases and reduce the resources required for reporting at every level. The 
accurate number of culture-confirmed cases and their mortality outcomes would be more helpful 
than cases innacurately misdiagnosed as melioidosis based on serological assays. Third, policy 
makers should initiate the development of standard operating procedures for B. pseudoamllei 
identification (for microbiological laboratories) and guidelines for diagnosis, treatment and 
prevention (for healthcare workers). In addition, policy makers should provide regular formal 
training to microbiology laboratories and healthcare workers nationwide. Lastly, policy makers 
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need to raise awareness of melioidosis by disseminating to both the public and and to healthcare 
workers key information about meliodosis such as its clinical manifestations, diagnosis (including 
identification of B. pseudomallei), and prevention. Appendix 2 is an example of an initiative to 
raise awareness of melioidosis among the public  and health care workers in Thailand. The 
pamphlet contains information on melioidosis, and was developed and published in July 2018 
under a collaboration between Department of Disease Control, BOE, MoPH and Mahidol-Oxford 
Tropical Medicine Research Unit, Mahidol University, Thailand. This pamphlet will be distributed 
to hospitals nationwide in Thailand by BOE, MoPH, Thailand.  
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Appendices 
Appendix 1. Interviewee-based questionaire to collect information of farmers' 
demographics, sampled rice field and agricultural practice 
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Appendix 2. A brochure for public about melioidosis developed and 
distributed by Bureau of Epidemiology, Ministry of Public Health, Thailand 
(in Thai) 
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